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Survivors of critical illness experience a significant burden of persisting physical,
psychological and cognitive dysfunction during recovery as a result of the interaction
between factors relating to the ICU environment, the invasive treatments required
and the pre-morbid health of the patient. Little is known about the long term
complications of critical illness and the impact they have on recovery. Physical
morbidity is common due to generalised muscle atrophy and weakness due to the
catabolic state and immobility associated with critical illness. There is a high
prevalence of anaemia in critically ill patients due to iatrogenic blood loss and the
inflammatory state impairing erythrogenesis but little is known about its persistence
and effects on physical recovery. The studies presented in this thesis aimed to
evaluate the prevalence of anaemia and physical morbidity in survivors of critical
illness and to explore the potential contribution of anaemia to impaired physical
function and poor quality of life during recovery.
The TRAC study was a single centre, prospective, observational cohort study aimed
to determine the prevalence and pathophysiology of anaemia following critical
illness. Indices of erythropoiesis, inflammation and health related quality of life were
measured over 6 months and showed that anaemia persists up to 6 months and was
associated with evidence of an ongoing inflammatory state and impairment of
erythropoiesis. Health related quality of life was also noted to be impaired raising the
possibility that anaemia may affect quality of life following critical illness.
i
The Ps and Qs study was a two centre, prospective observational study aimed to
investigate actual and perceived physical function during recovery from critical
illness and the associated impact upon health related quality of life. Simple measures
of psychological state and organ function were also recorded. The study showed that
survivors of critical illness had a normal pre-morbid perceived physical function but
a reduced quality of life. Both were significantly worsened by the critical illness and
remained impaired up to 6 months. Actual physical function in our heterogeneous
population was reduced to levels associated with very severe chronic disease. There
was evidence of a significant level ofpost traumatic stress disorder, persisting
anaemia and malnutrition but no other organ dysfunction during recovery.
Further analysis of the Ps and Qs data was performed to investigate potential links
between anaemia, physical function and quality of life. Perceived physical function,
actual physical function and quality of life were all impaired in the presence of
anaemia. Additionally, anaemia was associated with a longer ICU stay and increased
age but not with severity of illness or the degree of organ failure developed during
ICU stay. The persistence of anaemia was also associated with malnutrition and
inflammation.
In conclusion these studies show that physical function and health related quality of
life are dramatically affected by critical illness. There is a high prevalence of
anaemia in survivors of critical illness, which is associated with ongoing
inflammation and impaired erythropoiesis. Importantly, the data also show that
quality of life and physical recovery are further impaired in the presence of anaemia.
Further studies are required to evaluate the effects of anaemia on physical recovery
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1.1 What is critical illness?
Critically ill patients have an acute physiological insult of life threatening severity and
high short term mortality. Without the timely provision of aggressive physiological
support to the failing organs it is almost certain that the patient would die. The primary
aim of an intensive care unit is therefore "to prevent unnecessary suffering and
premature death by intensive treatment of a reversible illnesses for an appropriate period
of time" (Gibney 2001).
The demand for intensive care is increasing with more than 100,000 patients admitted to
UK critical care units per year. This is due to increased sophistication in intensive care
support, surgical techniques and medical interventions which allow life to be prolonged
in circumstances which were not previously possible. There are also increased societal
(and to some degree medical) expectations ofwhat can be achieved in critical care from
a positive depiction ofmedical technology in the media. Patients previously considered
too sick to benefit from intensive care are being referred for assessment and admitted.
Whilst intensive care can lead to improved clinical outcomes (Rivers, Nguyen et al.
2001; Simchen, Sprung et al. 2007) it can also prolong death. Critical care physicians
must balance the prudent use of resources and equity of access against the finite capacity
for the provision of critical care. As delaying and withholding therapy is associated with
a high mortality (Kumar, Roberts et al. 2006; Chalfin, Trzeciak et al. 2007) it is
important that intensive care beds are available for those who will benefit the most
rather than being used for ultimately futile causes.
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Critical care research has understandably focused on short term changes in physiological
parameters and survival to ICU and hospital discharge. However it has become
increasingly apparent with improved short term mortality from critical illness, with 75%
ofpatients now surviving to be discharged home, many patients experience significant
and persistent problems with physical and psychological functioning after discharge.
The focus of research is therefore changing to include investigation of the potential
causes of long term morbidity and impaired quality of life. It is hoped that not only will
this lead to improvement in patient centred outcomes but also help infonn the discussion
on admission to intensive care so that prolonged treatment in patients who will
ultimately not have meaningful survival can be avoided.
1.2 The treatment of critical illness and its potential
complications
Critical illness is not just the time spent on ICU. It begins with the onset of acute
deterioration and ends when the patient's risk of late sequelae, such as ongoing
mortality, has returned to the baseline risk of a similar patient who had not incurred the
acute critical illness (Angus and Carlet 2003). Several studies have suggested that ICU
admission has minimal effect on long term outcome when the effects of hospital
admission are controlled for (Keenan, Dodek et al. 2002; Keenan 2003), however in
many cases the increased risk of death and morbidity remains and may never return to
the levels of the normal population (Niskanen, Kari et al. 1996; Wright, Plenderleith et
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al. 2003). The development of critical illness can occur in any individual and result in
being admitted to intensive care for a wide variety of reasons.
The ICU population is therefore a complex heterogeneous population with intensive care
treatment being a complex, individualised intervention. A complex intervention was
defined by the Medical Research Council (MRC) as an intervention comprising a
number of separate elements which seem essential to the proper functioning of the
intervention even though the 'active ingredient' of the intervention is difficult to specify
(MRC 2000). Thus analysing the effect of 'ICU admission' involves delineating the
components of critical illness and the interventions provided in intensive care units and
determining how they inter-relate to the final patient centred outcome. The burden of
critical illness can be described as a continuum beginning with the development of the
critical illness and continuing into the long term recovery (Figure 1.1). Using this model
it is possible to consider some possible patient and process of care factors which have
the potential to influence subsequent long term outcome (Figure 1.2).
Pre-ICU factors would include:
• Underlying illness - malignancy related compared to acute infection
• Reason for ICU admission - respiratory failure compared to trauma
• Pre-ICU management - resuscitation, antibiotic timing
• Access to ICU - bed availability
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Figure 1.1The burden of critical illness
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Intra-ICU factors would include:
• Patient course and events - organ dysfunction, sepsis, tracheostomy, ability to
wean
• Treatments - monitoring, sedation, feeding, transfusion practice
• Organizational - staffing patterns, protocol use
• Iatrogenesis and environmental - hospital acquired infection, noise pollution
(adaptedfrom (Angus and Carlet 2003))
Post ICU factors would include:
• Social status and financial security
• Personal support networks
• Access to rehabilitation services
• Ongoing organ dysfunction e.g. renal failure requiring dialysis, persisting sepsis
• Ongoing morbidity from complications of ICU, e.g. delirium and cognitive
impairment, pain, malnutrition
The general perception among patients, families and healthcare professionals that
patients undergo a rapid convalescence and recover to their previous life is unfounded.
Many patients experience significant and persistent problems with physical, non-
physical and social functioning after discharge from critical care (Broomhead and Brett
2002). These problems are frequently unrecognised. The importance of trying to screen
for and detect potential patient problems and to prevent the development of
complications is now recognised as being of prime importance in ICU practice and
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research. The 2002 European Society of Intensive Care 'Round Table' consensus
statement (Angus and Carlet 2003)and the National Institute for Clinical Excellence
(NICE) guideline 2009 on rehabilitation from critical care (Tan, Brett et al. 2009) have
reinforced the need to address post ICU morbidity by delineating those complications
that are due to pre morbid patient factors, those due to the underlying illness and those
due to intra-ICU events. To this end a brief review of the impact of specific organ
failures and common complications of ICU treatment on post ICU mortality and
morbidity is detailed below together with a full literature review on anaemia, a common
complication of critical illness.
1.3 The impact of respiratory failure and the development of
Acute Respiratory Distress Syndrome
The heterogeneity of the ICU population and the complications they develop as a
consequence of critical illness makes it difficult to describe the population in which the
patient centred problems may develop. Acute respiratory failure is the most common
organ failure in a general intensive care unit (Walsh 2003). Patients who develop Acute
Respiratory Distress Syndrome (ARDS) represent one of the best studied post critical
illness populations, as the entity ofARDS has a specific definition and as a population
with a single severe organ failure (respiratory failure), it is possible for the population to
be characterised. It is also relevant to the whole ICU population as ARDS is common
and has the potential to develop in any patient with critical illness. Furthermore, its
effects are relatively independent of the precipitating 'critical illness event' and these
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effects persist after the initial critical illness has resolved which allows extrapolation of
some of the factors affecting the ARDS population into the general ICU population as
part of a 'post ICU' syndrome.
Severe respiratory failure has approximately a 14% - 17% (Pettila, Pettila et al. 2002) in
hospital and 22% 3 month mortality. It is often followed by failure in other organs and
death more commonly occurs because ofmulti organ failure with isolated irreversible
respiratory failure only accounting for 3-10% of deaths in ICU (Flaatten, Gjerde et al.
2003) (Estenssoro, Dubin et al. 2002). When severe respiratory failure is accompanied
by other organ failure, the ICU mortality increases to 11 % with one other organ failure,
and up to 70% with 3 additional organ failures (Flaatten, Gjerde et al. 2003).
The Acute Respiratory Distress Syndrome (ARDS) was originally described in 1967 in
12 patients with acute respiratory distress, cyanosis refractory to oxygen therapy,
decreased lung compliance and diffuse infiltrates on the chest radiograph (Ashbaugh,
Bigelow et al. 1967). This definition has been reviewed overtime and in 1994 a
consensus definition which included acute onset, bilateral infiltrates on chest radiograph,
pulmonary artery wedge pressure (PAWP) <18mmHg and a Pa02:FiC>2 ratio < 200. The
underlying pathophysiology of diffuse alveolar damage from disruption of the alveolar-
capillary barrier resulting in the bidirectional leak of fluid, proteins and inflammatory
mediators and the disruption of normal surfactant production and action, is complex and
dependent on many host and precipitating insult factors. The syndrome can progress to a
form of fibrosing alveolitis in the longer term. Clinical risk factors for developing ARDS
include direct factors such as pneumonia, aspiration of gastric contents and lung
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contusion, and indirect factors such as non-pulmonary sepsis, massive transfusion,
pancreatitis and poly-trauma (Bersten, Edibam et al. 2002). The incidence ofARDS is
between 28-59 per 100,000 people and is thought to be increasing, possibly due to ICU
factors such as aggressive fluid administration (Bersten, Edibam et al. 2002; Rubenfeld
and Herridge 2007). Controversially, the mortality from ARDS is difficult to define. A
recent review suggests that mortality has not improved since the North American
European Consensus Conference (NECC) statement in 1994, remaining around 40%
(Phua, Badia et al. 2009). Other studies suggest that a mortality rate of 30% is more
likely (Wheeler and Bernard 2007). This is despite changes in intra-ICU practice aimed
at reducing not only the development ofARDS but also the complications associated
with it.
In the longer term survivors ofARDS have significant long term physical and
neuropsychological consequences which are attributable to ARDS itself not just critical
illness (Davidson, Caldwell et al. 1999). Survivors of ARDS have persistent functional
disability at 1 year and even in the longer term following discharge from ICU. The
pulmonary function of these patients has generally returned to normal by 6 months
(Rubenfeld and Herridge 2007). The major sequelae are related to neuromuscular,
cognitive and psychological dysfunction. They lose up to 20% of their baseline body
weight and describe muscle weakness and fatigue as the main reasons for their
functional limitation (Herridge 2002). The objective measures of physical limitation
such as distance walked were all reduced even at 12 months (Herridge, Cheung et al.
2003). As well as loss of muscle mass the development of critical illness neuropathy,
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entrapment neuropathies and heterotopic ossification appear to contribute to the physical
morbidity.
The psychological impact in survivors ofARDS is large. At discharge from hospital
100% ofpatients show signs of cognitive impairment with 30% still having significant
deficits at 1 year (Hopkins, Weaver et al. 1999). The prevalence of clinically significant
depressive symptoms was described as 17-43% at ICU discharge with a 21-35%
prevalence of psychiatrist diagnosed post traumatic stress disorder (PTSD) which falls to
25% prevalence at 5 years post ICU discharge. These symptoms all had a negative effect
on the patient's quality of life (Schelling, Stoll et al. 1998) (Davydow, Desai et al. 2008)
and ability to return to work (Rothenhausler, Ehrentraut et al. 2001).
In summary the long term impact of respiratory failure is complex and multifactorial. It
is principally related to extrapulmonary factors. As short term survival from respiratory
failure is improving it is likely that we will see increasing numbers ofpatients with the
long term effects of severe respiratory failure.
1.4 The impact of sepsis
Sepsis is the leading cause of death in critically ill patients with mortality ranging from
28% to 80% depending upon severity, number of subsequent organ failures, age and co¬
morbidities of the study population (Angus, Linde-Zwirble et al. 2001). There is a
persistent increased risk of dying in survivors of sepsis compared to other critical illness
survivors, for up to 5 years (Quartin, Schein et al. 1997; Keenan 2003). Survivors of
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sepsis have residual organ dysfunction which causes symptoms of dyspnoea, fatigue and
impaired function and a reduced quality of life which is similar to that of other survivors
of critical illness (Granja, Dias et al. 2004; Yende and Angus 2007).
1.5 The impact of neuromuscular failure
Survivors of critical illness have a significant burden of neuromuscular related morbidity
(Young 1995). The neurological complications of critical illness involve the central and
peripheral nervous system and so the specific effects of neurocognitive impairment,
neuromuscular impairment, delirium and traumatic brain injury are discussed below.
1.5.1 Neurocognitive impairment
The preservation of neurocognitive function is highly prized among the general
population and in survivors of critical illness. 89% of Americans would not wish to
survive if they had severe irreversible neurological damage (Fried, Bradley et al. 2002).
Neurological dysfunction is common during critical illness (Jones, Griffiths et al. 2006)
and is associated with increased mortality (Vincent, Moreno et al. 1996; Russell, Singer
et al. 2000). Studies assessing long term neurological outcomes in the critically ill found
that the prevalence of long term neurocognitive dysfunction ranges from 25% to 78%
(Hopkins and Jackson 2006). The defects described include impairments in memory,
attention, executive function and psychiatric disturbance. There is not a uniform cause of
post ICU neurological impairment. It is not associated with factors associated with the
severity of illness such as APACHE scores, duration of ICU stay, ventilation and
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duration of sedatives. Potential causes which may interact to produce the dysfunction
include hypoxaemia, use of sedatives and analgesics, hypotension, delirium and
metabolic derangement reflecting the two most biologically plausible mechanisms of
neurotransmitter abnormalities (dopamine excess secondary to anticholinergic side
effects of common medications) and occult diffuse brain injury. Patient factors such as
pre-morbid neuro-psychiatric dysfunction and genetic factors are also important
(Milbrandt and Angus 2005). Surprisingly, age alone is not associated with
neurocognitive dysfunction in its own right, but many of studies excluded patients with
pre-existing neurocognitive dysfunction. Ofpotential relevance, the prevalence of pre¬
existing dysfunction in elderly ICU patients has been estimated at 35% (Pisani, Redlich
et al. 2003).
Cognitive impairments are rarely recognised or evaluated in survivors of critical illness
(Jackson, Hart et al. 2003), but have potentially huge impact upon individuals. In
patients with ARDS and neurocognitive defects roughly a third returned to work or
study, a third were on new disability support as they were unable to return to work and a
third were not working or had retired (Hopkins, Weaver et al. 2005). This has huge
socio-economic implications for health and social care provision.
1.5.2 Neuromuscular impairment
Physical impairments following critical illness such as heterotopic ossification,
entrapment neuropathy, critical illness neuropathy (CIN) and myopathy (CIM) also
impair function and quality of life. CIN and CIM can have particularly profound effects
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on patients. The absence of a motor response is often interpreted as a grave prognostic
sign leading to undue pessimism and limitation of treatment in many patients. It
increases the requirement for invasive ventilation (Garnacho-Montero, Amaya-Villar et
al. 2005) and doubles the length of time ofweaning (De Jonghe, Bastuji-Garin et al.
2004). The mortality of patients who develop CIN or CIM is increased, ICU mortality
was 48% compared to 19% (in those without CIN/CIM) in one study (Leijten, Harinck-
de Weerd et al. 1995). In the longer term CIN was often associated with persistent
disability whilst myopathy tended to be associated with a rapid and complete recovery.
Long term data is lacking but 70% ofpatients have been described as making good
functional recovery (spontaneous breathing and independent walking) and 30%
remaining severely disabled (Latronico 2003). The disabilities described were mainly
profound muscle weakness and dyspnoea secondary to respiratory muscle weakness
(Fletcher, Kennedy et al. 2003).
Risk factors for the development of neuromuscular weakness include the severity of
illness, specific pharmacological agents especially neuromuscular blocking agents, poor
glycaemic control and a persistent inflammatory state. Neuromuscular blocking agents
and aminoglycosides alter neuromuscular transmission causing pharmacological muscle
denervation, and their use should be restricted to cases where the risks of these agents is
outweighed by the potential benefits (Murray, Cowen et al. 2002). Other drugs such as
propofol and corticosteroids may cause damage in response to the priming effect of
critical illness especially when there is a marked systemic inflammatory response.
Propofol may cause the 'propofol infusion syndrome' characterised by severe metabolic
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acidosis, rhabdomyolysis and neuromuscular weakness due to the uncoupling of
oxidative phosphorylation and direct muscle damage. Corticosteroids have long been
recognised as a cause ofmuscle damage but it has only been recently that their use has
been demonstrated as an independent risk factor for critical illness neuropathy and
myopathy (De Jonghe, Sharshar et al. 2002). Poor glycaemic control and severe
electrolyte abnormailites are also considered risk factors for developing neuromuscular
weakness (Hermans, Wilmer et al. 2007).
Prevention and treatment of these complications through changes in sedation, glycaemic
control, the use of neuromuscular blocking agents and steroids is being investigated,
with the focus of improved ICU care being to reduce the incidence of these
complications.
1.5.3 Delirium
Delirium is an acute central nervous dysfunction resulting from a number of common
insults experienced by the critically ill. It occurs in 60-80% of patients in ICU and is
often not recognised and is considered one of the six leading causes of preventable
injury in the elderly (Rothschild, Bates et al. 2000). The development of delirium in ICU
is associated with significant morbidity (delirium is an independent predictor of nursing
home placement and subsequent development of dementia) and higher mortality (Ely,
Shintani et al. 2004). It persists in 11% of patients at hospital discharge. Strategies aimed
at reducing the development of delirium such as choice of sedative drug (Pandharipande,
Pun et al. 2007; Riker, Shehabi et al. 2009), combined with strategies aimed at reducing
the impact of the development of delirium such as the daily interruption of sedation and
15
a multidisciplinary approach to the detection and subsequent treatment of delirium
(Kress, Pohlman et al. 2000; Lat, McMillian et al. 2009) are having marked effects on
this outcome. As such the Society of Critical Care Medicine has now recommended
delirium assessment as a standard of care in intensive care units.
1.5.4 Head Injury
Differentiation between pre-morbid neurocognitive deficits, the impact of trauma and
the effects of critical illness in this population is difficult. Traumatic brain injury tends to
produce focal rather than diffuse changes in the brain leading to characteristic patterns of
dysfunction distinct from critical illness. Frontal and temporal lobes are most commonly
affected leading to impaired memory, attention and executive function (van 2005). The
more severe the brain injury the more severe the subsequent impairment (Demery,
Pedraza et al. 2002). It tends to recover over time particularly in cases ofmild to
moderate injury (Belanger, Curtiss et al. 2005). Thus traumatic brain injury and critical
illness is associated with poor outcome, but head injury patients represent a distinct
group of survivors from critical illness alone as it is the head injury itself which has the
overwhelming impact on subsequent recovery. There is undoubtedly overlap between
the two groups and much can be learned from each group to help improve the other.
Certainly head injury outcomes are improved by the provision of specialist critical care
(Suarez 2006).
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1.6 Impact of Post Traumatic Stress Disorder and
psychological dysfunction
Critical illness and its treatments expose patients to extreme physiological and
psychological stressors such as pain, severe dyspnoea and administration of exogenous
catecholamines and sedatives, whilst the patient is in a state of altered consciousness,
helplessness and with an impaired ability to communicate. Post Traumatic Stress
Disorder (PTSD) is a complex disorder with high rates of psychiatric co-morbidity
(including the development of harmful coping strategies such as alcohol and drug
addiction) which occurs in 5-64% of the ICU population (Kessler 2000; Griffiths,
Fortune et al. 2007). The prevalence of clinically significant symptoms is 22% and
actually clinically diagnosed PTSD 19% (Cuthbertson, Hull et al. 2004). Risk factors for
developing PTSD included degree of exposure to benzodiazepines, physical restraint,
duration ofmechanical ventilation and non daily interruption of sedation (Davydow,
Desai et al. 2008), although the risk is not always related to the severity of illness. The
development of PTSD in survivors of critical illness significantly impairs quality of life
(Girard, Shintani et al. 2007; Sukantarat and Williamson 2007).
Clinically significant depression is present in 28% of patients after ICU admission
(Davydow, Gifford et al. 2009) and is associated with an impaired quality of life. The
development of depression is not associated with ICU related factors but is strongly
influenced by psychological and physical impairments to recovery. It appears that the
initial elation at having survived is replaced by frustration and anger during the
17
protracted recovery process. Severe anxiety symptoms producing avoidant behaviour are
seen in 50-70% ofpatients and are more common, and more persistent, in those who
have impaired recollection of ICU stay (Scragg, Jones et al. 2001).. Sexual dysfunction
is common and has been reported in 25% ofpatients. Reasons for dysfunction included
lack of desire, impotence, dyspnoea, surgical disfigurement and fear of precipitating a
'relapse' (Griffiths, Waldmann et al. 2007).
1.7 Impact of liver failure
The prognosis of patients who are admitted to ICU with decompensated liver failure
who are not suitable for liver transplantation is poor. The hospital mortality of these
patients depends upon the associated other organ failures: 68% if associated with
respiratory failure, 88% with sepsis and 94% for any other organ failure or a creatinine
ofmore than 120 pmol/1 (Mackle, Swann et al. 2006). Most patients will die within the
first month after ICU discharge (Gildea, Cook et al. 2004). However in those who do
survive the subsequent quality of life is related to the effects of their liver failure which
tends to overwhelm the ICU related effects. Generally quality of life is poor (Roth, Lynn
et al. 2000) and a significant proportion of the few patients who survived to 1 year
described significant pain, which is uncommon in chronic liver failure. These patients
also described a wish to die rather than to continue to suffer pain and fluctuating
conscious level. The principal problems described are related to the development of
encephalopathy, recurrent infections, weakness, malnutrition and redevelopment of
ascites and itch.
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1.8 Impact of renal failure
Acute renal failure (ARF) in the context of critical illness is associated with a high
mortality and this mortality is in excess of that which is found in patients with pre¬
existing established dialysis dependent renal failure admitted to ICU (Clermont, Acker
et al. 2002). Risk factors for the development ofARF included previous ischaemic heart
disease, stroke, pulmonary disease, diabetes, cancer, connective tissue disease and
alcoholism. 64% ofpatients who develop ARF have died by 1 year following ICU
discharge. However in survivors renal recovery occurs in 78% (Bagshaw, Laupland et
al. 2005) and the majority of patients who did not recover adequate renal function had
significant pre-existing renal impairment. There is no investigation of the long term
effects on quality of life in patients who have established renal failure following critical
illness. In the chronic renal failure literature it seems likely that the symptom burden
imposed by the complications of renal failure such as anaemia, the burden of dialysis
and the necessary lifestyle modifications to achieve good dialysis, are likely to conceal
the effects of critical illness. In chronic renal failure 61% ofpatients on developing the
requirement for dialysis could not perform their normal activities, 50% of patients
described severe difficulties with mobility and pain and 14% had problems with self care
(Bagshaw, Laupland et al. 2005). Treatments such as erythropoietin (Obrador and
Pereira 2002) are having a significant impact on quality of life and such improvements
may provide insight into what areas critical care interventions could focus upon to try
and achieve similar results.
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1.9 Impact of cardiac dysfunction
Myocardial dysfunction such as biventricular dilatation and reduced ejection fraction is
associated with acute sepsis and septic shock. This dysfunction persists despite
resuscitation and the development of the hyperdynamic phase of septic shock and is not
due to myocardial hypoperfusion but rather cytokine mediated effects on myocardial
contractility (Court, Kumar et al. 2002). There are no studies examining the long term
effects of isolated cardiac failure secondary to critical illness in the absence of infarction
(Broomhead and Brett 2002). Animal models suggest that cardiac function returned to
normal within a few days of recovery from a septic episode. Postural hypotension, most
likely due to residual autonomic neuropathy decreases mobility and independence due to
associated 'dizziness' (Griffiths 1999).
Heart failure in its own right is a progressive chronic disease with substantial morbidity
and mortality. In hospital mortality is 5% and 33% of patients will die within their first
hospitalisation with acute heart failure and 50% will require rehospitalisation within 6
months of the original admission (Aghababian 2002; Jong, Vowinckel et al. 2002). With
such severe disease burden the effects of critical illness are to some degree masked by
the effects of heart failure but, undoubtedly in trying to optimise therapy in one disease
process there are improvements in the other. There is an extensive literature describing
the actual morbidity and impairments to quality of life in heart failure (Jeon, Kraus et
al.). Generally, in cases of severe heart failure dyspnoea, fatigue, loss of appetite and
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psychological reactions to an individual's potential mortality appear to be the most
prominent symptoms.
1.10 The impact on care givers
75% ofpatients who survived at least 2 months following ICU require significant
caregiver support. Only 33% of the caregivers were working and 30% had reduced or
given up work in order to care for the patient (Im, Belle et al. 2004). 33% of care givers
had symptoms consistent with clinical depression. In the SUPPORT trial 20% ofpatients
reported a family member who had given up work, 30% lost the major source of income
and had lost the majority of the family savings (1995). Depression, lifestyle disruption
and employment reduction in caregivers is independent of pre-morbid health (Van Pelt,
Milbrandt et al. 2007).
1.11 The burden of critical illness
There is a significant physiological and psychological burden imposed upon survivors of
critical illness and their families and carers. Identifying the common and important
problems experienced by these patients will hopefully enable patient centred
rehabilitation strategies to improve the speed and the quality of that recovery. Anaemia
is a common complication of critical illness with a multitude of biologically plausible
mechanisms by which it could impact upon recovery from critical illness.
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1.12 The anaemia of critical illness
The cells of the blood are produced from self renewing progenitor stem cells in the bone
marrow that subsequently develop into recognisable precursor cells and then mature
functional cells in the circulation. Erythropoiesis occurs under the influence of
erythropoietin, a glycoprotein hormone secreted by the kidneys with a half life of
approximately 5 hours, in response to hypoxia. The hormone acts on the red marrow to
cause increased output of erythrocytes until the rise of haemoglobin concentration
restores normal delivery of oxygen to the tissues. Other growth factors and cytokines
modulate the effects of erythropoietin depending upon the clinical state under which the
stimulus for erythropoiesis develops.
Certain dietary constituents such as iron, vitamin B12, folic acid, vitamin B6 and amino
acids are required for the normal development of the cells and the appropriate
production of haemoglobin. A normal western diet provides approximately 15mg per
day of iron ofwhich 1 mg is actually absorbed and utilised. 2 micrograms per day of
Vitamin B]2 and 3 mg per kilogram per day of folate are also required for normal
haemoglobin production.
1.12.1 Definition of anaemia
The symptoms and signs of anaemia are characterized by a decreased oxygen carrying
capacity of the blood which in turn is determined by the mass of circulating red blood
cells. Red cell mass is not easily measured and the clinical definition of anaemia is based
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on the haemoglobin (Hb) concentration or haematocrit (Hct) ofwhole blood. The World
Health Organisation (WHO) definition of anaemia is an Hb concentration below the
normal range of a population. For a typical 'western' population the WHO have
therefore defined anaemia as a haemoglobin concentration of <130 g/L in males and 120
g/L n females (Organisation 1968). The anaemia of critical illness is defined as the
development of haemoglobin concentrations below the normal range in response to an
illness of acute onset and is of such severity that advanced physiological support for the
failing organ or organs is required.
1.12.2 Physiological response to anaemia
1.12.2.1 Oxygen content
Oxygen is principally carried in the blood bound to haemoglobin (98.5% or
~19.7ml/100ml blood) with only a small amount dissolved in the blood (0.3ml/100ml
blood). The oxygen content of arterial blood (Ca02) is described using the equation:
Ca02 (ml/lOOml) =1.34 (ml 02/g ofHb) x Hb (g/dl) x Sa02 + (0.23 x Pa02 (KPa))
This relationship states that each gram of haemoglobin will bind 1.34 mL O2 when it is
fully saturated with oxygen which equates to 19.7ml/100ml for a haemoglobin
concentration of 15 g/dL whereas only 0.3 ml/100ml is dissolved in the blood. This
relative strength of haemoglobin compared to partial pressure of oxygen in arterial blood
(Pa02) in determining the oxygen content of the blood is such that a 50% reduction in
haemoglobin concentration is fully expressed as a 50% reduction of CaC>2. However a
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50% reduction in PaC>2 only results in a 20% decrease in CaC>2. Haemoglobin
concentration therefore has a large impact on arterial oxygenation compared to
hypoxaemia.
1.12.2.2 Oxygen delivery
Oxygen delivery (DO2) is the product of cardiac output (CO) and oxygen content
(Ca02):
DO2 = CO x Ca02 mL min"1
Inadequate oxygen delivery can therefore occur from decreased cardiac output, or
decreased oxygen content (decreased haemoglobin concentration or arterial oxygen
saturation), or increased oxygen consumption.
1.12.2.3 Oxygen extraction
At rest the normal healthy person consumes approximately 250 ml of oxygen per minute
The oxygen consumption (VO2) is a function of the cardiac output and the difference
between the arterial and venous blood:
V02 = CO x (Ca02 - Cv02)
Oxygen extraction ratio O2ER is the ratio of O2 uptake to O2 delivery:
02ER = VO2/DO2
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The normal O2ER is 0.2 to 0.3 indicating that only 20-30% of the oxygen delivered to
the capillaries is taken up by the tissues. The oxygen transport system tries to maintain
an adequate provision of oxygen to the tissues, depending upon their requirements, and
must also be able to respond to changes in conditions where the oxygen demand of a
given tissue or even the body as a whole can vary widely. The relationship between
oxygen delivery and oxygen uptake is often described as the DO2-VO2 curve (Figure
1.3). As oxygen delivery decreases below normal the oxygen extraction increases
proportionally and the oxygen uptake remains constant. When extraction is maximal
(usually 50 to 60% depending on tissue) further decreases in oxygen delivery are
accompanied by proportional decreases in oxygen uptake. Oxygen uptake is therefore
'supply dependent' and energy production is limited by the supply of oxygen.
As illustrated above the body responds to the development of anaemia by increasing
cardiac output and an increase in oxygen extraction. The increased cardiac output
appears to be due to a reduced blood viscosity decreasing resistance to flow and
facilitating left ventricular emptying. This results in increased stroke volume and cardiac
output. This compensatory mechanism operates only when the anaemia is severe as
increasing cardiac output produces increased oxygen consumption in the myocardium at
a time when delivery may be precarious and extraction is already maximal. The second
compensatory mechanism is to match oxygen delivery to oxygen demand such that
blood flow is redistributed to areas of high demand.
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Figure 1.3 Diagram describing the normal relationship between oxygen
delivery (D02) and oxygen uptake (V02)
02ER = oxygen extraction ratio
Adapted from Marino, P. L. The ICU Book (Marino 1997)
1.12.2.4 The concept of a critical haemoglobin concentration
The haemoglobin concentration at which the critical oxygen delivery occurs can be
considered to represent a critical haemoglobin concentration. It is dependent upon the
metabolic activity of the body as a whole or on certain critical organs or tissues whose
oxygen requirements are high. The lower limit of tolerance to acute isovolaemic
anaemia has not been fully established.
In animal studies a critical haemoglobin level has been demonstrated to be
approximately 40 g/L (Wilkerson, Rosen et al. 1988; Rasanen 1992; Van der Linden,
Schmartz et al. 1998). In human studies isovolaemic haemodilution to a haemoglobin
concentration of 50 g/L produced an increase in cardiac output and reduction in oxygen
delivery, although there was no major change in VO2 or plasma lactate reflecting
inadequate total body oxygenation. There was some evidence of organ specific hypoxia
with asymptomatic ECG changes noted in some subjects at haemoglobin concentrations
of 50-70 g/L (Weiskopf, Viele et al. 1998; Leung, Weiskopf et al. 2000). Another study
found evidence of cognitive dysfunction at haemoglobin concentrations of less than 60
g/L (Weiskopf, Kramer et al. 2000). Clinical experience with Jehovah's Witnesses
suggest that mortality is only increased at haemoglobin concentrations less than 50 g/L
(Viele and Weiskopf 1994).
The adequacy of any haemoglobin concentration in a given clinical situation depends on
whether a sufficient amount of oxygen is carried to meet the metabolic requirements. In
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patients with critical illness oxygen demands are high and the potential for anaemia to
impact adversely upon oxygen delivery is significant.
Thus the critical haemoglobin concentration is defined as the haemoglobin concentration
below which oxygen consumption is supply dependent assuming normovolaemia. It
represents the point where cardiac output and oxygen extraction are maximal and thus a
reduction in the oxygen carrying capacity in the blood (a drop in Hb) will cause tissue
hypoxia. It is not a fixed value and varies between organs and the metabolic state of the
patient.
1.12.2.5 Detecting inadequate oxygen delivery
As blood transfusion has risks the optimal situation in clinical practice would be where a
transfusion could be individually titrated to the patient's oxygen delivery requirements at
any given time. It is difficult to detect tissue hypoxia clinically until it is severe. There
are no specific clinical signs and whole body oxygen requirements are not representative
of individual organ hypoxia. Assessment of the adequacy of oxygen delivery relies on
the detection of anaerobic metabolism such as lactic acidosis, but whole blood lactate
concentration is not specific for tissue hypoxia.
1.12.2.6 Transfusion thresholds
In response to the lack of an ideal monitor 'inherited' transfusion thresholds, based on
haemoglobin concentration of 10 g/dL historically from the 10/30 rule of Adams and
Lundy (haemoglobin more than 10 g/dL and haematocrit more than 30%) based on
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clinical observation (Adams 1942) and since the TRICC study (Hebert, Wells et al.
1999) a restrictive threshold of 7 g/dL, have evolved which result in transfusions
occurring in response to a haemoglobin concentration rather than on the adequacy of
oxygen delivery. Though these thresholds represent a distillation of clinical experience
and have erred on the side of optimising the oxygen carrying capacity of the blood there
is a lack of evidence to support them. As more is known about the potential risks of
blood and of the efficacy of transfused blood in actually improving oxygen carriage
these thresholds need to be reviewed.
1.12.3 Prevalence of anaemia of critical illness
Estimates of the prevalence of critical illness anaemia varies due to differences in ICU
case mix, illness severity and transfusion practice internationally, nationally and even
within the same hospital's ICUs.
1.12.3.1 Pre-existing anaemia
In a cohort study of 3534 patients admitted to European ICUs (the ABC study) the mean
haemoglobin concentration at ICU admission was 11.3 g/dL with 30% of patients having
a haemoglobin concentration of less than 10 g/dL at admission. Only 13% ofpatients
had a recent history of anaemia and those with severe anaemia had no history of acute
blood loss or anaemia (Vincent, Baron et al. 2002). The CRIT study in the United States
again found a mean admission haemoglobin concentration of 11 g/dL (Corwin,
Gettinger et al. 2004). A cohort study of 1023 sequential admissions to 10 separate
Scottish ICUs found that the median haemoglobin was 10.5 g/dL with 25% of patients
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had a haemoglobin concentration less than 9 g/dL. This suggests that 20-30% ofpatients
have moderate to severe anaemia with only 10-15% having documented pre-existing
anaemia.
1.12.3.2 Anaemia during ICU admission
In non-bleeding patients haemoglobin concentrations decrease by approximately 0.5
g/dL per day (Chohan, McArdle et al. 2003; Nguyen, Bota et al. 2003). The most rapid
decline in haemoglobin concentration occurs within the first 3-4 days of critical illness.
Following this phase the rate of decline decreases and a plateau is reached, due to an
empiric transfusion threshold being chosen, and as a consequence when this threshold is
breached, the anaemia is treated with blood transfusion 'artificially' maintaining the
haemoglobin concentration. As such the haemoglobin concentration at which this
plateau occurs is strongly influenced by transfusion practice. The TRICC trial (Hebert,
Wells et al. 1999) compared liberal (Hb maintained between 100 to 120 g/L) and
restrictive (Hb maintained between 70 to 90 g/L) transfusion strategies in non-actively
bleeding patients. The primary outcome, 30 day all cause mortality was 18.7% in the
restrictive group and 23.3% in the liberal group. Cardiac complications were also more
common in the liberal group. Other trials in orthopaedic (Carson, Duff et al. 1998),
vascular (Bush, Pevec et al. 1997) and coronary artery bypass graft (CABG) patients
(Bracey, Radovancevic et al. 1999) have also found no difference on morbidity or
mortality by the adoption of a restrictive transfusion practice. Thus in addressing the
long standing practice in which the development of anaemia is perceived as harmful
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these studies suggest that there is no harm and in fact there is benefit I the adoption of a
restrictive transfusion practice.
Since the TRICC study showed that there was no harm and probable benefit in the
adoption of a restrictive transfusion strategy (Hebert, Wells et al. 1999) there has been
an adoption ofmore consistent practice (Chohan, McArdle et al. 2003). Typical pre-
transfusion haemoglobin values in ICU are between 78 to 85 g/L.
Audit of transfusion practice of a UK ICU showed that in patients who stayed more than
24 hours, 55% developed an haemoglobin of less than 90 g/L and that this anaemia
occurred early (Chohan, McArdle et al. 2003). At ICU discharge 90% of patients were
anaemic for gender reference range and 50% had severe anaemia with a haemoglobin of
less than 100 g/L (Walsh, Saleh et al. 2006).
1.12.3.3 Anaemia after ICU discharge
Few patients are transfused after ICU discharge despite anaemia being common at
discharge. Patients describe fatigue, breathlessness and other morbidity associated with
anaemia during their hospital stay but few receive transfusions. The transfusions usually
occur at haemoglobin concentrations of 8-9 g/dL (Vincent, Baron et al. 2002; Corwin,
Gettinger et al. 2004). As a consequence it has been shown that 77.4% of all ICU
survivors are anaemic when discharged from hospital and 32.5% have a haemoglobin
concentration less than 10 g/dL (Walsh, Saleh et al. 2006).
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1.12.4 Aetiology of anaemia of critical illness
Anaemia can result from blood loss, decreased red cell production, increased red cell
destruction or a functional anaemia in response to changes in plasma volume.
1.12.4.1 Blood loss
Blood loss can occur due to diagnostic sampling, bleeding episodes or practical
complications of ICU interventions. The average volume ofblood sampled in a critically
ill patients is 41mis per day (Vincent, Baron et al. 2002) and diagnostic blood loss
contributes on average to 1 to 2 units of blood loss during their hospital stay (Smoller
and Kruskall 1986).
Significant overt bleeding (>300 mis) has been shown to occur in 21% patients
(Garrioch, Fletcher et al. 2002). Gastrointestinal bleeding is relatively uncommon in
critically ill patients and its contribution to the development of anaemia although
significant has probably been overstated, especially with increased use of stress ulcer
prophylaxis and increased early enteral feeding. The development of acute renal failure
is strongly associated with the development of anaemia (Corwin, Parsonnet et al. 1995)
and may be due to iatrogenic losses occurring when haemodialysis or haemofiltration
circuits fail unexpectedly. Audits of transfusion practice have found that 45-80% of red
cell transfusions do not occur in the context of acute bleeding (French, Bellomo et al.
2002; Rao, Boralessa et al. 2002). Other mechanisms must therefore contribute to its
development.
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1.12.4.2 Decreased red cell production
Critically ill patients have been shown to have an inappropriately low reticulocyte count
in response to anaemia (von Ahsen, Muller et al. 1999; van Iperen, Gaillard et al. 2000)
suggesting suppression of the normal bone marrow response. The term 'acute anaemia
of chronic disease' (Corwin 2001) was coined to describe the anaemia which appears to
develop in the critically ill, as it has many similarities with the anaemia of chronic
disease. It is a normocytic normochromic anaemia associated with a reduced reticulocyte
response, disturbances in iron homeostasis and is potentially driven by a persisting
inflammatory state.
Inflammatory cytokines such as tumour necrosis factor a (TNF-a), interleukin-1 (IL-1)
and interleukin-6 (IL-6) have been shown to directly inhibit erythrogenesis (Jongen-
Lavrencic, Peeters et al. 1995) and are frequently elevated in patients with sepsis
(Blackwell and Christman 1996). The administration of recombinant human
erythropoietin (rHuEPO) in high doses can stimulate the bone marrow of critically ill
patients (Corwin, Gettinger et al. 1999; van Iperen, Gaillard et al. 2000). Critically ill
patients have inappropriately low erythropoietin concentrations for the degree of
anaemia (Krafte-Jacobs, Levetown et al. 1994; Rogiers, Zhang et al. 1997; von Ahsen,
Muller et al. 1999; van Iperen, Gaillard et al. 2000). This is thought to result from
cytokine mediated inhibition of the erythropoietin gene (Wojchowski and He 1993;
Jelkmann 1998). Inflammation may also impair iron availability for erythropoiesis. Iron
is an acute phase protein and serum ferritin is increased and serum transferrin decreased
as part of the acute phase response. ICU patients typically have a low serum iron, total
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iron binding capacity but serum ferritin is elevated or normal (Biesma, Van de Wiel et
al. 1995; Rodriguez, Corwin et al. 2001) in a primitive immune response attempting to
deprive invading pathogens of iron. This response may impair iron availability for
subsequent erythropoiesis.
1.12.4.3 Increased red cell destruction
There is no direct evidence that critical illness reduces red cell life span. However
decreased red blood cell survival could occur in critical illness in response to
complement activation and increased red cell destruction, though no evidence of
haemolysis has been found (von Ahsen, Muller et al. 1999). Several studies have
reported reduced red cell deformability in patients with sepsis (Card, Mohandas et al.
1983) which may be associated with reduced viability.
7.72.4.4 Functional anaemia
Critical illness is often associated with intravascular hypovolemia requiring fluid
resuscitation. The administration of non-haemoglobin containing fluids will cause
haemodilution and the altered plasma volume affects measured haemoglobin or
haematocrit values which could be interpreted as anaemia or may cause a functional
anaemia even in the presence of normal red cell mass.
The development of the anaemia of critical illness is therefore multi-factorial but the
main determinants are whole blood loss with phlebotomy as a major cause and a blunted
erythropoietic response.
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1.12.5 The risks of blood transfusion
Blood transfusion has many risks associated with it, from direct iatrogenic complications
such as receiving the wrong blood group or contaminated blood (such as hepatitis C) to
organ dysfunction, immunosuppresion and decreased survival.
1.12.5.1 Risks of infection
The risks of contracting HIV or hepatitis C is approximately l in 2 million units
transfused. Hepatitis B is estimated to be transmitted from 1 to 200 permillion units
transfused. The risks of death from sepsis related to blood contaminated by bacteria is
approximately 1 per million units transfused and in endemic areas parasitic diseases
such as malaria can pose a significant risk (Bihl, Castelli et al. 2007). 1 direct death from
bacterial infection in transfused blood occurred in the UK in 2008. There are also several
suspected cases of transmission of variant Creutzfeld Jacob Disease (vCJD) through
blood transfusion (Allain, Stramer et al. 2009). This led to the universal leucodepletion
of blood components in the UK as a precaution against this happening again.
1.12.5.2 Adverse reactions to transfusion
Allergic reactions to transfusions vary from the febrile non-haemolytic transfusion
reaction which is clinically benign to anaphylaxis. The acute haemolytic reaction results
from haemolysis of donor cells by host antibodies and is usually related to ABO
incompatibility and the wrong blood being given to the patient. It has the potential to
cause renal failure. Anaphylaxis occurs in approximately l in 20,000 transfusions and
requires prompt life saving treatment .World wide fatal ABO mismatch reactions occur
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roughly 1 per million units transfused. In the UK the Serious Hazards of Transfusions
(SHOT) report for 2008 showed that for the 2.5 million transfusions occurring in the UK
the incorrect blood component transfusion (IBCT) rate was 16.8 per 100.000. No
fatalities occurred but there were 4 episodes of sugnficant morbidity. There were 9
deaths in total attributed to transfusion reactions. Other risks such as fluid overload,
hypothermia and the development of coagulopathy also occur.
Idiosyncratic immune reactions such as Transfusion Related Lung Injury (TRALI) and
other organ dysfunction such as transfusion related immunomodulation (TRIM) leading
to increased vulnerability to infection and malignancy also occur. TRALI has a similar
presentation to acute respiratory distress syndrome and as a consequence is likely to be
under-diagnosed in the critically ill. There is considerable overlap in pathogenesis in the
two conditions and it may well be that TRALI contributes to the development ofARDS
(Kleinman, Caulfield et al. 2004).
1.12.5.3 Risks of transfusion in the critically ill
Blood transfusion is a common occurrence in the critically ill with 40-50% of all
patients admitted to ICU receiving at least one allogeneic transfusion (Koch, Li et al.
2006). The indications for these transfusions are often obscure and they are often used to
treat anaemia rather than as a specific intervention (Koch, Li et al. 2006). The ABC
study in Europe and CRIT study in the United States reported that blood transfusion was
associated with increased mortality in ICU patients. A recent European study SOAP
study used the same approach as the ABC study but found different results. Initially it
36
was found that there was a direct relationship between the number of blood transfusions
and mortality rate. However the patients who received transfusion were found to be
older, more likely to have sepsis, cirrhosis or haematological malignancy and have a
greater severity of illness on admission to ICU. After controlling for these factors it was
found that blood transfusion was not associated with a worse mortality rate.
The differences between the earlier two studies and the Sepsis Occurrence in Anaemic
Patients (SOAP) study highlights an important event that occurred during the CRIT and
ABC studies, namely that there was a shift from the general use of non-leucodepleted
blood to leucodepleted blood as the standard blood product during the late 1990's and
early 2000. It was proposed that residual leucocytes in packed red cells could induce
immunological effects and potentiate inflammatory response. During the ABC study
46% centres used leucodepleted blood with 19% never using this product to 76% of
centres in the SOAP study routinely using leucodepleted blood. A recent meta-analysis
investigating the efficacy of leucodepleted blood in reducing adverse events only
showed an improvement for reducing post operative infections (Fergusson, Khanna et al.
2004).
Blood transfusion has also been associated with an increase in nosocomial infections
(Taylor, OBrien et al. 2006) and ARDS (Zilberberg, Carter et al. 2007). Ideally there
would be clear clinical indications for blood transfusion which facilitate appropriate
transfusion to patients who would benefit but avoid transfusion when the balance of
risks of acute anaemia and transfusion are less clear cut.
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1.12.5.4 Risks of transfusion in patients with ischaemic heart disease
The resting oxygen extraction of the myocardium is near maximal. The increase in
cardiac output in response to anaemia increases myocardial oxygen consumption and
this must therefore be met by increased coronary blood flow through vasodilatation.
Coronary artery disease restricts coronary blood flow and therefore oxygen delivery.
The risk ofmyocardial ischaemia in anaemic critically ill patients with ischaemic heart
disease is therefore significant and effects of specific transfusion thresholds have
potentially profound consequences.
In patients at high risk for, or with established ischaemic heart disease there have been
several studies showing a relationship between myocardial ischaemia, adverse cardiac
events and anaemia (Nelson, Fleisher et al. 1993; Carson, Duff et al. 1996; Hogue,
Goodnough et al. 1998). A retrospective analysis of the TRICC study data showed a
trend towards better outcome in patients with ischaemic heart disease and had a Hb >
100 g/L. However a recent study has shown that in anaemic patients who present to
hospital with a suspected acute coronary syndrome (ACS) blood transfusion increased
the risk of developing an acute myocardial infarction or death (Singla, Zahid et al. 2007;
Willis and Voeltz 2009).
1.12.6 The risks of anaemia
Anaemia reduces the oxygen carrying capacity of the blood. It has been associated with
increased morbidity and mortality in myocardial infarction (Lipsic, van der Horst et al.
2005), heart failure (O'Meara, Clayton et al. 2006) and per-operatively. As discussed
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above a critical haemoglobin concentration is defined as the haemoglobin concentration
below which oxygen consumption is supply dependent assuming normovolemia is
maintained. The risks of anaemia itself remain difficult to determine as erythropoiesis is
affected by many factors which could also be associated with poor clinical outcomes and
significant co-morbidities. When some of these factors are controlled for, conclusions
can be drawn that although the development of anaemia is undoubtedly be associated
with poor clinical outcome the subsequent treatment of that anaemia may be more
harmful than the anaemia itself.
1.12.7 Efficacy of blood transfusion as a treatment for anaemia
There is considerable literature on the effects of transfusion on oxygen kinetics but
clarity is lacking due to varying methodology, different cohorts studied and
contradictory findings. A review identified 14 studies examining the effects of
transfusion on oxygen delivery and oxygen consumption (Hebert 2000). The studies
only had patients with moderate anaemia (Hb range 8.3-11.0 g/dL). Transfusion
consistently increased DO2 but oxygen consumption only increased in 5 of the studies
and these studies calculated oxygen consumption from pulmonary artery catheter
measurements which can introduce error in to the measurements to such a degree that
direct measures of oxygen consumption have been recommended for future studies.
Determining the significance of anaemia requires any transfusion to be considered as a
risk factor. Ischaemic complications of anaemia such as MI, neurological or renal injury
were not decreased by transfusion even when co-morbidities were controlled for
(Murphy, Reeves et al. 2007). This lack of benefit may reflect that haemoglobin levels
39
rarely limit D02 in clinical practice and the possible negative effects relate to increased
blood viscosity, pro-inflammatory effects and the reduced efficacy of the blood itself.
The decreased efficacy is due to the development of storage lesions and even potentially
decrease actual oxygen delivery to tissues due to decreased deformability of red cells,
sludging and capillary occlusion (Spiess 2007). A recent paper has shown that the use of
old blood (more than 2 weeks old) caused a statistically significant increase in ventilator
days, renal failure, sepsis and in-hospital mortality (Koch, Li et al. 2008). In the
critically ill transfusion has been shown to produce only a modest and transient rise in
haemoglobin concentration further questioning the efficacy of transfusion as a treatment
for anaemia (McArdle 2001). The assumption that blood transfusion is an effective
therapy is now questionable.
1.12.8 The risks of erythropoietin
Increased erythropoiesis will result in increased haemoglobin and potentially reduce the
need for blood transfusions. Erythropoiesis-stimulating agents (ESAs) are drugs which
aim to elevate or maintain red blood cell levels and decrease the need for transfusions.
The most common drugs are epoetin alfa and darbepoetin alfa. Treatment of anaemia
with these agents can improve patient's quality of life, especially in renal failure
(Obrador and Pereira 2002) and cancer (Sabbatini 2000). Concerns over the size of the
early studies and the measures of quality of life used, has caused the magnitude of these
benefits to be questioned. Subsequent conflicting results from subsequent randomized
controlled trials investigating ESAs means that the use of these promising agents has
been reviewed. The CHOIR (Correction ofHemoglobin and Outcomes in Renal
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Insufficiency) (Singh, Szczech et al. 2006) showed that in trying to produce a normal
haemoglobin level rather than aiming for a modest increase in haemoglobin showed no
improvement in QOL and increased the risk cardiovascular problems. Other trials such
as the Normal hematocrit study (Besarab, Bolton et al. 1998) and TREAT study (Pfeffer,
Burdmann et al. 2009) have not shown any significant improvement in quality of life but
did show an increase in nonfatal myocardial infarction, nonfatal stoke and death (Unger,
Thompson et al.).
Peri-operative studies of the administration of rHuEPO have shown reduced time to
recover to baseline haemoglobin (Levine, Rosen et al. 1989; Mercuriali, Zanella et al.
1993). Critically ill patients also respond to rHuEPO and this has been shown to reduce
the number of red cells transfused (Corwin, Gettinger et al. 1999). However recent
studies have failed to reproduce this reduction in transfusion rates and have shown a
trend towards an increased risk of adverse thrombotic events in patients treated with
rHuEPO (Corwin, Gettinger et al. 2007).
The results of these studies mean that, at present, we have no obvious alternative
treatment to anaemia during critical illness other than blood transfusion.
1.13 The impact of the 'anaemia of critical illness'
Anaemia is a common, preventable and potentially treatable complication of critical
illness. It is caused by blood loss and impaired erythropoiesis. Most transfusions during
critical illness are to treat anaemia rather than acute bleeding and, although there has
been a great improvement in transfusion practice, many transfusions are probably
41
unnecessary. Red cell transfusion has risks both in short term morbidity and mortality.
Less is known about the long term consequences of anaemia. Chapter 2 of this thesis
examines the time course of anaemia following critical illness and the impact on quality
of life.
1.14 Quality of life following critical illness
The ideal outcome following critical illness is for the patient to return to their pre¬
existing state or that expected of a person of the same age and medical condition (Black,
Jenkinson et al. 2001). Outcomes research, particularly in critical illness, is complex due
the heterogeneity ofpatients, disease processes and clinical practice within intensive
care units. There is a need for the assessment of outcomes which reflect patients' long
term health and well being. However a plethora ofmeasures have been used which have
often been developed in non-critical illness patient populations. In the following sections
the most common outcome measures will be reviewed with particular emphasis on the
measures used in the subsequent research chapters of the thesis. Discussion ofmeasure
selection for the studies will be included in the appropriate chapter. The information that
outcome measures provide must be valid, reliable and responsive.
1.14.1 Terminology of social science and outcomes research
The following sections represent a distillation of information of social science
terminology from two principal sources: Hayes et al 2000 (Hayes, Black et al. 2000) and
Black et al 2001 (Black, Jenkinson et al. 2001).
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1.14.1.1 Validity
A valid assessment is one that measures what it claims to measure. It requires
comparison with some standardized criteria. This is not always easy as there are few
'gold standards' against which comparison can be made but there are standard criteria
for validity which can be used.
Face validity refers to whether items on a questionnaire make sense, are easily
understood and are appropriate to the phenomenon being measured. It is produced by
having 'experts' review the contents of the test to see if the items seem appropriate. This
method has inherent subjectivity.
Content validity refers to the extent to which a measure represents all aspects of a given
social concept. It is important that items appropriate to the phenomenon under
investigation are chosen and if they are weighted in some way, that the weighting reflect
the perceived level of difficulty or health problem.
Construct validity reflects the ability of an instrument to measure an abstract concept or
construct. It is important in the absence of a gold standard so that theories of the whole
attribute of interest are formed and then the extent to which the measure under
investigation provides results that are consistent with the original theories are assessed.




Reliability is generally understood to be the extent to which a measure is stable or
consistent and produces similar results when administered repeatedly, i.e. the proportion
of true variation in scores derived from a particular measure. The total variation in any
given score consists of true variation (the variation of interest) and error variation (which
includes random error and systematic error). Reliability is generally measured using
Cronbach's alpha statistic, a coefficient between 0 and 1. It is used to rate the internal
consistency or correlation of the items in a test. A good test is one that assesses different
aspects of the trait being studied. If a test has a strong internal consistency it should
show only moderate correlation among items. If the correlations are too low then it is
possible that different traits are being measured. If the correlation is too high then it is
likely that some of the items are measuring the same thing and are redundant.
Test-retest reliability is measured by administering the questionnaire on two occasions
separated by a few days. Ideally they should produce almost identical results.
Confounding variables are one aspect of the reliability of a test. Confounding variables
are a possible patient factor which is omitted from the measure used but which is
actually causing the effects seen. Reliable quality of life measures should not vary
according to extraneous factors such as income, gender and ethnicity.
1.14.1.3 Responsiveness




Intensive care survival studies generally report on sample sizes of less than 20% of the
enrollable population (Hayes, Black et al. 2000) and further loss to follow up of 30% of
the recruited population (Hopkins and Jackson 2006). Bias, in various forms, is therefore
a fundamental problem in ICU follow up studies. Bias is also a potential problem in
quality of life assessments as these assessments predominantly focus on the ability to
function whilst in some patients this may not be the most important aspect of their
quality of life. This bias may impair the validity of a given assessment as the designers
of the assessment may have pre-conceived ideas ofwhat is important to a given patient
population. It is therefore appropriate for such quality of life tools to use a wide
spectrum of health care practitioners and patients themselves in the designing of
measures to ensure that they are valid. Unfortunately this is not often the case. Because
of the great potential for bias within the ICU survivor population and in quality of life
studies, the degree of extrapolation of results from ICU follow up studies using quality
of life measure to the entire survivor of critical illness population must be done with
caution.
The types of bias common in ICU studies are discussed below.
1.14.1.4.1 Selection bias
Selection bias occurs when one or more groups of people are over or under-represented
in a study population. With the high drop out rate in many ICU follow up studies the
population at 6 months may not represent the original study population. This may be
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referred to as 'drop out bias', and is thought to be a problem at drop out rates ofmore
than 15% of the original group.
1.14.1.4.2 Participant bias
Participant bias occurs when patients behave in a fashion such that their responses are
systematically higher or lower than normal. Survivors of critical illness often have a
'desire to please' and therefore under-report problems especially in the early phases of
recovery. This may skew results at this time.
1.14.1.4.3 Observer bias
Observer bias occurs when investigators behave in some way such that the data collected
is systematically higher or lower than it actually is.
Measurement bias occurs when some aspect of the measure skews the response in a
particular direction.
The methods by which we tried to reduce bias and account for its effects are discussed in
section 5.2.1.
1.14.1.5 Survival
Survival is an incomplete endpoint for the recovery of critical illness. ICU patients are
not representative of the general population. They have considerable co-morbidity and
pre-existing physical limitation. This makes survival data difficult to compare. Most
ICU follow up studies compare the study group to matched general population samples
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as they are readily available. Ideally ICU patients should be compared with age and
gender matched hospital patients with the same disease but not requiring ICU care. In
general ICU patients show a high initial mortality which diminishes with time. The
survival curves paralleled with the general population between 2-4 years following ICU
discharge. The risk factors for decreased survival are age, severity of illness and
diagnostic category (Ridley and Plenderleith 1994; Niskanen, Kari et al. 1996; Wright,
Plenderleith et al. 2003).
1.14.1.6 Non-mortality outcomes
Non-mortality outcomes can be broadly classified as measures of:
• Physical impairment and disability




• Health related quality of life
1.14.1.7 Impairment
Impairment refers to objective measures of anatomical, physiological or biochemical
status rather than the subjective problems that patient's report. Measures of impairment
have largely focused on the respiratory system. Respiratory volumes, gas flow loops,
diffusion capacity and imaging of the respiratory tract have all been studied mainly due
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to the high level of research into patients who develop ARDS. Pulmonary function tests
generally have returned to normal by 6 months and diffusion capacity by 1 year. Only
6% of patients de-saturate during exercise at 1 year.
1.14.1.8 Quality of life
Quality of life is a descriptive term that refers to people's emotional, social and physical
well being, and their ability to function in the ordinary tasks of living. Quality of life is
measured using specially designed questionnaires which measure a person's ability to
function in the ordinary tasks of living. It is to some degree distinct from utility
measures which measure quality adjusted life years. Quality of life measures attempt to
directly assess the impact of a disease or treatment on a person's ability to function not
the value that they place upon a particular health state which is assessed by utility
measures.
A great strength of quality of life measures is that they provide information for planning
multi-disciplinary care packages with those responsible for different aspects of the
patient's care such as physiotherapists, dieticians, occupational therapists, social workers
and the primary carers themselves.
However it should not be assumed that generic measures of quality of life
comprehensively measure quality of life status or the effects of an intervention in
specific populations. This is due to the domains used to classify quality of life having
differing importance to different individuals and as many measures are developed by
health care professionals looking at a specific condition and then subsequently used
different populations from that in which they were originally intended. This represents a
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systematic difficulty in the use of quality of life measures in a heterogeneous population
such as survivors of critical illness. It is therefore appropriate to try and use generic,
widely used and well validated tools for assessment. It may also be appropriate to try
and avoid measures which generate a single score to represent the diverse and complex
factors which determine quality of life.
In a consensus conference on surviving critical illness two measures of quality of life
were recommended for use in the critically ill: the medical outcomes short form 36
question health survey (SF-36) and the EuroQol-5D (EQ-5D) (Angus and Carlet 2003).
The SF-36 is a quality of life measure and the EQ-5D has health utility aspects.
1.14.1.8.1 SF-36
The medical outcomes short form 36 question health survey (SF-36) is a widely used,
generic, patient-report measure created to assess health related quality of life (HRQoL)
in the general population. It was developed as part of the Medical Outcomes Study, a
two year study ofpatients with chronic conditions (Ware and Sherbourne 1992). It is the
most commonly used generic instrument for measuring quality of life (de Haan 2002). It
is simple to administer either by the patient or via the telephone and takes approximately
ten minutes to complete. In areas outside of critical care it has good reliability with
Cronbach's alpha (a) coefficient generally exceeding 0.8 for all scales except social
functioning. It has been shown to be responsive to change again especially in the
physical function domains, has good test-retest reliability (a = 0.81) (Brazier, Harper et
al. 1992) and shows sensitivity to change over time (Garratt, Ruta et al. 1994; Beaton,
Hogg-Johnson et al. 1997). Its validity is supported by comparison to similar domains of
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condition specific measures. It has been shown to be appropriate for critically ill patients
(Chrispin, Scotton et al. 1997; Ridley, Chrispin et al. 1997; Weinert, Gross et al. 1997;
Cuthbertson, Scott et al. 2005) and as a proxy measure from next of kin (Rogers, Ridley
et al. 1997).
The SF-36 questionnaire comprises eight dimensions: physical functioning (PF) 10
items; social functioning (SF) 2 items; role limitations due to physical problems (RP) 4
items; role limitations due to emotional problems (RE); general mental health (MH) 5
items; energy / vitality (Vi) 4 items; bodily pain (BP) 2 items; general health perceptions
(GH) 5 items. Item scores for each dimension are summated and transformed using a
scoring algorithm into a scale ranging from 0% (worst health) to 100% (best health).
The SF-36 may have ceiling effects. A ceiling effect occurs when test items aren't
challenging enough for a group of individuals and hence the score will not increase for a
subset of people who have improved because they have already reached the highest
score possible.
1.14.1.8.2 EQ-5D
EQ-5D is a standardised instrument for measuring health outcome. It is applicable to a
wide range of health conditions and treatments and provides a simple descriptive profile
and a single index value for health status. It can be completed either as a postal
questionnaire or by face to face interview in clinics or other settings and takes 5-10
minutes to complete. It has been recommended by national bodies such as the National
Institute for Clinical Evidence (NICE) for the use in clinical and economic evaluation of
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health care. There is a wide body ofnormative data both for the general population and
specific illness groups.
The EQ-5D consists of five dimensions: mobility, self care, usual activities, pain /
disorder and anxiety / depression, with three response options: nil, moderate and severe
and respondents are also asked to indicate their present health state using a visual
analogue scale.
The responsiveness ofEQ-5D in critically ill patients was assessed and found to detect a
significant increase in mobility, significant decreases in self care and usual activities and
no significant change in pain and discomfort, anxiety and depression or the visual
analogue scale (Vainiola, Pettila et al.). Age, severity of illness, ICU length of stay and
diagnostic category have been shown to be related to reduced EQ-5D and EQ-VAS
scores (Badia, Diaz-Prieto et al. 2001; Dowdy, Eid et al. 2005). However when pre¬
morbid factors (co-morbidity, smoking status, education and social status) are accounted
for the ICU variables may not be as strongly associated with EQ-5D (Badia, Diaz-Prieto
et al. 2001). It can be used retrospectively to determine health related quality of life prior
to ICU admission (Badia, Diaz-Prieto et al. 2001).
1.14.1.9 Other measures of health related quality of life
Sickness Impact Profile (SIP) is a measure of the impact and disability on daily life, and
has been validated in various patient populations including ICU patients (Frick,
Uehlinger et al. 2002). It is a multidimensional cumulative health index consisting of a
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list of 136 questions, divided into 12 categories of daily living. These categories can
then be aggregated into 'physical', 'psycho-social', and 'independence' categories. The
questionnaire can be self administered or taken with the help of an interviewer. Patients
are asked to indicate those items that describe a dysfunction that they experience at this
time. Scores of 0-5 are found in a healthy population and 5-15 corresponds to moderate
disability and a score ofmore than 15 reflects significant impairment of quality of life.
The original form has been found to be reliable, valid and sensitive to change (Black,
Jenkinson et al. 2001; Frick, Uehlinger et al. 2002).
Nottingham Health Profile is a measure ofperceived distress. It was designed to assess
severe ill health and may be prone to ceiling effects. It has two parts. Part one measures
perceived or subjective functional status by answering 38 questions associated with 6
dimensions. Each dimension has the potential score 0-100 where 0 indicates good health
and 100 indicates poor health. Part 2 focuses upon the quality of life. This second part is
no longer recommended by the developers. NHP focuses on the severe extremes of ill
health and may be highly skewed thus minor improvements are likely to be missed. The
validity and criterion validity has been established in critical care patients. The reliability
and responsiveness of the NHP has not been established in critical care. The test-retest
coefficients have been described from 0.77 to 0.85 for part 1 and found to be very poor
for part 2 leading to the recommendation for its withdrawal (Hunt 1997).
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1.14.1.10 Functional status
Impairment may not always affect a person's health or functional status by giving rise to
symptoms or limitations in their ability to function. Low haemoglobin may be associated
with breathlessness and an inability to walk to the shops. However diminished function
(such as the need to use a car to get to the shops) may not be reported if quality of life is
not affected (Hayes, Black et al. 2000).
1.14.1.10.1 Frenchay Activities Index
The Frenchay Activities Index (FAI) (Holbrook and Skilbeck 1983) is a measure of
instrumental activities of daily living. It was developed for use in patients recovering
from stroke. The FAI assesses range of activities associated with everyday life and
provides a broad measurement of actual activity rather than focusing on issues related to
self care alone (Wade, Legh-Smith et al. 1985). The FAI compromises 15 activities,
each ofwhich is scored on a 4 point scale to yield a score from 0 (inactive) to 45 (active)
and the scoring is based upon the frequency with which the activities is carried out. It
takes approximately 5 minutes to administer and this can be done either as an interview
or mailed questionnaire and can be used with proxy respondents. It correlates with the
SF-36 score physical functioning subscale. It has been validated in a normal UK
population, has good construct validity in middle aged and elderly respondents and good
test retest reliability (Turnbull, Kersten et al. 2000). Men generally score lower on the
subscale relating to domestic chores but this is often related to marital status.
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1.14.1.10.2 Six minute walk test
Timed walk tests were originally developed as non-laboratory estimates of physical
fitness in healthy subjects that correlate with maximal oxygen uptake. These tests have
also been shown to have some similarity with the activities of daily living. The six
minute walk test (6MWT) (Butland, Pang et al. 1982; Guyatt, Sullivan et al. 1985) is a
functional walking test in which the distance that a patient can walk within six minutes
and is administered according to the American Thoracic Society (ATS) protocol (2003).
It has excellent test-retest reliability (Liu, Drutz et al. 2008) and correlates with other
physiological measures (Eng, Dawson et al. 2004) and can detect change well. It is
sensitive to clinical signs of disease as shortest distances observed were observed in the
patients with greatest co-morbidity (Enright 2003). It may also reflect prognosis (Bittner,
Weiner et al. 1993) and quality of life (Guyatt, Townsend et al. 1991).
1.14.1.10.3 Hand grip dynamometry
Hand grip strength has been found to be a consistent predictor of clinically important
outcomes such as survival and postoperative complications in many different
populations (Bohannon 2008). Low grip strength is associated with a greater likelihood
of functional disability in many studies (Shibata, Haga et al. 1992; Sarkisian, Liu et al.
2001) especially in pneumonia (Bohannon, Maljanian et al. 2004; Vecchiarino,
Bohannon et al. 2004). It has also been found to be a good indicator of nutritional status
(Davies, Jones et al. 1984).
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1.14.1.10.4 Other measures of functional status
Karnofsky Performance Index was developed as a measure of overall health status in
lung cancer patients with scores ranging from 0 (dead) to 100 (normal) (Karnofsky,
Graef et al. 1948). It is not designed for the measurement of quality of life but rather
assesses physical function according to clinician's opinion rather than the patient. It
correlates well with the physical component of the SF-36 score.
New York Heart Association (NYHA) functional grades are a functional and therapeutic
classification for the description ofphysical activity for patients with cardiac disease
(Association 1964). It ranges from grade I, no limitations, to grade IV any physical
activity results in discomfort with symptoms of cardiac insufficiency even present at
rest. It correlates poorly with exercise testing suggesting high inter-observer variability.
It is an expert panel measure, principally for patients with heart failure, and there has
been little assessment of its validity, reliability and responsiveness in critical care
patients.
The Barthel Index was developed to compare physical functional status before and after
an intervention and indicate potential nursing requirements (Mahoney and Barthel
1965). It is only suitable for institutionalized patients. The score elicits a score from 0
(wholly dependent) to 100 (wholly independent).
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1.14.1.11 Neuropsychological measures and mental function
Most tests have been developed for use in patients recovering from head injury. There is
little evidence for there use in other groups. The Hospital Anxiety and Depression Scale
(HADS) is a self assessment scale to measure mood disorders of anxiety and depression
in non-psychiatric patients. It compromises 14 items that are divided into two subscales
for which each patient rates the item on a four point scale. It does not include somatic
symptoms ofdepression. It is brief and easy to administer. It has been shown to be a
valid tool for use in the critically ill (Rowan 1992).
1.14.1.11.1 Davidson Trauma Scale
Davidson Trauma Scale (DTS) (Davidson, Book et al. 1997) is a self rating scale which
assesses 17 symptoms that correspond to DSM-IV and each is rated for both frequency
and severity on 5 point scales using a past-week time frame. It has been shown to be
reliable (a coefficient 0.97-0.99) for the frequency, severity and total scales and the test-
retest correlation was also shown to be good. The scale is sensitive (0.69) and specific
(0.95) accurately identifying patients who meet the diagnostic criteria for PTSD with a
DTS ofmore than 40. The DTS when compared to other scales appears to detect
clinically important change in response to treatment (Norris 2004).
1.14.2 Summary of outcome measures in critical care used in this thesis
In assessing outcomes in critical illness it is difficult to find recommendations on which
measures should be used. It has been proposed that an agreed list ofmeasures should be
developed which studies should endeavour to use in their research. This would allow
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comparisons between studies to be made more easily. In the research chapters of this
thesis the most common measure of quality of life (SF-36) has been used. In assessing
physical function we have used the six-minute walk test as our gold standard and
compared it to other actual and perceived measures ofphysical function, principally the
FAI. FAI has not been used in the critical illness population previously but was chosen
because of its ability to reflect a broad spectrum ofphysical function and its good
correlation with the SF-36 measure.
1.15 Aims of thesis
Patients who survive critical illness have an excess mortality compared to age / gender
matched general populations for many years after the original illness (Wright,
Plenderleith et al. 2003) with 20-25% of patients dying within the following 12 months.
The cumulative burden ofmortality and morbidity among survivors is largely unknown.
Many survivors suffer from a range of disabilities that comprise a "post intensive care
syndrome". Morbidity ranges from physical disability to psychological problems. The
research of this thesis aimed to address one of the common complications of critical
illness, anaemia (The TRAC Study, Chapter 2), and to determine the impact of critical
illness on physical function and quality of life (Ps and Qs Study, Chapter 3). A third
chapter (Chapter 4) explores the possible links between anaemia, physical function and




The Resolution of Anaemia following Critical illness
2.1 Introduction
Anaemia is a common complication of critical illness (Corwin, Gettinger et al. 2004).
Once present it frequently persists until intensive care unit discharge (ICU) unless
modified by blood transfusion or less well established transfusion practices such as
erythropoietin administration. The Transfusion requirements in Critical Care (TRICC)
study (Hebert, Wells et al. 1999) established that a restrictive transfusion policy was at
least as effective as a liberal transfusion strategy (as detailed in section 1.12.3.2) and has
resulted in a more consistent use of restrictive transfusion practice with typical median
pre-transfusion haemoglobin values between 78-85 g/L (Chohan, McArdle et al. 2003).
When a restrictive transfusion policy is employed the prevalence of anaemia is as high
as 80% (Walsh, Lee et al. 2006). Recent studies have shown that anaemia is still
frequently present at hospital discharge (Walsh, Saleh et al. 2006) and has
normochromic normocytic characteristics similar to that of the anaemia of chronic
disease. Other epidemiological studies followed patients for up to 28-30 days following
ICU admission, but did not report anaemia outcomes specifically for the post ICU
recovery period (Vincent, Baron et al. 2002; Corwin, Gettinger et al. 2004). It is not
known how long anaemia persists among ICU survivors or what factors influence its rate
of recovery.
Many patients suffer reduced quality of life after hospital discharge, often associated
with symptoms typical of anaemia such as fatigue and breathlessness (Herridge 2002;
Herridge, Cheung et al. 2003). Whilst these symptoms may have a multi-factorial
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aetiology in other settings such as chronic renal failure (Obrador and Pereira 2002),
cancer (Caro, Salas et al. 2001) and cardiovascular disease (Horwich, Fonarow et al.
2002; Silverberg, Wexler et al. 2002) anaemia is specifically associated with a poor
quality of life and treatment of the anaemia improves symptoms (Ross, Fahrbach et al.
2003). These observations are consistent with hypothesis that anaemia contributes to
morbidity following critical illness.
Our primary aim was to determine the time period between ICU discharge and
resolution of anaemia in a cohort ofpatients discharged with significant anaemia
(haemoglobin <100 g/L). Our secondary aims were to investigate what factors contribute
to the persistence of anaemia and to measure quality of life in patients discharged from
intensive care with anaemia.
2.2 Methods
2.2.1 Design and setting
We performed a prospective cohort study following patients over a 6 month period
following ICU discharge. The study received local ethics approval and informed consent
was obtained from the patients. Patients were recruited from the 18-bedded medico-
surgical ICU of the Royal Infirmary of Edinburgh, a university hospital receiving acute
admissions for all specialities except neurosurgery, colorectal surgery and urology.
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2.2.2 Recruitment
We planned to recruit all eligible patients over a 6 month period. As an exploratory
study no formal power calculation was made. We intended to recruit 40 patients which
we believed would give adequate data to define the common patterns of anaemia that
occur. Based on our own data, 62% ofpatients are discharged from the study ICU with
significant anaemia (haemoglobin less than 100 g/L) and admission rates were expected
to be approximately 700 patients per year. With a 25% ICU mortality we therefore
anticipated 300 patients to be discharged with significant anaemia per year. Allowing for
patients not meeting inclusion criteria and assuming a 50% agreement of approached
patients to actually take part in the study we predicted a recruitment rate of 100 patients
per year. We estimated it would take 20 weeks to recruit the 40 patients.
Our inclusion criteria were: patients requiring > 24 hours of advanced physiological
support (invasive ventilation alone or non-invasive ventilation plus at least one other
organ failure); haemoglobin concentration <100 g/L at ICU discharge; age >16 years.
Exclusion criteria were: pre-existing haematological disorder; treatment with
immunosuppressant or cyto-toxic drugs; acute or chronic renal failure requiring renal
replacement therapy at time of discharge; patients residing out-with reasonable
geographical follow up; patients discharged for palliative care or not expected to survive
to hospital discharge, and patients unable to give informed consent.
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2.2.3 Patient characteristics
We recorded demographic data, clinical diagnosis, Acute Physiology and Chronic
Health Evaluation score (APACHE II) (Knaus, Draper et al. 1985) score and worst
Sequential Organ Failure Assessment (SOFA) (Vincent, de Mendonca et al. 1998) score
during ICU stay, haemoglobin concentration on admission to ICU and ICU length of
stay. We recorded the number of blood transfusions received whilst in ICU. At follow-
up we recorded whether patients had received further blood transfusions, iron, vitamin
B12 or folate supplements during the study period.
2.2.4 Study protocol
Patients were followed up at 1, 3, 6, 9, 13 and 26 weeks post ICU discharge either in
hospital or their homes. We measured haemoglobin (Hb) concentration (g/L), mean cell
haemoglobin (MCH, pg), mean corpuscular haemoglobin (MCHC, g/dL), mean red cell
volume (MCV, fL) and serum creatinine (Creat, pmol/L) at all visits. We used locally
defined reference ranges for haemoglobin to define anaemia (male <130 g/L; female
<115 g/L). We obtained advice from an expert group prior to the study and established a
range ofmeasures to assess:
1. Iron status: ferritin, percentage hypochromic red cells (%HYPO), reticulocyte
haemoglobin (RH, pg)
2. Erythropoiesis; serum erythropoietin concentration (EPO, mlU/ml), soluble
Transferrin receptor concentration (sTfR, nmol/L), reticulocyte count (Retics,
number x 109/l)
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3. Inflammation; C-reactive protein (CRP, mg/dL) and serum Interleukin-6
concentration (IL-6, pg/ml)
We defined the following abnormalities apriori:
Absolute iron deficiency was defined as a plasma ferritin concentration of <12 pg/L or
<100 pg/L in the presence of elevated inflammatory markers as ferritin is an acute phase
protein and is elevated in the presence of inflammation. Patients with ferritin >100 pg/L
were defined as having no evidence of iron deficiency irrespective of inflammatory
markers (Cavill 1999).
Functional iron deficiency (impaired incorporation of iron during erythropoiesis despite
adequate body iron stores) was defined as the presence of >5% hypochromic red cells
(%HYPO) and / or reticulocyte haemoglobin (RH) of <28 pg (Thomas and Thomas
2002).
Vitamin B12, plasma folate and red cell folate deficiency were defined as values below
the local laboratory reference ranges, (<150 ng/L, <2.0 pg/L, <95 pg/L respectively).
Inappropriate erythropoietin response to anaemia was defined as a circulating
erythropoietin concentration that was lower than published normal values relating
haemoglobin with plasma erythropoietin concentration (Kendall 2001; Elliot,
Virankabutra et al. 2003). Specifically, we defined an abnormal erythropoietin
concentration as <40 mlU/ml and <20 mlU/ml for the haemoglobin concentrations of
<100 g/L and 120 g/L respectively.
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Persistent inflammation was defined as detectable (>10 pg/ml) circulating interleukin-6
(IL-6) and / or C-reactive protein (CRP) >5 mg/dL (Abel, Spannbrucker et al. 1996). IL-
6 was chosen as a marker of inflammation as unlike other pro-inflammatory cytokines it
remains elevated in the presence ofpersistent inflammation and its repeated
measurement is a good indicator of activation of the cytokine cascade in various
conditions (Martin, Boisson et al. 1997; Oda, Hirasawa et al. 2005).
Evidence of new erythropoiesis (a measure ofbone marrow responsiveness) was defined
as a reticulocyte count above the normal range (>55 x 109) (Hirose, Yamane et al. 2005)
and / or an increase in soluble transferring receptors (sTfR) concentrations above normal
values using a locally determined control distribution.
Assessment of renal function was made by serial calculation of the estimated glomerular
filtration rate (eGFR) from the plasma creatinine concentration at all visits (Burden and
Tomson 2005).The schedule for blood sampling is detailed in Table 2.1.
Quality of life was assessed using the Medical Outcomes Survey 36-Item short form
health survey (SF-36) (Ware J E 1992) at 3 and 6 months and compared to published
normal populations (Jenkinson, Layte et al. 1997; Keller, Ware et al. 1998) and data
from a Scottish unselected ICU survivor cohort study (Cuthbertson, Scott et al. 2005).
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2.2.5 Analytical Methods
Analyses of the standard haematological and biochemical parameters were carried out in
the local hospital laboratory using the Sysmex KX21 Counter for haematogical
parameters and Sysmex Corporation analyser for biochemical parameters. %HYPO, RH
analyses were carried out within 3 hours of sampling at specialized hospital centres.
Specialized analyses ofpercentage hypochromic red cells and reticulocyte haemoglobin
were analysed by the Haematology Laboratory, Wishaw General Hospital, Scotland,
UK. Specialized analyses of reticulocyte count, mean cell haemoglobin concentration
and mean cell haemoglobin were analysed by the Haematology Laboratory, Monklands
General Hospital, Scotland, UK.
Samples for serum assays were spun within 2 hours and stored at -80°C. Serum
erythropoietin concentrations were measured by enzyme linked immunosorbant assay
(ELISA) at Simbec Research Ltd, Methyr Tydfil, UK. Serum IL-6 and sTfR
concentrations were measured using ELISA kits (Quantikine R&D Systems,
Minneapolis, USA).
In addition to the above quantitative measures the expert panel met to review all the data
from all the patients after the study completion. A consensus 'expert opinion' was
reached regarding the main factors contributing to the pathogenesis of anaemia




2.2.6.1 Time to resolution of anaemia
Haemoglobin values against time were plotted and the proportion of anaemic patients at
each time point was calculated. The lower limits for gender specific population reference
ranges were used as the cut off values. To assess the rate of recovery from anaemia we
calculated rates of increase in haemoglobin between visits. An increase of 10 g/L per
week is frequently quoted as a healthy response to blood loss. We also included a lower
cut off at 5 g/L to assess for a reduced rather than an absent response often seen in acute
illness.
2.2.6.2 Responders and Non-Responders
We explored differences between patients who recover more quickly from anaemia after
ICU discharge, 'responders' with those who remained anaemic or recovered slowly,
'non-responders'). Responders were defined as the patients who had returned to sex
specific reference range by 13 weeks following ICU discharge and Non-responders as
those patients whose haemoglobin concentration remained below sex specific reference
range at 13 weeks. To explore factors associated with poor recovery we compared
variables at week 3. Week 3 was chosen as it was expected that the greatest divergence
between the two groups would be apparent early in those who would recover.
2.2.6.3 Statistical Methods
The data is presented with the median value 1st and 3rd quartiles and range for the
measured parameters. For the Responder / Non-Responder groups we used the Mann-
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Whitney test for continuous data and Fisher's Exact test to compare proportions.
Microsoft Excel and GraphPad Prism were used for analysis and graphical figures.
2.3 Results
2.3.1 Study recruitment
We recruited 30 patients (77% recruitment rate for eligible patients, Figure 2.1). Six
patients (20%) died during the study follow up and 5 patients (17%) were lost to follow
up.
2.3.2 Baseline characteristics
Demographic and clinical characteristics for the study cohort are shown in Table 2.2.
The timing and causes of death during the study period are shown. No patients had a
known associated malignancy independent of their reason for ICU admission which
could have contributed to the persistence of their anaemia.
No patients received blood transfusions during the study follow up period and none were
prescribed iron, folate or vitamin B12 supplements. No patients received exogenous
erythropoietin during the study.
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Figure 2.1 Recruitment to TRAC study
Table 2.2 Demographics, baseline characteristics and study mortality
Demographic Number. Median (1st & 3rd Quartiles;
Range)
Gender (c?/§) 20/10
Age (years) 66.5 (55, 77; 35-83)
APACHE II at admission 21 (16, 24; 7-38)
Worst SOFA score during ICU stay 9.5 (7.2, 14.0; 5-18)
ICU length of stay (days) 12(9, 23; 2-46)
Haemoglobin at ICU admission (g/L) 96 (80, 104; 65-164)
eGFR at study entry (ml/min/1.73m2) 84.9 (53, 102;13-154)
Primary Diagnosis Number
Respiratory




Post cardiac arrest 1
GI
Perforated Viscus 4




Ruptured abdominal aortic aneurysm 2
Unexpected complication of surgery
Excess bleeding (thyroidectomy) 1
Protracted surgery (elective abdominal
aortic aneurysm repair)





No organism identified 1
Deaths
Characteristics, Time in study
Male 85y, 1 week
Male 83y, lweek
Female 49y, 3 weeks
Male 81 y, 9 weeks
Female 62y, 9 weeks








Two of the female patients were pre-menopausal. One patient had normal menses and
was no longer anaemic by the third week of follow up. The other patient did not return
to normal menses until 3 months following ICU discharge; her haemoglobin returned to
normal range by 6 months.
There was no association between age, ICU length of stay, severity of illness at ICU
admission (APACHE II), or during ICU stay (SOFA max), or the number of transfusions
received in ICU and time to recover from anaemia in those patients whom completed the
study.
2.3.3 Time course of anaemia after ICU discharge
Haemoglobin concentrations during the study period are shown in Figure 2.2. Among
the patients remaining in the study, 63% (12/19) were anaemic at 13 weeks and 53 %
(10/19) were anaemic at 26 weeks. 32% (6/19) and 16% (3/19) of the patients had a
haemoglobin concentration <110 g/L at 13 and 26 weeks respectively. Among the
patients whose anaemia recovered during the study period the median time to entering
the gender specific normal reference range was 11 weeks (1st and 3rd quartiles 9 and 26;
range 1 to 26 weeks). Using rates of increase in haemoglobin concentration between
visits, from weeks 1 to 3 only 30% (n=7) patients demonstrated a haemoglobin increase
of >10 g/L per week and 60% (n=13) an increase >5 g/L per week. Amongst those
patients still anaemic at 6 weeks post-ICU discharge, none demonstrated an increase >5
































Figure 2.2 Changes in haemoglobin concentration during course of study
The proportion of patients still anaemic are shown in boxes above each time
point.
Table 2.3 Rate of change of haemoglobin for all patients in TRAC study









whose Hb did not
increase by an
average 1 Og/L per
week since last
visit
71 (20) 71 (15) 100(16) 84(16) 100(12) 100(10)
Number of
anaemic patients





54 (15) 38(8) 81 (13) 74(14) 83(10) 100(10)
2.3.4 Aetiology of anaemia
Baseline haemoglobin levels (median (1st, 3rd quartile)) for patients at recruitment (week
0) were 88.5 g/L (84.0, 95.0). Subsequent values and additional haematological
parameters are summarised in Table 2.4.
2.3.4.1 Absolute iron deficiency
Ferritin concentrations were >12 pg/L in all patients throughout the study. Some
anaemic patients with detectable circulating inflammatory markers had ferritin values
12-100 pg/L, particularly at later time points, but this was unusual. The data suggested
that absolute iron deficiency was rare, but may have been present in a small number of
patients during the later stages of recovery. This suggestion comes from extrapolation of
the data regarding ferritin concentrations at later time points. A rapid decline in ferritin
concentration was seen although never to a concentration less than 12 pg/L. With the
observed rate of decline seen in some patients it was possible they may, in due course,
have developed absolute iron deficiency.
2.3.4.2 Functional iron deficiency
The HR was >28 pg throughout the study in virtually all cases. Some patients had >5%
hypochromic red cells early in the study, but this was not seen later in the study. Among
patients with >5% hypochromic red cells the mean cell haemoglobin concentration
(MCHC) was normal. These data suggest that detection of functional iron deficiency
was test specific. If present, based on percent hypochromic red cells it was only present
in the early post-ICU period.
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2.3.4.3 Evidence of vitamin B12 or folate deficiency
Only one patient had a vitamin B12 level marginally below the reference range (value
165 ng/L) at week 26. One patient had a folate level marginally below the reference
range (value 1.8 pg /L) at week 13, which recovered without treatment by week 26. For
all other cases and time points there was no biochemical evidence of vitamin B12 or
folate deficiency. The data showed that vitamin B12 and folate deficiency rarely
contribute to anaemia after intensive care.
2.3.4.4 Persistent inflammation
IL-6 and CRP concentrations were elevated in most patients at ICU discharge and
persisted in many patients at the early evaluation time points .There was a highly
variable pattern during long-term follow up, but some patients continued to have
elevated circulating concentrations of inflammatory markers at 3 and 6 months after ICU
discharge (Figure 2.3).
2.3.4.5 Inappropriate erythropoietin response
We found that inappropriately low erythropoietin concentrations were highly prevalent
throughout the study, and were present in all patients who remained anaemic during the
later stages (Figure 2.4). These data showed that the healthy erythropoietin response to
anaemia was either blunted or absent.
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Figure 2.4 Erythropoietic parameters -




































Figure 2.5 Indices of new



























Figure 2.3 Inflammation parameters - CRP and IL-6
Box and whisker plots showing median, inter-quartile range and range for
measured serum IL-6 (light grey) and CRP (dark grey) concentrations. Normal
concentrations (non inflammatory states) less than 12 pg/ml and 5mg/dL
respectively.
Figure 2.4 Erythropoietic parameters - Erythropoietin and reticulocyte
count
Box and whisker plots showing median, inter-quartile range and range for
measured plasma reticulocytes (retics, left axis) and serum erythropoietin
concentration (EPO, right axis). Evidence of new erythropoiesis was defined as
a reticulocyte count >55x109/l. Evidence of an erythropoietin response to
anaemia was dependent upon the degree of anaemia (Specifically we defined
an abnormal erythropoietin concentration as <40 mlU/ml and <20 mlU/ml for
haemoglobin concentrations of <100 g/L and <120 g/L respectively).
Figure 2.5 Indices of new erythropoiesis and iron status
Distribution of hypochromic red cells (%HYPO, light grey), reticulocyte
haemoglobin (CHR, mid grey) and soluble transferrin receptor concentrations
(STfR, dark grey). Box and whisker plots showing median, inter-quartile range
and range for percentage of hypochromic red cells in plasma (left axis), amount
of reticulocyte haemoglobin (left axis) and concentration of soluble transferrin
receptor in serum (right axis).
2.3.4.6 Evidence of new erythropoiesis
A minority of patients (approximately 20%) had elevated sTfR concentrations during the
study period, but these levels were only modestly increased compared to controls and
did not appear to relate to the degree of anaemia. There was a range in patterns of
reticulocyte response (Figure 2.5). Patients who remained anaemic at later time points
tended to demonstrate a lack of reticulocyte response to anaemia. Together, the data
showed a hypo-active bone marrow given the degree of anaemia.
2.3.5 Quality of Life
Results from the SF-36 assessments at 3 and 6 months are shown in Figure 2.6 and
Table 2.5 together with comparative data from the UK normal population matched for
the median study group age (Ware J E 1992; Jenkinson, Layte et al. 1997). Data from a
Scottish study of quality of life after ICU discharge are also shown for comparison
(Cuthbertson, Scott et al. 2005). This study group had a similar mean age to our study
group. Our patients had low quality of life scores across all domains but particularly for
the role physical.
2.3.6 Comparison of responders and non-responders at week 3 after ICU
discharge
2.3.6.1 Baseline Characteristics
There were no statistically significant differences in baseline characteristics between the
groups (Table 2.6).
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It is notable that the responder group were generally younger, 57 years (54-63), median
(1st and 3rd quartiles) compared to 69 years (64-75) and had a shorter ICU stay 11.0 (4-
12) days compared to 14.5 (9-17). The number of transfusions received during ICU stay
failed to reach significance. The Non-responder group received more blood during there
ICU stay, 2 (0 - 8), median (1st and 3rd quartiles) for Responders versus 7 (4 - 16) units
for Non-responders. There were no clinically or statistically important differences in
measures of absolute or relative iron deficiency, vitamin status, red cell folate, or
serum folate between responders and non-responders either at 3 weeks after ICU
discharge or at any time point over the study period (data not shown).
2.3.6.2 Parameters at week 3
A comparison ofpatient parameters at the 3 week time point is shown in Table 2.6.
Patients whose anaemia did not recover by week 13 had significantly higher CRP
concentrations (p=0.013) and a trend to a greater proportion of patients having
abnormally high IL-6 concentrations (p=0.06) at week 3 after ICU discharge. These
patients had lower reticulocyte counts (p=0.014) consistent with persisting marrow
hypo-responsiveness in the post-ICU period.
There was no difference in circulating erythropoietin concentrations between the groups
as both groups had inappropriately low erythropoietin concentrations 3 weeks after ICU
discharge. Examining trends over time, the non-responder group tended to have higher
indices of inflammation and lower indices of erythropoiesis over the course of the study.
Graphs showing these trends are shown in Figures 2.7 and 2.8. Data for sTfR is not
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Table 2.6 Comparison of Haemoglobin 'Responders' and 'Non-

































Ferritin pg/L 3 months
Vitamin B12 ng/L
3 months











2/7 (28.5%) 5/12 (41.6%) 0.654
115(110.0-120.5) 105 (100.5- 115.0) 0.208
14(10.2-19.25) 13.2 (10.7-14.2) 0.690
5/7 (71%) 8/11 (72%) 1.000
5 (5-11) 60 (27.8- 124.5) 0.013 *
2/7 (28%) 8/8 (100%) 0.007*
11.99 (8.01 - 14.44) 32.48 (18.03-49.62) 0.197
1/7 (14%) 6/9 (66%) 0.060
62.1 (53.2-98.0) 43.6 (33.8-54.8) 0.014*
2/7 (29%) 9/11 (81%) 0.049*
90.0(15.0- 130.0) 365.5 (45.5-512.5) 0.0312*
348 (297-541) 359 (285-589) 0.7577
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Figure 2.7 Haemoglobin concentrations of responder and non-responder
groups
Median and interquartile range shown
Figure 2.8 Changes in inflammatory markers between responder
and non-responder groups































































shown due to the very small numbers of patients in each group with data available.
There was no statistically significant difference in quality of life of these two groups but
it is again worth noting that the responder groups did score higher in the role physical at
3 and 6 months (Figure 2.9 and Table 2.7).
2.3.7 Renal Function
As part of the inclusion criteria for the study, no patient was enrolled if they required
renal replacement therapy at time of ICU discharge. No patients required further renal
therapy during follow up. We measured the patient's serum creatinine at every visit and
calculated the eGFR accordingly. Of all 30 patients recruited, 9 had eGFR <60
ml/min/1.73m2 (range 13 to 59) at discharge from ICU. Of these 5 patients were
classified as 'non-responders' and 3 did not return to an eGFR of greater than 60
ml/min/1.73m2 during the study period. Analysing the group of patients which
completed the study there was no statistical association between the presence of eGFR
less than 60 ml/min/1.73m2 at ICU discharge and recovery from anaemia.
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Figure 2.9 SF-36 physical (PCS) and mental (MCS)
component summary scores for responder and
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Table 2.7 Quality of life measures in responder and non-responder groups





























Median and interquartile range shown
2.4 Discussion
This was the first study examining the time course and pathophysiology of anaemia
during long term follow up after critical illness. The results of this prospective cohort
study indicated that anaemia recovered at rates expected for healthy individuals in only
30% of cases. In the majority of patients recovery was slow or absent such that 63% and
53% of all patients were still anaemic at 3 and 6 months respectively, and 32% and 16%
respectively had haemoglobin values less than 110 g/L.
2.4.1 Critique of study methodology
Our cohort was an unselected mixed general ICU population with a high illness severity
and varied case-mix. Patient numbers were relatively small as the protocol required
frequent follow-up either in hospital or at the patients' home and multiple blood
analyses. This may have deterred a proportion of eligible patients. As a result there was
a possibility of type II error, so we limited analysis to descriptive methods, with the
exception of the exploratory comparison of patients whose anaemia recovered at 13
weeks versus those with persisting anaemia. We achieved high rates of follow-up and
sampling, which decreased the chance of bias. The investigations used to describe the
aetiology of anaemia and the definitions of different contributory factors were pre¬
defined by an independent expert panel of haematologists. Some important subgroups
were excluded, notably patients with persisting acute renal failure or pre-ICU chronic
renal failure. These patients have an independent reason for erythropoietin deficiency
and impaired erythropoiesis, and also tend to have greater ongoing blood loss from
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sampling and dialysis circuits (Lipkin, Kendall et al. 1990). Although treatment
decisions were not dictated by the study, no patients received any blood transfusions,
iron, folate or erythropoietin therapy or other treatments that might have confounded our
findings.
2.4.2 Meaning of our findings
Our data strongly suggest that recovery was limited primarily by a hypo-reactive bone
marrow. This may have been in part a result of inappropriately low circulating
erythropoietin levels, although this was a feature ofboth responders and non-responders
early in the study follow up. It is well documented that circulating erythropoietin
concentrations are lower than expected in anaemic patients during ICU stay (Elliot,
Virankabutra et al. 2003) and our data indicate that this persists into the recovery period.
The hypo-reactive bone marrow that characterized the non-responding patients is typical
of an anaemia of chronic inflammatory disease in which pro-inflammatory mediators
inhibit erythrogenesis (Baer, Dessypris et al. 1990; Wolfe and Michaud 2006).
Circulating IL-6 and CRP concentrations were higher in the non-responder group during
this early period of recovery, which supports the conjecture that persistent anaemia after
critical illness is associated with a chronic inflammatory state. During follow up, 65%
and 60% of patients still had detectable circulating IL-6 concentrations, at 3 and 6
months respectively after ICU discharge, and 48% and 31 % had elevated CRP
concentrations. This is a possible explanation for the "inappropriate" erythropoietin
response and impaired erythropoiesis. Inflammatory mediators are known to inhibit
erythropoietin production and the marrow response to circulating erythropoietin (Corwin
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and Eckardt 2005; Ferrucci, Guralnik et al. 2005). Serum from ICU patients, particularly
those with sepsis, directly inhibits erythroid precursors, and can induce apoptosis of red
cell precursors (Lang, Lang et al. 2003; Lang, Lang et al. 2005).
There was little evidence of iron, folate or B12 deficiency at any point in the study. In a
small number ofpatients ferritin concentrations fell late in follow up period, particularly
in patients whose anaemia recovered, often in association with normalisation of
inflammatory markers. This could indicate either resolving inflammation, as ferritin is
an acute phase protein, or a decrease in iron stores resulting from active erythrogenesis.
None of these patients developed evidence of absolute iron deficiency during the study
period using our pre-defined criteria. The interpretation of the indices of functional iron
deficiency was difficult and contradictory between methods of assessment. Overall there
was little evidence for significant functional iron deficiency. The high percent of
hypochromic red cells observed in some patients early after ICU discharge was
consistent with previously reported findings during ICU stay (Rogiers, Zhang et al.
1997; Bellamy and Gedney 1998; Patteril, vey-Quinn et al. 2001). Although this could
indicate impaired incorporation of iron into red cells another explanation could relate to
red cell shape changes that occur during sepsis and inflammation (Herridge, Cheung et
al. 2003; Piagnerelli, Boudjeltia et al. 2003) which are not accounted for in the
automated red cell analysis. It is also possible that functional iron deficiency only
becomes apparent when the marrow is stimulated with exogenous erythropoietin.
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2.4.2.1 Interplay between cytokine activation and recovery from critical
illness
Cytokine changes during critical illness have been studied extensively. Cytokines are
produced in response to a variety of tissue insults and contribute to tissue dysfunction
(Oberholzer, Oberholzer et al. 2000). Studies have consistently shown that pro¬
inflammatory cytokines are higher in non-survivors than in survivors of critical illness
(Dimopoulou, Orfanos et al. 2008) and that IL-6 either alone, or in combination with
severity of illness scoring, is of use in predicting outcome (Wunder, Eichelbronner et al.
2004). Little is known, however, about cytokine changes during the recovery period. In
patients with community acquired pneumonia whom required admission to hospital, the
presence of an elevated IL-6 concentration at subsequent discharge from hospital was
associated with an increased risk of death over the subsequent 3 months, even though
only 13% of these patients had abnormal vital signs at discharge (Yende, D'Angelo et al.
2008). This suggests that many patients have a persisting inflammatory response even
though the clinical signs have resolved (Halm and Teirstein 2002). The persistence of
low grade inflammation and immunosuppression may play an important role in
complications after hospitalization after community acquired pneumonia such as
cardiovascular death, renal failure and repeat infections (Ridker, Rifai et al. 2000;
Mortensen, Coley et al. 2002; Shlipak, Fried et al. 2003) and it may therefore be that the
cytokine profiles during recovery influence different mechanisms or cause specific
mortality. Our data suggest that the bone marrow is another body system so affected.
This underscores the need to examine the cellular response and cytokine influences on
the recovery of the haematopoietic and immune system after critical illness.
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2.4.2.2 Immunomodulation of erythrogenesis
Inflammatory cytokines such as IL-6 can inhibit iron absorption and metabolism through
the regulation ofhepcidin (Nemeth and Ganz 2006; Nemeth 2008). Thus the persistence
of inflammation would continue to prevent resolution of anaemia. Looking at the time
course of IL-6 with anaemia in the responder and non responder groups there is a trend
showing that the resolution of inflammation is temporally related to the subsequent
resolution of anaemia.
2.4.2.3 Antibiotics and the bone marrow
It is also possible that the medications, especially antibiotics such as the oxylazones,
which critically ill patients are often exposed to during their ICU and hospital stay, could
directly inhibit erythropoiesis. If there is ongoing infection it is possible that the
exposure of such patients may be greater to such drugs inhibiting the bone marrow and
that this may also contribute to the anaemia seen. We did not specifically examine the
use of antibiotics in ICU or during the recovery period but anecdotally we did not have
any patients on protracted courses of oxylazones during recovery period. Due to the very
broad case mix contributing to a study group we felt that it is unlikely that this effect on
its own would have significantly contributed to different responses to anaemia.
2.4.2.4 Inflammation and renal function
The erythropoietin response must be considered in the context of the renal function of
the patients as the development of chronic kidney disease would affect the response to
anaemia. Despite none of our study group requiring renal replacement therapy at ICU
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discharge 30% had an eGFR consistent with chronic kidney disease. This must be
interpreted with some caution as eGFR has not been validated for use in acute renal
failure (which may be resolving by the time of ICU discharge), or oedematous states,
muscle wasting states and malnourishment, which many patients are suffering from at
the time of discharge. None of our patients went on to require renal replacement
strategies during the study period and only 16% (3/19) ofpatients who completed follow
up had an eGFR<60, though 2 of these patients did remain anaemic at 6 months. There
is also a prevalence of reduced eGFR measured within the general population without a
specific diagnosis or awareness of having chronic kidney disease. This prevalence can
be as much as 30% in those aged over 75 years (Cirillo, Laurenzi et al. 2006) and
therefore a level of abnormal eGFR is likely to be present in our study population. Elliot
et al demonstrated that EPO levels were the same for critically ill patients with and
without acute renal failure and this persisted into the chronic phase of critical illness
(Elliot, Virankabutra et al. 2003). Thus although the development of chronic kidney
disease during recovery from critical illness will affect the recovery from anaemia it
would have been difficult to exclude patients from the study on the basis of their eGFR
at ICU discharge alone. There was no statistical difference in eGFR at discharge
between groups who recovered from anaemia compared to those that did not.
2.4.2.5 The clinical importance of anaemia during recovery from
critical illness
The clinical importance of anaemia during recovery from critical illness is unknown. It
is well documented that patients suffer fatigue and breathlessness following critical
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illness even without demonstrable lung pathology (Herridge, Cheung et al. 2003). It is
possible that anaemia contributes to these symptoms. Our patients had low quality of life
scores at 3 and 6 months after ICU discharge in all domains, but especially in the role
physical. The observed scores were lower than reported in a non-selected population of
patients surveyed after intensive care discharge in a similar (Scottish) population
(Cuthbertson, Scott et al. 2005). These data suggest an association between anaemia at
intensive care discharge and poor long term quality of life. Our data suggest that
anaemia is potentially important during recovery from critical illness, and supports the
hypothesis that treating anaemia could potentially improve some of the symptoms
suffered by patients.
A study in long term ICU patients showed that treatment with erythropoietin had modest
effects on haemoglobin concentration and blood transfusions and no effect on recovery
rates (Silver, Corwin et al. 2006). Recent data suggest that erythropoietin treatment
alone during ICU care is not effective for reducing red cell transfusion (Corwin,
Gettinger et al. 2007) and in fact may actually be detrimental due to increased
complications, especially venous thrombosis. Our data suggest that an abnormal
erythropoietin response and significant anaemia persists for at least 6 months after ICU
discharge in many patients, particularly those with persisting inflammation. It is likely
that red cell transfusions either alone or in combination with erythropoietin are required
to achieve haemoglobin concentrations approaching reference values in the post-
intensive care period. Few studies have evaluated the importance of treating anaemia
during this period, and specifically whether interventions with blood transfusions or
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erythropoietin during recovery improve patient quality of life, as has been reported for
anaemia associated with other chronic diseases (Horwich, Fonarow et al. 2002; Obrador
and Pereira 2002; Silverberg, Wexler et al. 2004). Current recommendations are based
on the findings of the TRICC trial in which restrictive and liberal strategies were only
compared during ICU care. This practice may not be appropriate to the extended
recovery period.
2.5 Conclusions
We have shown that anaemia persists for at least 6 months following intensive care
discharge in many patients with no history of pre-illness anaemia. The erythropoietin
response to anaemia is blunted during this period and bone marrow is hypo reactive in
many patients, especially those with persistent systemic inflammation. Patients
discharged with anaemia from intensive care have a reduced quality of life compared to
other ICU groups. A greater focus upon the treatment of the anaemia of critical illness in
the recovery phase rather than the acute phase could be a mechanism by which the
potentially detrimental effects of such interventions could be avoided.
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Chapter Three
The Ps and Qs Study




Critical care medicine represents the provision of advanced, aggressive and expensive
medical support to individuals with an illness of life threatening severity and high short
term mortality. Critical care research has, until recently, understandably focused on short
term physiological parameters and short term clinical outcome measures such as survival
to ICU and hospital discharge. With improved short term survival from critical illness,
research is now focusing on the long term impact upon the individual and their families.
Surviving critical illness is just the beginning and recovery from critical illness is
protracted and associated with significant morbidity. Health Related Quality of Life
(HRQL) is the term used to refer to the subjective experience of the effect of health and
treatment on a patient's satisfaction with life.
But what is health? The WHO provides a standard language and framework for the
description of health and health related states in the International Classification of
Functioning, Disability and Health (ICF) (Organisation 2002). Everyone experiences a
decrement in their health at some point but the impact of this change in health status will
be different for each individual depending upon many factors including previous health,
previous family experience, expectations of health, and environmental and socio¬
economic factors. As a consequence the ICF aims to place the effects of a change in
health in context by recording the impact on an individuals function rather than in
respect to the severity of the cause of the disability itself.
Pre-existing disease will therefore modulate the impact of critical illness on an
individual. It was noted in the TRAC study (Chapter 2) that patients with a significant
96
pre-morbid illness burden and subjectively a greater degree of overall illness burden
during recovery from critical illness often reported a greater quality of life than those
who were healthier both before and after the critical illness. We therefore proposed that
the change in health Rather than the actual level of disability was the most important
determinant of quality of life following critical illness.
3.1.1 Health Related Quality of Life following critical illness
There are many methods of determining HRQL (Black, Jenkinson et al. 2001). The two
measures recommended by the 2002 consensus conference on surviving critical illness,
the SF-36 and EQ-5D have only been used in 2% of ICU studies. Studies have shown
conflicting results.
3.1.2 Pre-morbid HRQL
Cuthbertson et al showed that pre-morbid quality of life in critically ill patients was
impaired compared to the normal population (Cuthbertson, Scott et al. 2005). It was also
significantly reduced in the physical components at three months following ICU
discharge and gradually returned to the pre-morbid values, but remained less than the
general population, at 1 year. Mental components of quality of life were not impaired at
any time point. Wehler et al found that preadmission HRQL was severely impaired in
intensive care patients due to a significant level of chronic co-morbidity prior to the
acute event and that this co-morbidity contributed to the reported reduced HRQL in the
recovery period (Wehler, Geise et al. 2003). These studies show that HRQL in the
survivors of critical illness was impaired prior to the illness requiring ICU admission.
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Angus et al demonstrated that in an apparently previously fit cohort ofpatients who
developed ARDS as part of their critical illness, significant impairment of quality of life
was evident and these patients remained at an increased risk of death during the
extended recovery period after ICU discharge (Angus, Musthafa et al. 2001). They
assessed the physical function and recalled pre-morbid quality of life and found that it
was essentially the same as that of a non-critically ill population. Many of the symptoms
during recovery were associated with pulmonary impairment. It was therefore suggested
that it was physiological impairments developed as a consequence of critical illness (in
this case specifically pulmonary problems) that were contributing to the reduced quality
of life.
It seems logical that if a significant burden of pre-illness ill health is present in patients
who go on to have a critical illness this will contribute to the quality of life after
recovery. As previously 'fit' patients go on to have a similar magnitude of impairment to
quality of life (as measured by HRQL scores) it remains unclear how much pre-morbid
health contributes to post critical illness quality of life. It may therefore be that the
change in quality of life is a more meaningful measure of the impact of critical illness on
quality of life.
3.1.3 Complications of critical illness and HRQL
Garcia Lizana et al showed that it was mental elements rather than physical disability
which showed the greatest impairment following critical illness compared to pre-morbid
state (Garcia Lizana, Peres Bota et al. 2003). However 25 % of their patients had
reduced mobility and autonomy, with 8% described as being severely incapacitated
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suggesting that there was a significant burden ofphysical disability present. Davidson et
al, (Davidson, Caldwell et al. 1999) found that the HRQL in patients with ARDS
compared to a matched cohort of patients who did not develop ARDS, was significantly
reduced and suggested this reduction was caused exclusively by the development of
ARDS and its sequelae. This exemplifies the concept that it is the complications of
critical illness rather than the initial critical event which contribute to the long term
outcomes ofpatients. There is some debate however, about what contributes to reduced
quality and quantity of life in patients who survive critical illness. Herridge et al
demonstrated that in ARDS survivors most pulmonary physiological impairments, as
measured by pulmonary function tests, had returned to normal by 6 months (Herridge,
Cheung et al. 2003). Although many of the symptoms described by the patients were
attributable to pulmonary problems the objective pulmonary physiological burden was
modest. It was therefore proposed that significant symptoms of impairment were due to
common extra-pulmonary complications of critical illness, especially neuro-muscular
impairment. These complications have been discussed in detail in Section 1.3.
3.1.4 Time course of HRQL following critical illness
In a study assessing quality of life in patients discharged from a general ICU with
principally medical, cardiovascular and pulmonary problems, Graf et al observed no
improvement in the mental health dimensions of SF-36 score over time whereas the
physical health summary scale consistently improved over the 9 months of the study
(Graf, Koch et al. 2003). They concluded that quality of life after intensive care was a
dynamic process. Hofhuis et al showed that in critically ill patients, pre-morbid HRQL
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was worse than for the general population, and that critical illness was associated with a
decline in HRQL which took 6 months to return to pre-morbid levels. Furthermore, early
measures ofpost ICU HRQL were better in those patients who survived to 6 months
than those who did not (Hofhuis, Spronk et al. 2008). In various sub groups such as
those with sepsis (Hofhuis, Spronk et al. 2008) HRQL was again shown to be impaired.
From our own work in the TRAC study (Section 2.3.5) we noted a significant
impairment of quality of life in anaemic patients following critical illness. It was
observed during the follow up that the patients who had co-morbidities prior to critical
illness often had a better reported quality of life during the recovery period than 'fitter'
individuals suggesting that it is the change in function rather than the absolute level of
function which impacts upon the individual. It was also observed that there was a
temporal relationship in the reporting of quality of life and physical function. The TRAC
study patients reported at 3 months that they had impaired physical function but a good
quality of life whereas at 6 months when there had been some improvement in physical
function they reported their quality of life as worse. We believe that this reflects a
change in expectations of health following critical illness.
3.1.5 Investigating health related quality of life
The link between critical illness and post ICU disability is therefore challenging to
evaluate. It is multi-factorial in nature and relates to intrinsic patient factors but also to
events in ICU practice and subsequent periods of rehabilitation. The questions posed by
current literature are whether patients with significant co-morbidity and therefore
reduced quality of life prior to the development of critical illness account for the
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majority of the reduced quality of life found in patients who survive critical illness, and
whether it is physical or psychological morbidity which has the greatest impact on post
ICU health. These questions have led us to investigate the relationship between changes
in quality of life after intensive care, together with measurement of functional ability and
patient's perception of health. We also sought to determine what common complications
of critical illness may be contributing to the persistence of adverse physical function and
quality of life.
3.2 Hypothesis and Objectives
3.2.1 Hypothesis
We hypothesised that health related quality of life following critical illness was impaired
due to impaired physical function.
3.2.2 Objectives
We aimed to examine the relationship between pre-morbid physical function and quality
of life and the same measures during recovery from critical illness to determine whether
the change in perceived functional ability had a greater impact on physical quality of life
recovery than could be accounted for by the actual limitation of function encountered by
these patients. We also aimed to determine the prevalence of common physiological
abnormalities encountered during recovery from critical illness and to examine their
impact on physical function and quality of life.
Our research questions were:
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• What is the impact of critical illness on perceived physical function?
• What is the impact of critical illness on physical components of quality of life?
• What is the actual physical function in a general cohort of survivors of critical
illness?
• What is the time course of recovery of quality of life, perceived and actual
physical function following critical illness?
• Does the change in perceived and actual physical function affect the physical
components of, and overall quality of life, in survivors of critical illness?
• Does the magnitude of change in perceived physical function reflect the
magnitude of impairment in physical quality of life?
• Does the magnitude of change in perceived physical function reflect the degree
of actual physical impairment?
• What is the relationship between anaemia, inflammation, nutritional status, renal
function and serum albumin and impaired physical recovery from critical illness?
• What is the prevalence of significant psychological morbidity (post traumatic
stress disorder) in our study cohort and does the presence of significant
psychological illness affect physical components of, and overall, quality of life?
Our primary outcome measures were:
• Change in SF-36 score from recalled assessments of pre-morbid quality of life
compared to follow up at 3 and 6 months post ICU discharge.
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• Change in FAI score from recalled assessments ofpre-morbid perceived physical
function compared to follow up at 3 and 6 months post ICU discharge.
• Distance walked in metres as part of a formal 6 minute walk test at 3 and 6
months following ICU discharge.
Our secondary outcome measures were:
• Haemoglobin concentration at 3 and 6 month follow up.
• Assessment of nutritional status at ICU discharge and 3 and 6 month follow up -
body weight, serum albumin, anthropometry (mid arm circumference, mid calf
circumference).
• Assessment ofhepatic and renal function with serial measurements of serum
bilirubin and creatinine concentrations at 3 and 6 months following ICU
discharge.
• Assessment of other possible contributory symptoms - fatigue, pain and lack of
appetite - using visual analogue scales.
• Secondary assessment ofphysical function with hand grip dynamometry.
• Secondary assessment of quality of life using the EURO-QOL thermometer
visual analogue scale.




3.3.1 Selection of outcome measures
3.3.1.1 Measures of quality of life
3.3.1.1.1 SF-36
SF-36 is discussed in Section 1.14.1.8.1. Many of the studies characterizing health
related quality of life in the survivors of critical illness have methodological problems
(Heyland, Guyatt et al. 1998). The use of SF-36 in patients recovering from critical
illness is supported in many studies (Chrispin, Scotton et al. 1997; Chaboyer and Elliott
2000; Hayes, Black et al. 2000) and it has been extensively validated in other patient
populations. It was recommended for use in assessing patient centred outcomes by the
2002 Consensus conference (Angus and Carlet 2003). In critically ill patients the test has
been found to take longer to administer, 20 minutes compared to 10 minutes usually,
however this is still thought to be acceptable to patients and carers. The internal
consistency in the critically ill population was found to be good with Cronbach's a
coefficient exceeding 0.85. Its validity has also been described as good (Chrispin,
Scotton et al. 1997).
3.3.1.1.2 The EuroQol VAS thermometer
The EuroQol thermometer is a component of the EuroQol 5-D questionnaire, a generic
instrument designed to measures health outcome (1990). The thermometer represents a
visual analogue scale to record perceptions of the patient's current overall perceived
health. It is can be seen as a supportive assessment due to the more reflex nature of the
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response to visual analogue scales, to see how the patient was feeling on the day of the
assessment as this may affect their responses to the more formal assessments of quality
of life.
3.3.1.2 Measures ofphysical function
3.3.1.2.1 The Frenchay Activities Index (FA!)
The Frenchay Activities Index (Holbrook and Skilbeck 1983) is discussed in Section
1.14.1.10.1. Physical function represents an important patient centred outcome following
critical illness. The Frenchay Activities Index (FAI) was developed to measure social
activities in stoke patients. The index aims to reflect higher order activities of daily
living (ADL) and was developed due to the limited scope of conventional measures of
ADL which had generally focused on abilities of self care. It has not been assessed or
validated in critical care populations but has had extensive use in elderly and young
physically disabled populations due to its broader scale incorporating complex
functional status, social and life-style activities more relevant to the post critical illness
population. It has been validated in the normal population (Turnbull, Kersten et al.
2000). The use ofproxy recall of these measurements has been investigated. A proxy is
generally considered to be a person, usually a family member, who is in physical contact
with the patient at least three times per week and performs at least two care-giving tasks
on those occasions. The proxy scores in many studies correlate well with the patient's
scores but there are often marked differences in specific areas. The best agreement was
for objective items of preparing meals, washing-up, washing clothes, shopping and
driving. The poorest agreement was for participation in hobbies, social outings and
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heavy housework (Tooth, McKenna et al. 2003; Tooth, McKenna et al. 2003). The
recalled use of FAI by the patient has also been assessed and found to correlate well
with the proxy assessment of their physical function prior to illness such as stroke and
there is some anecdotal evidence that this method may be extrapolated to critical illness
(Wyller, Sveen et al. 1996).
The FAI was chosen because it does not require training to administer, it takes only five
minutes to complete (which was felt to be an important factor in patients who were
coming for a battery of assessments) and it can be used as an interview or mailed
questionnaire with excellent correlation between the methods (r=0.94) (Carter, Mant et
al. 1997) which would allow data to be collected even if the patient was not able to
attend follow up clinics. It has been proven (in patients with stroke) to be appropriate for
recalled use so that pre-morbid functional status can be assessed and subsequent change
recorded (Holbrook and Skilbeck 1983). The use of proxy respondents has been well
validated (Segal and Schall 1994). The measure has also been shown to have excellent
correlation with the physical component summary score of SF-36 and adequate
correlation with the EQ-5D. It has also been found to have adequate correlation with
measures of actual physical function such as the timed up and go test.
3.3.1.2.2 The Six Minute Walk Test
The six minute walk test (6MWT) represents an objective rather than subjective
evaluation of functional capacity and is discussed in Section 1.14.1.10.2. It was chosen
as it was developed to evaluate exercise tolerance in patients with respiratory disease
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(the most frequent diagnosis in survivors of critical illness), is easy to administer and
better tolerated than other measures such as the 12 minute walk test and is more
reflective ofperformance in activities of daily living than other walking tests (Solway,
Brooks et al. 2001). The 6MWT is unique in its ability to evaluate, in a non-laboratory
setting, cardiovascular and respiratory exercise performance. It also shows similarity
with the activities of daily life (Grotz, Hohensee et al. 1997; Enright 2003). It does not
assess balance, quality ofmovement, use of assistive devices and amount of physical
assistance needed (Barak and Duncan 2006). The distance walked is potentially
influenced by some common neuromuscular complications of critical illness such as
muscle weakness, balance problems and neuropathies. The 6MWT was therefore chosen
over other measures such as the shuttle test as it is regarded to be safer, easier to
administer, better tolerated and reflects normal activity.
3.3.1.2.3 Hand grip dynamometry
Hand grip dynamometry is discussed in Section 1.14.1.9.3. Survivors of critical illness
are a diverse patient group with many different factors contributing to their functional
limitation during recovery. Hand grip strength has been found to be a consistent
predictor of clinically important outcomes such as survival and postoperative
complications in many different populations (Bohannon 2008). For our study cohort we
felt that low grip strength, which is associated with a greater likelihood of functional
disability in many studies (Shibata, Haga et al. 1992; Sarkisian, Liu et al. 2001),
especially in pneumonia the commonest admission diagnosis for our study cohort
(Bohannon, Maljanian et al. 2004; Vecchiarino, Bohannon et al. 2004), would be a
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valuable measure in the assessment ofphysical function. It has also been found to be a
good indicator of nutritional status (Davies, Jones et al. 1984).
3.3.1.3 Measures ofpost traumatic stress disorder
Psychological symptoms have been shown to occur commonly in critically ill patients
and have significant impact on QOL and actual morbidity following critical illness.
Cuthbertson et al found a high incidence of symptoms consistent with Post Traumatic
Stress Disorder (PTSD) 3 months after ICU discharge and a significant need for further
psychological support services post critical illness (Cuthbertson, Hull et al. 2004).
Jackson et al investigated the prevalence and types of neuropsychological impairment
among general medical ICU patients (Jackson, Hart et al. 2007). They found that
impairment was common and occurred with a greater than anticipated frequency when
compared with relevant normative data. These studies also established a role for the
Davidson Trauma Score (DTS) in recovering ICU patients whereas previously it had
only been used in specific groups such as burns, neurological injury and cardiac surgery.
The DTS has been used widely in the initial assessment of patients who have undergone
a range of physically or psychologically traumatic events that could be related to the
development of PTSD. The DTS measures all 17 primary PTSD symptoms relating to
the 3 main symptom areas, Intrusion, Avoidance and Hyper-arousal, with specific
criteria for both frequency and intensity rated on a five point scale. Two threshold scores
are used to convert the continuous scores into dichotomous categories for the analyses of
the data. A score of 40 or greater is associated with high specificity for the DSM-IV
diagnosis of PTSD. A score of 27 - 39 identified individuals with a high levels of PTSD
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psychopathology but who have equivocal diagnostic criteria for PTSD. We aimed to
quantify the risk factors for symptoms related to the diagnosis of PTSD using a measure
validated in a variety of trauma populations in a general cohort of critically ill patients at
3 and 6 months post ICU discharge using the DTS.
3.3.1.4 Organotopic Measures
In addition to assessments ofphysical function and quality of life we performed simple
tests to look for evidence for organotopic sequelae in the long-term recovery after
critical illness which may contribute to impaired quality of life.
3.3.1.4.1 Anaemia
Anaemia is an important and common complication after critical illness. 80-90% of
survivors of critical illness are anaemic at ICU discharge (Walsh, Saleh et al. 2006) and
75% ofpatients are still anaemic when discharged home (Saleh 2006). There is clear
evidence for an association between anaemia, physical function and HRQL in patients
with chronic renal failure (Obrador and Pereira 2002), cancer (Caro, Salas et al. 2001)
(Cella 2002)and chronic inflammatory disease (Peeters, Jongen-Lavrencic et al. 1996)
and heart failure (Silverberg, Wexler et al. 2002). Treating this anaemia has been shown
to improve quality of life. Haemoglobin concentration was therefore measured at ICU
discharge and at 3 and 6 months.
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3.3.1.4.2 Nutrition
Up to 40% of hospital patients in the UK are underweight (Elia and Stratton 2000). In
ICU patients there is extensive muscle catabolism despite aggressive nutrition because
of inflammation and the stress response to critical illness. This process is exaggerated by
immobility and critical illness neuropathy. Previous work conducted in our population
has found that patients typically lost 20% of body mass during ICU admission and many
had not regained pre-illness weight 12 months after discharge. In patients recovering
from ARDS it was noted that marked reductions in aerobic capacity, physical function
and HRQL was attributable to muscle cachexia rather than residual pulmonary disease
(Herridge, Cheung et al. 2003).
Grip strength has been shown to be an indicator of nutritional status (Webb, Newman et
al. 1989; Wang, Sea et al. 2005) and potentially a more appropriate marker than weight
loss and albumin in patients with serious post operative complications, a patient group
with many characteristics similar to the survivors of critical illness (Klidjian, Foster et
al. 1980). Hand grip strength is also a marker of 'frailty' providing a measure of the
multiple problems and their potential impact upon an individual and is a consistent
predictor of important outcomes. It is has been found to be a robust measure of the
complex problems found in patients requiring rehabilitation reflecting the overall impact
of illness better than comparable laboratory and clinical measures of outcome. It was
therefore felt that it would be a worthwhile test in our battery of assessments. In addition
to this measure the standard nutritional measures ofweight, albumin and mid upper arm
circumference (MUAC) were included.
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3.3.1.4.3 Markers of inflammation
In the previous study described in Chapter 2 we found that there was a persistence of the
inflammatory state well into the recovery phase from critical illness. This persistence of
inflammation has been associated with anaemia, neuromuscular dysfunction, impaired
nutrition and impaired recovery from critical illness (Ho, Lee et al. 2008). We felt that
other markers of inflammation such as interleukins had a response time that was
potentially too short for the limited follow up clinics available to measure markers of
inflammation. C-reactive protein (CRP) rises within hours of an inflammatory stimulus
but remains elevated in the chronic inflammatory state and is used for monitoring the
progress of chronic inflammatory conditions such as rheumatoid arthritis. It was
therefore considered the most appropriate test for assessing inflammation during follow
up.
3.3.1.4.4 Renal and hepatic function
Simple laboratory measures of renal and hepatic function were measured to determine if
there was significant organ failure in the cohort which may be contributing to impaired
quality of life.
3.4. Methods
3.4.1 Study design and size
The study was an observational study. We aimed to recruit a prospective cohort of 140
to 200 patients discharged from the recruiting centres. We calculated that a total of 200
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evaluated patients would produce estimates of the prevalence of important complications
following critical illness at 3 months post ICU discharge and have a standard error of
3.5% or less. From previous studies we assumed 80% recruitment and 15% incomplete
follow up at 3 months. We estimated we would be able to recruit and assess 200 patients
over 12-13 months and that this would result in at least 100 patients completing 6 month
follow up.
3.4.1.1 Study Population
Patients were recruited from the Intensive Care Units of the Royal Infirmary of
Edinburgh (RIE) and Western General Hospital (WGH), Edinburgh. The RIE represents
an 18 bedded general ICU of a university hospital. It accepts patients undergoing liver,
kidney and pancreas transplant. These patients were excluded from the study as they had
a chronic pre-morbid condition due to the underlying need for a transplant which would
not reflect a general population. The WGH represents an 8 bedded general ICU of a
university hospital with a significant caseload from the neurosurgical services located on
this site. All patients admitted with a primary head injury diagnosis were excluded due
to established evidence that this will be the primary determinant of their outcome
following ICU stay.
3.4.1.2 Recruitment
All patients who required >48 hours of ICU (Level 3) care and were discharged alive
from the ICUs were considered. These inclusion criteria were chosen because patients
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requiring 48 hours of level 3 care comprise about 50% of ICU admissions, but utilise
>80% of ICU bed days and develop most complications.
The exclusion criteria were:
1. Patient transferred directly from ICU to another hospital.
2. Patient discharged for terminal care.
3. Follow up not feasible for geographical reasons (outwith Lothian, > 1 hour travel
from Edinburgh).
4. Primary neurological diagnosis requiring ICU admission (e.g. head injury; in this
population residual neurological handicap is the major problem).
5. Patients undergoing organ transplantation.
Screening for eligibility was performed on a daily basis by the study investigators. We
accounted for all eligible patients in the study log.
3.4.1.3 Consent and ethical issues at recruitment
Incapacity for adults is defined in the Adults with Incapacity (Scotland) Act 2000
section 1(6) as: being ' incapable of (a) acting; or (b) making decisions; or (c)
communicating decisions; or (d) understanding decisions; or (e) retaining the memory of
decisions ... by reason ofmental disorder or of inability to communicate because of
physical disability'.
Capacity is defined as the ability to comprehend and retain information material to the
decision to consent (in this case to take part in the research study). For this observational
study the ethical considerations related to the intrusion into patients and relatives time
during difficult life events related to the critical illness. It was felt that a patient could
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potentially benefit from inclusion in the study as the detection of significant medical
problems would be reported back to the patient's GP by the research team.
Approaching the relatives during the patient's critical illness was conducted with tact
and discretion but as the majority of our patients remained incapacitated during their
ICU stay it was necessary to obtain assent from the relatives for the patient to be
considered for the study. The relatives and subsequently the patients themselves were
provided with a study information sheet and given an opportunity to discuss the study
with the research team and an independent advisor.
As soon as the patient was discharged from level 3 care and competent, informed
consent was sought from the individual themselves before continuing in the study.
Ability to give informed consent was determined by an abbreviated mental test (AMT)
(Hodkinson 1972) score ofmore than 7. The AMT is one of the commonest used
screening tests for cognitive impairment as it only takes two minutes to complete. It is a
ten question test with a score of less than seven indicating cognitive impairment and has
been verified in a variety of clinical and research areas (Jitapunkul, Pillay et al. 1991)
and is recommend as a screening tool for cognitive impairment in all elderly patients
admitted to hospital. The research group also acted in the patient's best interest during
the study and when there was concern that the patient did not fully understand the nature
of consent even with an appropriate AMT score, enrolment was deferred and the patient
retested at a later date. Patients who did not regain capacity to give informed consent
continued in the study unless the patient's relatives expressed a wish for them not to
participate further. The study received approval from the regional ethics committee
(ethics number 04/MRE00/59).
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Figure 3.1 summarises the timing of assent and consent and the subsequent assessments.
3.4.1.4 Assessing baseline characteristics
3.4.1.4.1 Baseline assessment at time of discharge from ICU
At discharge from ICU patient consent (or proxy consent if the patient did not have
capacity) was sought to continue in the study. Ability to give informed consent was
determined by an AMT score ofmore than 7. Patients who did not regain capacity to
give informed consent continued in the study unless the patient's relatives expressed a
wish for them not to participate further. After consent we recorded the following
baseline data for the recruited patient: age; sex; pre-illness chronic co-morbidity using
the Charlson Co-morbidity Index (Charlson, Pompei et al. 1987; Needham, Scales et al.
2005). We performed a case-note review of ICU records and recorded the following
measures from ICU stay: admission diagnostic category (namely surgical, medical or
trauma), APACHE II score (a measure of illness severity during the first 24 hours of
ICU care), worst organ failure developing during ICU stay for each of respiratory,
cardiovascular, renal, coagulation, and liver systems using the Sequential Organ Failure
Assessment (SOFAmax), a validated daily measure of organ severity graded 0 to 4 and
ICU length of stay.
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Figure 3.1 Recruitment and follow up
Patients were recruited into the study and underwent assessment according to study protocol.
FAI = Frenchay Activity Index; SF-36 = Short form quality of life questionnaire; 6-MWT = 6 minute walk
test; HGS = hand grip strength; DTS = Davidson's Trauma Scale; VAS = visual analogue scores 114
Table 3.1 Timing of assessments
Measure ICU discharge 3 month follow up 6 month follow up
Quality oflife measure
SF-36 Recalled for pre¬
morbid state
X X
































BMI (Kg/m2) X X
MUAC (cm) X
Visual analogue scales and Psychometric assessments






X indicates that measure was assessed at this time point.
SF-36 = medical outcomes questionnaire; FAI = Frenchay Activity Index; EQ-5D
VAS = EuroQol health status thermometer; BMI = body mass index; MUAC =
mid upper arm circumference; VAS = visual analogue scale
3.4.1.5 Initial assessment and follow-up visits
Figure 3.1 and Table 3.1 summarise the timing and nature of tests at follow up visits.
Initial assessments were conducted in hospital following discharge from intensive care
and before discharge from hospital. The patient was asked to complete SF-36 and FAI
relating to the 4 weeks before the critical illness. The final haemoglobin concentration,
serum creatinine, albumin and bilirubin before ICU discharge were also recorded.
Follow up visits were conducted at the Clinical Research Facility of the Royal Infirmary
ofEdinburgh or in the patients' home if this was preferred. To minimise loss to follow
up, an appointment was given for follow up prior to discharge from hospital and a
further letter sent 1 month prior to the clinic date as a reminder. One week prior to
attendance patients were contacted by post to confirm travel arrangements. During these
visits the patients underwent a structured visit protocol involving completion of the
questionnaires relating to functional activity, quality of life and post traumatic stress
disorder, venepuncture and clinical assessment for the simple organotopic measures and
subsequently measures of actual physical function with the 6MWT and hand grip
dynamometry performed. The protocols for the individual components of the visit are
documented below.
3.4.1.5.1 Recalled assessments for pre-morbid condition and
contemporaneous FAI, SF-36 and EQ-5D VAS at 3 and 6 months following
hospital discharge
The assessment was carried out by trained investigators. The patient was first assessed
with the AMT and a score of less than 8 caused the test to be deferred until the cause of
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the deterioration has been recovered from. Following an appropriate AMT the test was
administered in a structured and reproducible way and repeated at 3 and 6 months
following hospital discharge. The FAI questionnaire is included in Appendix 1. The EQ-
5D VAS, standard scales for pain and fatigue were also completed.
3.4.1.5.2 Patient assessment for the 6MWT
The American Thoracic Society has issued guidelines for the 6MWT (2003) and these
were adhered to during the study. A self powered non-adjustable treadmill was used.
Standardized phrases whilst using the test were also used as investigator encouragement
can alter the result by up to 30%. This technique has been used in previous ICU studies
(Cooper, Ferguson et al. 1999; Herridge, Cheung et al. 2003). The distance walked in 6
minutes was recorded. In patients who were unable to attempt the 6MWT due to
symptom severity were classified as 0m distance walked.
3.4.1.5.3 Patient assessment of hand grip strength
Hand grip strength was measured using a Takei Digital TAK005 hand grip
dynamometer in the non-dominant hand 3 times with the best result recorded.
3.4.1.5.4 Patient assessment for PTSD
Following an appropriate AMT the DTS questionnaire was administered by trained
investigators at discharge and the 3 and 6 month follow up visits. The questionnaire is
included in Appendix 2.
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3.4.1.5.5 Organotopic measures
Baseline values to assess renal (creatinine), markers of inflammation (CRP) and
haematological function (haemoglobin) were determined by review of the last blood
results available on the patient prior to discharge from level 3 care. This endpoint was
chosen as there was a potential for great variability in time to hospital discharge which
could act as a confounding variable should baseline samples be drawn then. Blood
sampling was repeated at the three and six month follow up visits. Nutritional status was
determined through measurement of body mass index (BMI), mid arm circumference
(MUAC) and measurement of hand grip strength.
3.4.1.5.6 Visual Analogue Scores
The patients were given copies of the EuroQOL 5D thermometer (Appendix 3) and
visual analogue charts for appetite (0 = poor appetite, 10 = good appetite), pain (0 = no
pain, 10 = severe pain) and fatigue (0= no fatigue 10 = severe fatigue) and asked to mark
their current status on the chart.
3.5 Analysis
Analysis of the data was as follows:
3.5.1 Characteristics of study cohort
Baseline characteristics and characteristics of ICU stay were recorded. All variables
were tested for normality. Descriptive statistics include median and inter-quartile range
and range unless otherwise stated. Student's t-test was used to compare means of
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normally distributed data. Non-parametric rank test (Mann-Whitney U test) was used in
non-normally distributed data.
3.5.1.1 Comparison ofpatients who survived and those who died
during follow up
Details of patients who died during the follow up period were recorded. Patients who
were lost to follow up were considered to be still alive. Differences in demographics,
characteristics of ICU stay and study parameters at ICU discharge between survivors
and non-survivors at recruitment were analysed with Student's t test or Mann-Whitney
test as appropriate.
For tests of statistical difference of a variable between time points only complete data
sets were included. We acknowledged that this may produce bias within the results and
that the data should be interpreted with caution.
3.5.2 Quality of life and perceived physical function for study cohort
SF-36 scores and FAI for entire cohort were described at each time point (recalled
scores for pre-morbid assessment assessed at ICU discharge and at 3 and 6 months).
Change in SF-36 and FAI scores over time for the entire cohort's data sets were also
analysed and the effect size of this change calculated. The effect size between these time
points were calculated according to Kazis (Kazis, Anderson et al. 1989) using the mean
change of a variable divided by its baseline standard deviation (SD). An effect size of
>0.2, >0.5 and >0.8 respectively were considered to be small, medium and large (Cohen
1988).
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To analyse changes between time-points only complete data sets were analysed. One
way ANOVA for repeated measures was used with Bonferroni's post test analysis was
used to determine the significance for each time point.
3.5.3 Actual physical function
3.5.3.1 6minute walk test data
Many patients attending clinics or being visited in their home refused to attempt the test.
The reasons for refusal were not always clear. For this reason patients who gave a
definitive reason for not attempting the test because they felt their symptoms precluded
this were scored as 0 metres walked. Other responses were excluded from the analysis.
6MWT results were recorded and tested for statistical difference between 3 and 6
months with the Mann-Whitney U-test.
3.5.3.2 Hand grip strength
The raw HGS data was transformed into percentage of normal for age and gender to
allow comparison of the group as a whole (Klidjian, Foster et al. 1980; Goode 1985).
The data was tested for statistics difference with Student's t-tests.
3.5.4 Assessment for post traumatic stress disorder
DTS sores were recorded for the entire cohort attending follow up clinics and the
proportion ofpatients meeting threshold criteria and actual criteria for PTSD recorded.
122
3.5.5 Prevalence of anaemia
For the entire cohort we analysed the prevalence of anaemia at ICU discharge and at
each time point for those remaining in the study. The change of haemoglobin over time
was analysed for those who had haemoglobin measures at all three time points. We
hypothesised that anaemia would contribute significantly to post ICU recovery and
therefore determined a priori to analyze the cohort according to groups dependent upon
haemoglobin concentration. These analyses are included in Chapter 4 of the thesis.
3.5.6 Organotopic measures
3.5.6.1 Renal function
The serum creatinine concentrations were converted to eGFRs according to (Levey,
Greene et al. 1993; Burden and Tomson 2005). Median, inter-quartile range and range
for entire cohort were recorded. Change in creatinine and eGFR between time points
was assessed with Student's t-test.
3.5.6.2 Nutritional status
3.5.6.2.1 Nutrition by hand grip strength
Hand grip dynamometry after conversion to percentage of normal for age and gender
was used to determine which patients may be at risk for protein malnutrition as
suggested by a HGS of less than 85% of normal. The proportions of patients with
evidence ofmalnutrition at each time point are described.
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3.5.6.2.2 Serum albumin
Serum albumin concentrations were recorded and analysed for change between each
time point with Student's t-test. The proportion of patients at each time point with low
albumin (Albumin < 30 g/L) was also recorded.
3.5.6.2.3 Weight and Body Mass Index
Weight and BMI (using height and weight as recalled by proxy for pre-morbid state)
was recorded and analysed for change with Student's t-test.
3.5.6.2.4 Anthropometry
Change in MUAC was assessed with Student's t-test between each time-point.
3.5.6.3 Markers of inflammation
C-reactive protein measures were analysed for statistical difference at 3 and 6 months
using Student's t-test. An elevated CRP was defined as >10mg/L.
3.5.7 Associations between physical components of quality of life and
perceived and physical function
3.5.7.1 Analysis of correlation between quality of life (PCS of SF-36)
and perceived physical function (FAI)
To answer the research question of whether physical quality of life as measured by the
SF-36 questionnaire reflects the activities of daily living as measured by FAI we
perfonned correlation analysis between the two scores at all time points we plotted the
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PCS scores against corresponding FAI scores and the strength of the association was
determined with Pearson's test for correlation for normally distributed data.
3.5.7.2 Analysis of correlation between quality of life (PCS of SF-36)
and actual physical function (6MWT)
To answer the research question of whether physical quality of life as measured by the
SF-36 questionnaire reflects the actual physical function we performed correlation
analysis between the PCS score and distance walked at 3 and 6 months. We plotted the
PCS scores against corresponding 6MWT distance and the strength of the association
was determined with Spearman's test for non-Gaussian distributions.
3.5.7.3 Additional exploratory analysis of the relationship between
PCS and FAI
To answer the question ofwhether a good physical quality of life is more common in
patients with good perceived physical function we performed an additional exploratory
analysis for the relationship between PCS and FAI. We compared the proportion of
patients who had impaired FAI scores of less than 28 for males and 31 for females in
patients who had either a normal (PCS>50) or abnormal PCS score (PCS<50) with
Fisher's Exact Test. The values for FAI were chosen as they are less than a median UK
gender specific score for population aged 55-64 years which includes the median age
range of our cohort.
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3.5.7.4 Additional exploratory analysis of the relationship between
PCS and 6MWT
To answer the question ofwhether a good physical quality of life is more common in
patients with good actual physical function we performed an additional exploratory
analysis for the relationship between PCS and 6MWT distance. We compared the
proportion of patients who had impaired actual physical function of 200m at 3 months
and 400m at 6 months (Herridge, Cheung et al. 2003) in patients who had either a
normal (PCS>50) or abnormal PCS score (PCS<50) with Fisher's Exact Test. These
distances were chosen as they were less than median values for a large cohort of
survivors with ARDS at 3 and 6 months and represented the best cohort of ICU
survivors who had their actual physical function measured with 6MWT.
3.5.7.5 Analysis of correlation between magnitude of change in PCS score
andmagnitude of change in perceived physical function (FA!)
To answer the question whether the change in PCS score reflected the magnitude of
change in FAI score we used correlation analysis. We plotted the change in PCS score
from pre-morbid to 3 months and from 3 months to 6 months against corresponding
change in FAI scores. The strength of the association was determined with Pearson's test
for normally distributed data.
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3.5.7.6 Analysis of correlation between magnitude of change in PCS score
andmagnitude of change in actual physical function (6MWT)
To answer the question whether the change in PCS score reflected the magnitude of
change in 6MWT distance we used correlation analysis. We plotted the change in
physical component summary score (PCS) from 3 months to 6 months against the
corresponding change 6MWT distances. The strength of the association was determined
with Spearman's test for non-Gaussian distributions.
3.5.7.7 Additional exploratory analysis of the relationship magnitude
of change in perceived physical function (FAI score) and PCS score
To answer the question of whether a good physical quality of life is more common in
patients with a significant improvement in the ability to perform the activities of daily
living as measured by the FAI score we performed an additional exploratory analysis for
the relationship between PCS score and the change in FAI score. We compared the
proportion of patients who had a significant improvement in FAI score of 4 (Harrington,
Taylor et al.) in patients with either a normal (PCS>50) or abnormal PCS score
(PCS<50) with Fisher's Exact Test.
3.5.7.8 Additional exploratory analysis of the relationship between
the magnitude of change in actual physical function (6MWTdistance) and
PCS score
To answer the question ofwhether a good physical quality of life is more common in
patients with a significant improvement in distance walked as measured by the 6MWT
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we performed an additional exploratory analysis for the relationship between PCS score
and the change in 6MWT distance. We compared the proportion of patients who had a
significant improvement in 6MWT distance of200m with either a normal (PCS>50) or
abnormal PCS score (PCS<50) with Fisher's Exact Test. As so few patients increased
the distance walked by this amount we also analysed the data for 100m to see if any
improvement in actual physical function was more common in patients with good PCS
scores
3.5.7.9 Analysis of correlation between magnitude of change in FAI
score andmagnitude of change in and actual physical function (6MWT)
and hand grip strength.
To answer the question of whether change in perceived physical function is reflected in
a change in actual physical function we analysed the change in FAI score from 3 months
to 6 months against corresponding change in 6MWT distances and hand grip strength.
The strength of the association was determined with Pearson's test for correlation for
normally distributed data (HGS) and Spearman's test for non-Gaussian distributions
(6MWT).
3.5.7.10 Analysis of relationship between common complications of
critical illness and physical components of quality of life
Tests of correlation between PCS score and serum albumin, serum creatinine, serum
CRP concentration and percentage change in hand grip strength were performed with
Pearson's test.
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3.5.7.11 Analysis of relationship between common complications of
critical illness and perceived physical function
Tests of correlation between FAI score and serum albumin, serum creatinine, serum
CRP concentration and percentage change in hand grip strength were performed with
Pearson's test.
3.5.7.12 Analysis of relationship between common complications of
critical illness and actual physical function
Tests of correlation between 6MWT distance and serum albumin, serum creatinine,
serum CRP concentration and percentage change in hand grip strength were performed
with Spearman's test.
3.5.8 Analysis of affect ofpost traumatic stress disorder on
physical components of quality of life
The data for PCS and DTS score at 3 and 6 months was analysed for correlation with
Spearman's test. The proportion of patients with threshold and diagnostic symptoms
(DTS score ofmore than 26) and diagnostic symptoms alone (DTS score ofmore than
39) and a PCS score of less than 50 was calculated and analysed with Fisher's Exact
Test at each time point.
3.5.9 Statistical software
Data was recorded in a Microsoft Access database and data extracted to Microsoft




There were 1399 admissions to the ICU during the study period. We recruited 68
patients to the study and 35 patients remained in the study for the 6 month duration. The
recruitment is summarised in Figure 3.2. Table 3.2a and 3.2b summarise the reasons for
exclusion and enrolment performance.
3.6.1.1 Loss to follow up
Reasons for loss to follow are summarised in Figure 3.3. 68 patients were recruited at
ICU discharge. At 3 months follow up, 14 (21%) of this cohort did not attend. 12 were
lost to follow up and 2 withdrew consent. At 6 months, a further 10 did not attend.
Again, the main reason for non-attendance was loss to follow up with 8 patients not
responding to contact and 2 withdrew consent.
3.6.1.2 Deaths
8 patients died prior to attending clinic at 3 months. At 6 months one person died prior
to attending.
3.6.2 Demographic and clinical characteristics of cohort
Demographic, clinical characteristics and characteristics of ICU stay for the study cohort
are shown in Table 3.3. There were 51 medical patients (25 male and 26 female) and 17
surgical patients 10 male and 7 female).
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Figure 3.2 Recruitment flow diagram
Number of patients excluded or discontinuing involvement in study at each stage
of study protocol.
*
reasons for exclusions can be found in Table 3.2
t reasons for exclusions can be found in Table 3.2
Table 3.2a Reasons for patient exclusion during study
Reason for exclusion in ICU
n (%)
Total n=222
Primary diagnosis neurological 127 (57.2)
Geographical 65 (29.3)









Transferred other ITU 17(42.5)
Discharged for palliative care 14(35)
Communication issues 4(10)
Transferred other hospital 3 (7.5)
AMT<7 2(5)
Table 3.2b Proportion of eligible patients continuing in study
Time point n (%)
ICU discharge 68/110 (62)
3 months 46/68 (68)
6 months 35/68 (51)





Lost to follow up
Withdrew
Figure 3.3 Proportion of patients lost to follow up during study
Figure detailing the proportion of the 68 patients enrolled in the study at ICU
discharge that were lost to follow up at 3 and 6 months.




Age (years) 60.5 (48.8, 70.0; 18-86)
APACHE II at admission 19.0(15.5,23.0; 2-36)
Worst SOFA max score during ICU stay 10.5 (7.0, 13.0; 3-18)
ICU length of stay (days) 11.3 (5.5,21.2; 2.9-67.8)
Haemoglobin at ICU admission (g/L) 93 (85.0, 101.0; 78.0-138.0)
Charlson co-morbidity index 2
Primary Diagnosis Number of patients
Respiratory
Infective exacerbation of COPD 1
Pneumonia 22
Sepsis - lung 3
Asthma 1












Liver failure - paracetamol overdose 1
Obstruction 3
Vascular
Ruptured abdominal aortic aneurysm 2
Trauma 3
Unexpected complication of surgery
Protracted surgery GI tract 1
Potential sepsis 1
Renal




No organism identified 2
Overdose 1
Data expressed as median (1st quartile, 3rd quartile; range); SOFA=Sequential Organ
Failure Assessment;COPD = chronic obstructive pulmonary disease; ARDS = Acute
Respiratory Distress Syndrome; Gl = gastrointestinal
The median age of the population was 60.5. For the 35 males and 33 females the median
age, (1st and 3rd quartiles and range) was 54 (46, 66; 18-76) and 62, (55,73; 26-86)
respectively. 4 patients required renal replacement therapy during their ICU stay.
The median APACHE II score and median cumulative SOFA score without the
neurological component suggest an ICU mortality ofmore than 40% for our cohort
(Vincent, de Mendonca et al. 1998). The median Charlson co-morbidity index was 2
reflecting an expected ICU mortality of 18% and 1 year survival of 86% in those that
survived to ICU discharge (Williams, Dobb et al. 2006).
3.6.2.1 Differences in ICU characteristics of survivors and non survivors
during follow up
In those patients who died during follow up 3 were surgical and 6 were medical. None of
the patients who died received renal replacement therapy compared with 4 of the
patients who did survive to 6 months. Table 3.4 shows the differences in ICU stay and
organotopic measures at ICU discharge between survivors and non-survivors. CRP
results were only available at 3 and 6 month visits as CRP was not routinely measured in
ICU. There was insufficient data to allow comparison of CRP between survivors and
non-survivors.
3.6.2.2 Summary ofmeasures for cohort at each time-point
Table 3.5 summarises the data for the entire cohort at each time-point. The median,
inter-quartile range and range for all parameters measured during the study are shown.
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Table3.4Comparisonofsurv v rsndnon-survivorscoh t SurvivorsNon-survivorsp- alues Ageyears59.0(48,6 ;18- 6)71.5(58.5,5;55-78)0.010 APACHEIIscore18(14,22;2-36)0(1 .5,2 ;7-26)0.135 ICUlengthofstay11.5(7.2,21.8;2.9-67 )5.(3 0,3 0-30.7)0.5 4 SerumCr atinine61(50,92;28-307)14(6 ,3 348-4 1)0.01 Haemoglobin93.0(85,104.0;79-138)5.(85.5,1078-119)0.6 1concentrationy Albumin25(21,28;1 -33)(18.5,713- 8)0.251 GenderM:F29:306 3
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The descriptive statistics are also shown for clarity with the associated figure for each
parameter where appropriate.
3.6.3 Quality of life
3.6.3.1 SF-36 scores for entire cohort
The SF-36 data was found to be normally distributed. Figure 3.4 (median, interquartile
range, range) summarises the individual component score data for the study population.
Normal data for UK population are included for comparison. The summary component
scores for the cohort are shown in Figure 3.5.
3.6.3.2 Change of SF-36 scores with time
There were 35 patients who had completed SF-36 questionnaires for pre-morbid, 3 and 6
month time points. The mean physical component score was found to change
significantly over time (p<0.018) with the Bonferroni post test showing the change from
pre-morbid quality of life to 3 months was significant (p<0.05, mean change 6.1, 95%
confidence interval of difference 0.91-11.41). The mental component score did not
change significantly, mean change pre-morbid to 3 months of 3.8 (95% confidence
interval of difference -1.5 to 9.0) and from 3 to 6 months -4.3 (95% confidence interval
of difference-9.5 to 1.0). The effect size for the physical component summary score and
mental component summary score was small at all time points in comparing baseline to
3 months (PCS -0.43, MCS -0.3) and 6 months (PCS -0.28, MCS 0.03), and from 3 to 6
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Figure 3.4 SF-36 individual component scores for cohort
Top panel shows physical components, bottom panel shows mental
components. PF = physical function, RP = role physical, BP = bodily pain, GH =
general health, Vi = vitality, SF = social function, RE = role emotional, MH =
















Premorbid 3 months 6 months
Figure 3.5 Summary component scores for cohort
Box and whisker charts showing data for physical component summary score







Premorbid 3 months 6 months
Figure 3.6 FAI scores for study cohort
3.6.4 Perceived physical function
3.6.4.1 FAI scores for entire cohort
The FAI data was found to be normally distributed. Figure 3.6 summarises the data for
the study population and for the gender groups. Median gender specific values for UK
population aged 55-65 years are included (Turnbull, Kersten et al. 2000).
3.6.4.2 Change of FAI scores with time
There were 25 patients who had completed FAI questionnaires for pre-morbid, 3 and 6
month time points. The mean FAI score was found to change significantly over time
(p<0.05) with the Bonferroni post test showing the change from pre-morbid to 3 months
was significant (p<0.0l, mean change 7.2, 95% CI of difference 2.1 -12.3). The effect
size was large for change in FAI pre-morbid to 3 months (0.9), small 3 to 6 months (0.2)
and medium pre-morbid to 6 months (0.6) respectively. This suggests that change in FAI
score from pre-morbid to 3 months is a useful measure of function as there is a large
consistent change throughout our population.
3.6.5 Actual physical function
3.6.5.1 Six minute walk test for cohort
Of the 40 out of 54 patients who were assessed at 3 months performed the test. At 6
months 33 out of 44 patients performed the test. Overall 10 patients did not attempt the
test as they were wheelchair bound due to a combination of chronic pain, loss of limbs
or unable to take more than a few steps at any time. 2 had unstable angina and were
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unwilling to walk. These patients were classed as 0 m walked. 2 patients were too active
and busy to attend the clinic and were excluded from analysis!
The 6 MWT data was not normally distributed. For the complete data set (patients who
attended both clinics) the difference between the groups was analysed with the Mann-
Whitney test. There was no significant difference in the distance walked at 3 compared
to 6 months (Figure 3.7). Data for normal population and population with severe heart
failure are used for contextual comparison. For patients who attended both clinics 36%
(12/33) and 48% (16/33) walked less than 100m and 250m respectively. At 6 months
42% and 48% walked the 100m or 250 m respectively.
3.6.5.2 Hand grip strength for cohort
The HGS data was found to be normally distributed. Figure 3.8 summarise the data for
the cohort. At 3 months only 18% (8/44) of patients had normal HGS. At 6 months 34%
(12/35) had normal HGS. For patients with a complete data set the HGS changed
significantly (p=0.04) for paired results but the effect size was medium (0.4).
3.6.6 Organotopic measures
3.6.6.1 Anaemia
The haemoglobin concentrations for the entire ICU cohort are shown in Figure 3.9. The
















Figure 3.7 Distance walked in 6 minute walk test
















Figure 3.9 Haemoglobin concentrations for cohort
Table 3.6 Proportion of study patients with anaemia at each time point
ICU discharge 3 month clinic 6 month clinic



















This shows that a third of our cohort was still anaemic at 6 months following ICU
discharge.
There were 25 patients who had haemoglobin measures at ICU discharge, 3 and 6
months. The haemoglobin level was found to change significantly over time (p<0.05)
with the Bonferroni post test showing a significant difference from ICU discharge to 3
months. The analysis for the anaemia subgroups is included in Chapter 4.
3.6.6.2 Nutritional measures
3.6.6.2.1 Weight
31 patients had weight measurement at 3 months and 34 at 6 months. 28 patients had
weight measured at both time points. The median weights and BMI are shown in Figure
3.10. BMI calculated using height and weight as recalled by proxy for pre-morbid state
and at each clinic. 12% (8/67) pre-morbidly, 21% (9/42) at 3 months and 12% (4/34) at
6 months had a BMI <20. The data show that 12.5% of the patients lost weight during
recovery.
3.6.6.2.2 Anthropometry
The values for mid ann circumference are shown in Figure 3.10. The circumferences did
not change significantly from 3 to 6 months. Using MUAC as a method of determining
BMI thresholds we noted that 16% (7/44) patients would be expected to have BMI <20
kg/m2 at 3 months and 11% (4/35) at 6 months.
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Figure 3.10 Weight, BMI and mid arm circumference during recovery
3.6.6.2.3 HGS as measure of nutritional state
Hand grip strength as a percentage of normal is shown in Table 3.7. These results show
that 73% of our cohort at 3 months had values of hand grip strength suggestive of
protein malnutrition and 49% at 6 months.
3.6.6.2.4 Albumin
Albumin concentrations for the study cohort are shown in Figure 3.11. The albumin at
ICU discharge was significantly lower than at 3 and 6 months (p<0.001).
3.6.6.3 Renal Function
eGFRs for entire cohort were calculated and are shown in Figure 3.12. The number of
patients with eGFR below 60 (chronic kidney disease grade 3) was 24%( 16/68) at ICU
discharge, 23% (10/44) at 3 months and 20% (5/25) at 6 months. There was no statistical
difference in the proportion ofpatients with an eGFR <60 at ICU discharge compared to
3 and 6 months.
3.6.6.4 Markers of inflammation
The CRP data was not normally distributed. The median values (1st and 3rd quartiles;
range) were 7.5 (5.0, 24.5; 5-290) and 5.0 (5.0, 27.0; 5-232) respectively at 3 and 6
months. There was no difference between the groups either for whole cohort data or for
complete data analysis only. 52% (17/33) of patients had an elevated CRP at 3 months
and 43% (10/23) at 6 months.
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Table 3.7 Hand grip strength and protein malnutrition
Number of patients
Hand Grip strength, Kg










Data expressed as median, inter-quartile range and range. Values for hand grip
strength (in Kg) and proportion of cohort with HGS <85% of gender and age






Discharge 3 months 6 months
Figure 3.11 Albumin concentrations for study cohort






Figure 3.12 Renal function, expressed as eGFR, for study cohort
3.6.6.5 Hepatic function
There was no evidence of an elevated Bilirubin within our population at any time point
and further analysis relating to hepatic function and primary outcome measures was
therefore not carried out.
3.6.7 Post Traumatic Stress Disorder
Results for Davidson's Trauma Score are shown in Figure 3.13. These results show that
at 3 months 17/48 (35%) patients had threshold symptoms for PTSD and 14/48 (29%)
reached diagnostic criteria for PTSD. At 6 months 9/36 patients (25%) met diagnostic
criteria for PTSD.
3.6.8 Visual analogue scores
The results are shown in Figure 3.14. The results show that most patients had a good
appetite, 50% had moderate pain and 25% severe pain, more than 50% had reported
significant fatigue and the majority ofpatients reported impaired general health.
3.6.9 Associations between quality of life and physical function
3.6.9.1 Correlation between PCS score and FAI
The physical component score (PCS) of the SF-36 quality of life measure correlated
with the perceived physical function (FAI) Table 3.8 and Figure 3.15. The results show
that there was significant correlation between the physical measures of quality of life
and perceived physical function at all time points. The R values suggest that the
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Figure 3.13 Davidson's Trauma Scores
Davidson's Trauma Score value for cohorts at 3 and 6 months, shown as
frequency score, severity score and total trauma score.
Appetite Pain Fatigue Euroqol
Figure 3.14 Visual analogue scores
For appetite the higher score reflects higher appetite levels. For pain and fatigue
scores the higher score reflects increased levels of pain and fatigue. The
EuroQol scale reflects higher general perceived health the higher the value.
Table 3.8 Correlation between Physical Component Summary scores
(PCS), perceived physical function (FAI) and actual physical function
(distance walked in 6MWT)
PCS V FAI Number Pearson r 95% CI p-value R2
Premorbid 38 0.398 0.089-0.636 0.013 0.158
3 months 45 0.449 0.179-0.656 0.002 0.202
6 months 35 0.518 0.224-0.726 0.001 0.269
PCS v Number Spearman r 95% CI p-value n/a
6MWT
3 months 42 0.495 0.216-0.700 0.001 -
6 months 33 0.437 0.010-0.684 0.011 -
Figure 3.15 Correlation between quality of life and perceived physical
function.
0 10 20 30 40 50 60 70
PCS
3.6.9.2 Analysis of the proportion ofpatients with impaired PCS and
FAi
The proportion ofpatients with abnormal PCS scores and FAI scores less than gender
and age normal values are shown in Table 3.9a, 3.9b and 3.9c. The proportion of
patients with abnormal PCS and FAI were found not to be different for pre-morbid
scores and values at 3 months. At 6 months there was a significant difference in the
proportions of patients with abnormal PCS and abnormal FAI compared to those who
did not (p=0.025 males, p=0.021 females, p<0.001 for entire cohort). These results
suggest that a greater proportion ofpatients with persisting perceived impairment also
have an impaired physical quality of life compared to those patients whose perceived
physical function had returned to normal.
3.6.9.3 Correlation between PCS and 6 minute walk test distance
walked
There was significant correlation between PCS and distance walked at 3 and 6 months
Table 3.8 and Figure 3.16. The Spearman R value suggests that the strength of this
association is poor. Interestingly there were some patients who reported a good physical
quality of life but were unwilling to attempt this test.
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Table 3.9a, 3.9b and 3.9c.
Proportion of patients with normal and abnormal PCS score, and abnormal
and abnormal FAI scores.
Table 3.9a Premorbid values. No significant difference was noted between the
groups
FAI score < gender normal
value
FAI score > gender normal
value




Table 3.9b 3 month values. No significant difference was noted between the
groups
FAI score < gender normal
value
FAI score > gender normal
value




Table 3.9c 6 mor
groups p=0.0004
ith values. There was a significant difference between the
FAI score < gender normal
value
FAI score > gender normal
value




Table 3.10a and 3.10b.
Proportion of patients with normal and abnormal PCS score, and abnormal
and abnormal distance walked in 6MWT.
3.10a 3 month values. No significant difference was noted between the groups
6MWT < 200m 6MWT > 200m




3.10b 6 month values. No significant difference was noted between the groups
6MWT < 400m 6MWT > 400m







































3.6.9.4 Analysis of the proportion ofpatients with impaired PCS and
reduced distances walked in 6 MWT
The proportions of patients with abnormal PCS score and impaired actual physical
function, as determined by a distance less than the mean distance walked by a cohort of
ARDS survivors at 3 and 6 months following ICU discharge, is shown in Tables 3.10a
and 3.10b. There was no significant difference in the proportion of patients with reduced
PCS and a reduced distance walked as part of the 6 minute walk test compared to those
who did not.
3.6.9.5 Analysis of the magnitude of change in PCS and
change in FAI score
The magnitude of change in PCS and FAI score correlated significantly from premorbid
to 3 months (p=0.038 and R2 0.096) and from 3 months to 6 months (p<0.001 and R2
0.376) Figure 3.17. The R2 values suggest that the actual association may not be that
strong especially at pre-morbid to 3 months. The scatter of the points suggest that some
patients have increased their PCS score with a decline in FAI score. Relatively few
patients had a decline in PCS with an improvement in FAI score. This suggests that a
change in FAI score (a measure of the ability to perform the activities of daily living) is
not well reflected in a change in physical quality of life as measured by the PCS score of
the SF-36 questionnaire. The improved correlation at 6 months suggests that the ability
to perform the activities of daily living is more important as recovery progresses and
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Figure 3.17 Correlation between change in PCS and FAI score from pre-morbid to 3 months (top
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Figure 3.18 Correlation between change in PCS score and actual measures of physical function.
Data for 6 minute walk test distance (top panel) and percentage normal hand grip strength
(lower panel) shown
3.6.9.6 Analysis of the magnitude of change in PCS score and
distance walked in 6MWT
The magnitude of change in PCS score and 6MWT distance correlated significantly
from 3 to 6 months (p=0.049) Figure 3.18. The Spearman R value suggests that the
association may not be that strong. This suggests that the change in 6MWT does not
reflect the change in physical quality of life in our cohort. This is likely to be due to the
number ofpatients who did not attempt the test due to co-morbidity such that there is a
clustering of patients with 0 distance walked with variable reported PCS scores. The
magnitude of change in 6MWT may not therefore be a useful measure of functional
activity in a general ICU cohort.
3.6.9.7Analysis of the magnitude of change in PCS score and %HGS
There was no correlation between change in HGS and change in PCS score, which
suggests that PCS scores do not reflect the change in actual physical function as
measured by % HGS. This may be due to the %HGS being prone to ceiling effects as it
is unlikely that patients will continue to improve when they have reached normal values.
3.6.9.8 Analysis of the proportion ofpatients with a significant
improvement in FAI score in groups of normal and abnormal PCS score
The proportion of patients with a significant improvement in FAI score was not different
between groups of normal and abnormal PCS score Table 3.1 la. The analysis was
repeated for any improvement in FAI score and again there was no difference in the
proportion of patients with any change in FAI score in groups of normal and abnormal
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PCS score, Table 3.11b. This suggests that the PCS score does not reflect significant
change in FAI score.
3.6.9.9 Analysis of the proportion ofpatients with a significant
improvement in 6MWT distance in groups of normal and abnormal PCS
score
The proportion of patients with an increase in 6MWT distance of 100m was not different
between groups of normal or abnormal PCS score Table 3.12a. A further analysis for a
change of only 50m was performed and again there was no difference in proportions
Table 3.12b. This suggests that the PCS score does not reflect clinically significant
changes in actual physical function.
3.6.9.10 Analysis of correlation between PCS, FAI and 6MWT and
organotopic measures
The results from correlation analysis for the primary outcome measures, PCS, FAI and 6
MWT and organtopic measures are shown in Table 3.13, Table 3.14 and Table 3.15
respectively.
3.6.9.10.1 Analysis of serum albumin concentration
Serum albumin concentration was found to correlate with distance walked at 3 and 6
months. It correlated with PCS at 6 months and almost reached significance at 3 months.
It correlated with FAI at 3 months and almost reached significance at 6 months.
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Table 3.11a, 3.11b
Proportion of patients with normal and abnormal PCS score, and
significant increase in FAI score
Table 3.11a. Values from 3 to 6 months. For a clinically significant increase in
FAI score of 4
FAI score not increased
by 4
FAI score increased by
4
PCS <50 at 6 months 18 8
PCS >50 at 6 months 2 2
Table 3.11b. Values from 3 to 6 months for any increase in FAI score
FAI score not increased
by 4
FAI score increased by
4
PCS <50 13 13
PCS >50 2 2
Table 3.12a, 3.12b
Proportion of patients with normal and abnormal PCS score, and
significant increase 6MWT distance
Table 3.12a. Values from 3 to 6 months for a clinically significant increase in
6MWT of 100m




PCS <50 21 5
PCS >50 2 2
Table 3.12b. Values from 3 to 6 months for a clinically significant increase in
6MWT of 50m
6MWT not increased by
50m
6MWT increased by 50m
PCS <50 19 7
PCS >50 1 3
Table 3.13 Correlation of PCS with organotopic measures
Number Pearson r 95% CI p-value R2
Albumin 3 42 0.303 -0.001-0.556 0.051 0.092
Albumin 6 27 0.408 0.033-0.682 0.0345 0.167
CRP 3 41 -0.171 -0.454-0.145 0.286 0.029
CRP 6 26 -0.248 -0.580-0.154 0.222 0.062
% HGS 3 42 0.496 0.226-0.695 0.001 0.246
% HGS 6 27 0.527 0.184-0.756 0.005 0.278
Creatinine 3 42 0.242 -0.066-0.509 0.121 0.059
Creatinine 6 26 0.030 -0.412-0.362 0.885 0.001
Table 3.14 Correlation of FAI with organotopic measures
Number Pearson r 95% CI p-value R2
Albumin 3 43 0.426 0.145-0.644 0.004 0.182
Albumin 6 21 0.429 -0.003-0.727 0.052 0.184
CRP 3 42 -0.126 -0.414-0.186 0.426 0.016
CRP 6 20 -0.517 -0.781-0.097 0.020 0.268
% HGS 3 42 -0.014 0.316-0.292 0.932 0.0001
% HGS 6 21 0.440 0.009-0.732 0.046 0.193
Creatinine 3 43 0.221 -0.085-0.489 0.155 0.049
Creatinine 6 20 0.292 -0.173-0.651 0.212 0.085
Table 3.15 Correlation of 6MWT with organotopic measures
Number Spearman r 95% CI p-value
Albumin 3 42 0.402 0.103-0.635 0.008
Albumin 6 26 0.406 0.001-0.602 0.040
CRP 3 41 -0.371 -0.62- -0.06 0.017
CRP 6 25 -0.621 -0.82- -0.29 0.001
% HGS 3 42 0.504 0.228-0.705 0.001
% HGS 6 26 0.562 0.212-0.785 0.003
Creatinine 3 42 0.251 -0.067-0.522 0.110
Creatinine 6 25 -0.145 -0.520-0.277 0.490
Overall these results suggest that serum albumin concentration is a useful marker of
physical function during recovery from critical illness.
3.6.9.10.2 Analysis ofpercentage of normal hand grip strength
Hand grip strength correlated with PCS and distance walked at 3 and 6 months. It also
correlated with FAI at 6 months. This suggests that %HGS is also a useful marker of
physical function.
3.6.9.10.3 Analysis of serum CRP concentration
CRP did correlate with distance walked at both 3 and 6 months but only with FAI at 6
months. It did not correlate with quality of life at any time point.
3.6.9.10.4 Analysis of serum creatinine
There was no correlation between serum creatinine and any primary outcome measure at
any time point.
3.6.9.11 Analysis of correlation between PCS score and DTS and
proportion ofpatients with threshold and diagnostic symptoms of PTSD at
3 and 6 months
There was no correlation between PCS and DTS at 3 or 6 months (Spearman r -0.089
and 0.152 respectively). The proportion of patients with threshold and diagnostic
symptoms ofPTSD and an abnormal PCS was found not to be significantly different at
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any time-point. We therefore found no association between psychological morbidity and
the physical aspects of quality of life.
3.7 Discussion
This prospective observational study evaluated the impact of critical illness on quality of
life and physical function. We investigated whether perceptions ofphysical ability
reflected actual physical functioning and whether it was the change in perception of
physical ability or the actual level of physical functioning which determined the quality
of life during recovery. We also examined the effects of the common complications of
critical illness; malnutrition, anaemia, persisting inflammation, hepatic and renal
dysfunction, on physical function and physical quality of life.
3.7.1 Strengths and Weaknesses
3.7.1.1 Discussion ofRecruitment andmethodology.
Recruitment and follow up was difficult in our cohort of patients. Despite keeping an
accurate follow up log, contacting patients both by telephone and letter prior to follow
up appointments, and even offering to visit patients in their own home, our drop out rate
was high. Only 68% and 55% of eligible patients were assessed at 3 months at 6 months
respectively. The problems with recruitment were due to the heterogeneity of the ICU
population. In our cohort, alcohol and drug problems were common. Follow up studies
in such populations are therefore prone to relatively high drop out rates due to the
chaotic lifestyles ofmany of the patients. The face to face nature of the follow up
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assessments with the added 'physical assessment' probably added to the drop out rate, as
our patients were often already burdened with a significant post ICU morbidity and
multiple other medical appointments making demands upon them.
This was compounded further for the measure of actual physical function, the 6MWT
which was universally disliked by our patients, even those with good actual physical
function. Landmark ICU follow up studies which have used the 6MWT have been in
specific groups within the ICU survivor population, such as patients with ARDS
(Herridge, Cheung et al. 2003). Though patients with ARDS do represent a well
characterised cohort, have the most extensive and intensive follow up to date, and set the
standards for other ICU follow up studies, the results cannot be easily generalised. The
patients were younger, with much less pre-morbid impairment than our general cohort.
In undergoing an intensive period of follow up during recovery it is likely that the
ARDS cohort would become actively involved in the follow up process due to the
potential for non-specific benefits of participation. Patients could potentially see the
research assessments as ways of benchmarking their progress and obtaining reassurance
and advice on their recovery as part of an informal ICU follow up / research clinic. This
concept of a patient's ownership of their rehabilitation and dual benefit from the
research process, although promoted to our cohort, did not appear to help retention
within the study. As a consequence, our patients found the 6MWT intrusive and were
very anxious that they would be perceived as failures, or that in some way it would
cause them to be considered as not being as 'disabled' as they felt they were. The data
for actual physical function therefore represents a small number of our cohort and we
had to include the data of patients who refused to take the test due to pain or severe co-
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morbidity by scoring them as 0 m walked. Despite the small numbers the data does
describe a very severe degree of actual physical limitation in our cohort, much more than
we expected, and is an interesting result with our patients potentially having worse
physical function than patients with end stage heart failure. However, as a result of our
experience with the 6MWT we would not recommend it for assessment in general
cohorts of ICU survivors.
We did find that hand grip dynamometry was an acceptable, portable test which, as
discussed later reflected physical function well in our cohort, and we would aim to
continue to utilise this measure in future studies.
Despite these weaknesses our cohort recruitment and demographics were similar to other
Scottish ICU follow up studies (Cuthbertson, Scott et al. 2005).
The questionnaires used in this study were easy to administer and helped reduce drop
out rates for certain aspects of the study, as patients would often complete the
questionnaires by telephone interview or by post even though they were unwilling to
attend for formal assessment either in their homes or at the follow up clinic.
3.7.1.2 Discussion ofAnalyses
We attempted to use standard statistical measures which had been established in other
ICU follow up studies as well as measures which hoped to clarify the clinical
significance of such a change, such as calculating effect size and assessing correlation
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between factors at each time point. The use of correlation in our analyses did provide
statistically significant p-values but often with test specific measures, such as R2,
suggesting that the strength of such associations was small. To overcome this problem
we sought to establish groups in which clinically significant change had occurred.
Despite these problems with recruitment, retention and inherent complexities in
describing the population and change within it we believe that this data describes a
general cohort of ICU survivors in terms of their physical functioning and provides some
indication as to magnitude of change in function and the relative impact change in
physical function has on post ICU quality of life.
3.7.2 Results
For clarity, the results from the study will be discussed with reference to the research
questions posed in the methods section of the study
3.7.2.1 Quality of life
3.7.2.1.1 What is the pre-morbid physical quality of life in a cohort of general
ICU survivors?
The results show that our patients have recalled quality of life prior to the development
of their critical illness that was impaired, especially in the physical domains.
3.7.2.1.2 What is the impact of critical illness on physical components of
quality of life?
The physical component summary score (PCS) declined significantly to 3 months post
ICU discharge and did not improve at 6 months. The mental summary scores did not
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change significantly. As discussed in Section 3.2.1 this is consistent with other larger
ICU follow studies and supports the hypothesis that it is the physical rather than
psychological morbidity which is contributing to the overall reduction in quality of life.
3.7.2.1.3 What is the time course of recovery ofphysical components of
quality of life?
There was little evidence of recovery ofPCS score up to 6 months following ICU
discharge. Only 27% (9/33) had a increase in PCS score of 5 and in fact 45% (15/33)
showed no change or a decline in PCS score from 3 to 6 months.
3.7.2.2 Perceived physical function
3.7.2.2.1 What is the pre-morbid perceived physical function in a cohort of
general ICU survivors?
The pre-morbid perceived physical function of the cohort was reduced compared to
gender and age matched values for a normal UK population.
3.7.2.7.2 What is the impact of critical illness on perceived physical function
For the whole population there was a significant decline in FAI score from pre-morbid
values to 3 and 6 months and remained reduced at 6 months following ICU discharge.
This shows that there is a marked reduction in perceived physical function caused by
critical illness.
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3.7.2.1.3 What is the time course of recovery ofperceived physical function
There was little evidence of recovery in perceived physical function up to 6 months
following ICU discharge. Only 33% (11/33) showed a clinically significant increase of
an increase in total score of 4 or more (Harrington, Taylor et al.) from 3 to 6 months.
3.7.2.3 Actual physical function
3.7.2.3.1 What is the 6MWT distance in a general cohort of ICU survivors?
The actual distances walked by our cohort was much lower than expected with the
median values of the cohort being well below that expected of patients with significant
heart failure.
3.7.2.3.2 What is the time course of recovery of actual physical function in a
general cohort of ICU survivors?
There was little evidence of improvement in distance walked from 3 to 6 months with
only 26% (8/30) showing an increase ofmore than 50m from 3 to 6 months
3.7.2.4 Description of the cohort in terms of PCS, FAI and 6MWT
These results describe a cohort with a reduced pre-morbid physical quality of life which
is further impaired by the critical illness. The impairment although improving, persists to
6 months. The individual mental components and mental summary scores of quality of
life were near normal and remained robust throughout the follow up period. The
activities of daily living as measured by FAI score were less than the normal population
pre-morbidly and again were severely impaired by the event of critical illness. This is
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reflected by severe impairment in the measured actual physical function at 3 and 6
months. This suggests that in our cohort there is a significant level ofpre-morbid
impairment ofphysical function with a further dramatic impairment as a consequence of
critical illness and that ongoing physical morbidity plays a large role in the impaired
quality of life seen in survivors of critical illness.
3.7.3 Discussion of the results of correlation analysis
3.7.3.1 Does physical quality of life correspond to perceived physical
function?
The PCS score did correlate with FAI score. The R2 value for the results of correlation
tests was low. This suggests that PCS may not accurately reflect measures of impaired
activities for daily living which are measured by the FAI.
3.7.3.2 Does physical quality of life correspond to actual physical
function?
The PCS score did correlate with the 6MWT distance but the Spearman R values were
low. The correlation, though weak, was stronger compared to correlation of the FAI
score with PCS. This suggests that actual physical function may be better reflected in the
PCS score.
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3.7.3.3 Does perceived physical function correspond to actual
physical function?
The FAI score correlated well with the 6 MWT distance suggesting that perceived
physical function corresponds to measures of actual physical function. It is interesting to
note from the plots that several patients are unable to complete the 6MWT but have
moderate to good FAI scores. This suggests that the 6MWT as a measure ofphysical
function may not be sensitive to levels of activity required for the execution of the
activities ofdaily living assessed by the FAI score.
3.7.3.4 Discussion of the result of the analysis of the proportions of
patients with impaired perceived and actual physical function in groups of
normal and abnormal PCS score
3.7.3.4.1 Proportions ofpatients with impaired FAI scores in groups of
normal or abnormal PCS score
The finding that patients with an impaired FAI score were more likely to have impaired
PCS scores at 6 months only reinforces that concept that as recovery progresses the
importance of being able to carry out the activities of daily living becomes more
important and has the potential to affect the physical component and therefore overall
quality of life following critical illness
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3.7.3.4.2 Proportions ofpatients with less than expected 6 MWT distances
in groups ofnormal or abnormal PCS score
There was no difference in the proportion of patients with impaired 6MWT distances in
groups of normal and abnormal physical quality of life. This suggests that the actual
physical function as measured by 6MWT does not affect physical quality of life.
3.7.3.4.3 Discussion of the results of the additional exploratory analyses
The finding that impaired perceived physical function (i.e. the ability to carry out
activities of daily living) was more common in patients with less than normal PCS score
whereas the patients with less than expected 6MWT distances did not more commonly
have impaired physical quality of life. This suggests that the ability to carry out the
activities ofdaily living is more important to quality of life than regaining actual
physical ability.
3.7.4 Discussion of the results of analysis of change in parameters during
follow-up
3.7.4.1 Does a change in perceived physical function correspond to a
change in PCS score?
The magnitude of change in PCS scores did correlate with the change in FAI score. The
patients with the biggest decline in PCS score were also noted to have an associated
large decline in FAI score. For the cohort as a whole the measures at 3 months had a
weak association whilst the strength of the association looked much stronger from 3 to 6
months. This suggests that an improving FAI score is reflected in the physical aspects of
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quality of life. In conjunction with the finding above 3.7.3.4.1 it reinforces the concept
that as recovery progresses, the importance ofbeing able to perform the activities of
daily living and therefore its impact on quality of life increases.
3.7.4.2 Does a change in actual physical function correspond to a
change in PCS score?
The magnitude of change in PCS score did correlate with the magnitude of change in
6MWT data but the strength of the association was weak. Examining the plotted data it
could be seen that at the extremes of the data patients who had the greatest improvement
in distance also had the greatest improvement in quality of life. The converse was also
true. In the majority of cases however there was little change in the 6MWT distance
despite varying degrees of change in PCS score. This may reflect an inherent
insensitivity of the 6 MWT for use in ICU survivors as there are too many potential
reasons why a test would not be attempted at a given time which was not related to
overall physical activity.
3.7.4.3 Discussion of the results of the analysis of the proportions of
patients with significant change in perceived and actual physical function
in groups of normal and abnormal PCS score
3.7.4.3.1 Proportions ofpatients with significant increase FAI scores in
groups of normal or abnormal PCS score
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There was no difference in the proportions of patients with a significant increase (or in
fact with any increase - data not shown) in groups determined by normal or abnormal
PCS score.
3.7.4.3.2 Proportions ofpatients with an increase 6MWT distance of 100m
in groups ofnormal or abnormal PCS score
There was no difference in the proportions ofpatients with an increase of 100m (or in
fact with any increase - data not shown) in groups determined by normal or abnormal
PCS score.
3.7.4.3.3 Discussion of the effects of change in outcome measure on
physical quality of life scores
We were unable to answer this research question adequately due to the severity of
impairment and lack of improvement within the cohort. However it would appear that
patients with improving FAI scores or improving 6MWT distances were no more likely
to have a normal PCS score suggesting that it is not the change in a parameter but the
actual level attained which determines the impact on quality of life. This further supports
the concept that within our cohort being able to carry out the activities of daily living
rather than the actual level of physical function is the important determinant of quality of
life.
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3.7.5 Discussion of the potential for %HGS to be a useful measure of
actual physical function
3.7.5.1 The magnitude of change in PCS score and change in %HGS
Disappointingly there was no obvious correlation between the magnitude of change in
PCS score and HGS. We had found this measure much more acceptable to our
population and the preliminary findings that the percentage scores correlated with PCS
scores, 6MWT distances and FAI at 6 months. It may therefore be that hand grip
strength reflects the degree ofphysical impairment but improvement of this score
(as it is a percentage of normal already) is prone to ceiling effects.
3.7.6 Discussion of the effects of common complications of critical illness
on physical functioning and quality of life
In considering the common organotopic sequelae of critical illness it can be seen that
over 50% of our cohort were anaemic at 3 months and 33% at 6 months supporting the
findings of the TRAC study that anaemia is common and persistent complication of
critical illness. Haemoglobin and physical quality of life on this initial analysis were
found not to be correlated. There was no statistical difference in the proportion of
patients with an eGFR <60 at ICU discharge compared to 3 and 6 months.73% of our
cohort at 3 months had values of hand grip strength suggestive of protein malnutrition
and 49% at 6 months. Albumin levels were impaired at ICU discharge but had recovered
to normal levels by 3 months. There was little evidence of ongoing inflammation.
Albumin may therefore be a useful measure of global recovery following critical illness.
Certainly an improving serum albumin concentration is a good indicator of the potential
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to survive critical illness (Blunt, Nicholson et al. 1998) and to have the physical reserve
to wean from ventilation (Sapijaszko, Brant et al. 1996).
Serum albumin concentration and % HGS both seem to reflect actual and perceived
physical function as well as physical quality of life and would appear to be useful
markers ofphysical function status in survivors of critical illness.
3.7.7 The effects of PTSD on physical quality of life
Our results show that although there is a significant prevalence of psychological
morbidity it has no influence on physical or indeed overall quality of life in our cohort.
At 3 months 17/48 (35%) patients had threshold symptoms for PTSD and 14/48 (29%)
reached diagnostic criteria for PTSD and at 6 months 9/36 patients (25%) met diagnostic
criteria for PTSD which shows that there is a significant burden ofpsychological
morbidity which may either be poorly assessed by the SF-36 measure of quality of life
or in this relatively short follow up time frame is masked by the relief of having survived
the critical illness.
The findings of a major UK ICU follow up study (The Practical Study) (Cuthbertson,
Rattray et al. 2007; Cuthbertson, Rattray et al. 2009) have found that ICU follow up
clinics and measures focused on psychological morbidity have little effect on quality of
life after critical illness. It may be that focusing on physical rehabilitation may make the
biggest impact on quality of life following critical illness but the significant
psychological burden present within the population still needs to be addressed.
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3.8 Conclusions
Physical aspects of quality of life are impaired before the development of critical illness
but are significantly worse after critical illness and have not recovered by 6 months after
ICU discharge. There is impairment in both subjective physical function and actual
physical function following critical illness and these measures correlate with the
physical summary score of the SF-36 quality of life measure suggesting that it is
physical morbidity rather than psychological morbidity contributing to the impaired
quality of life as psychological measures of quality of life are not impaired during
recovery. However the strength of this association may not be strong. The change in
perception of physical function especially at 6 months appears to be reflected in quality
of life scores. The association between actual physical function is less strong but this
may be due to the small numbers and inclusion of patients who did not attempt the test
for valid reasons as 0 distance walked on both occasions. This may be a reflection of the
severity of impairment of actual physical function in our cohort or due to the
insensitivity of the 6MWT in our cohort.
If FAI is considered a measure of the ability to execute the activities of daily living then
it would appear that recovery of these basic measures is the most important detenninant
of quality of life in survivors of critical illness.
Analysis of the organotopic measures show that serum albumin concentration and hand
grip strength are useful markers of physical function and should be included into future
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studies. There is significant and persisting anaemia and there are some measures
suggesting malnutrition up to 6 months after ICU discharge. However there is little
evidence of ongoing actual organ failure.
These findings suggest that the greatest area for potential impact on improving quality of
life following critical illness is to focus upon physical rehabilitation. Such studies should
consider using alternative measures of quality of life as the SF-36 score as it may not
reflect changes within the activities of daily living that are important determinants of
physical function quality of life. The FAI score may represent an alternative to the SF-36
score as it is a linear scale within each domain and was responsive in a general cohort of
ICU survivors. It was also quicker to administer than the SF-36.
The 6 MWT is not an ideal measure of actual physical function and the use of hand grip
dynamometry should be considered as an alternative. Other measures such as 'activity
meter' could become the gold standard for determining actual physical function in the
future.
The most striking finding of our research was the magnitude of physical impairment and
highlights the need for rehabilitation strategies to be focused upon this group ofpatients.
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Chapter 4
Anaemia, Quality of Life
and Physical Function
4.1 Introduction
As haemoglobin concentration is one of the prime determinants of oxygen carriage in
the blood it is reasonable to expect that impairment ofphysical function would occur in
the presence of abnormally low haemoglobin levels. Certainly looking at athletes,
especially in cycling and endurance sports, high haemoglobin level is perceived as
desirable. Thus increasing haemoglobin levels either by training, especially at altitude,
or by other artificial means such as erythropoietin use ('blood doping') or transfusion
('blood boosting') are sought as a means of improving physical performance. The
scientific basis for this has been established (Figure 4.1) (Astrand 1953; Joyner 2003).
4.1.1 The effects of haemoglobin on physical performance
Maximal oxygen consumption, VO2 max, is the maximum capacity of an individual's
body to transport and utilize oxygen during incremental exercise and reflects the
physical fitness of an individual. In athletes an acute reduction of circulating
haemoglobin concentration even when blood volume is maintained results in a
lowerVCb max and a reduced endurance performance due to the reduction in the oxygen
carrying capacity of the blood. Conversely, an increase in haemoglobin concentration is
associated with enhanced VO2 max and endurance capacity that is proportional to the
increase in oxygen capacity of the blood. The observed effects on endurance capacity
seem more pronounced than the effect on VO2 max (Gledhill, Warburton et al. 1999).
Thus the reinfusion of blood, increasing haemoglobin levels above an individual's
normal value increases VO2 max and enhances physical performance.
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Figure 4.1 Relationship between V02 max and haemoglobin concentration
Classic data showing the relationship between total body haemoglobin and V02
max for 94 subjects aged 7-30 years. Adapted from Joyner (Joyner 2003),
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During sub maximal exercise the reinfusion ofblood to produce supra-physiological
haemoglobin levels reduces heart rate and blood lactate levels suggesting improved
oxygen delivery and tissue perfusion (Ekblom 2000). The use of erythropoietin to
increase haemoglobin has been shown to increaseVO2 max and physical performance in
athletes (Joyner 2003). In non-elite athletes these effects may be more pronounced as
the elite are looking for a tiny competitive edge in an almost optimal physiological
machine. In us, less than perfect mortals, the ability to increase VO2 max produces
relatively more effect.
4.1.2 Anaemia in illness
What do we know about the effects of haemoglobin concentration in poor health?
Because anaemia is a common complication of illness, and is potentially treatable, there
is a large body of work investigating the consequences of anaemia in different medical
conditions. These conditions can be broadly considered as:
1. normal individuals developing a transient anaemia secondary to a reversible
cause
2. individuals who develop anaemia secondary to a chronic medical condition
Another population group in which anaemia is common and highly relevant to survivors
of critical illness (due to the prevalence of co-morbidity) is the elderly.
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4.1.2.1 'Transient anaemia'
4.1.2.1.1 Anaemia associated with the peri-operative period
Most studies investigating peri-operative physical function and anaemia have come from
trials evaluating the use of erythropoietin in the peri-operative period. Generally the
results have shown that erythropoietin affords a measurable improvement in fatigue,
exercise capacity, muscle strength and the activities of daily living (Carson, Terrin et al.
2003). It was suggested that improved haemoglobin levels in the severely anaemic
patients facilitated participation in rehabilitation programmes and led to greater
functional independence. The effects were most pronounced in studies investigating the
treatment of severe anaemia (haemoglobin levels less than 100 g/L and even 80 g/L) and
it was suggested that 'the rule of diminishing returns' applied in treating haemoglobin
levels that approached normal such that treating mild anaemia (below gender reference
range) or attempting to achieve high normal haemoglobin concentration produced
relatively little observed benefit.
4.1.2.1.2 Post partum anaemia
In the early post partum period women are generally anaemic. 43% of non-pregnant
women in developing countries and 12% in industrialized countries are anaemic during
pregnancy, rising to 56% and 18% respectively by the third trimester. In a study
comparing vaginal delivery against elective and emergency caesarean section it was
found that haemoglobin concentration correlated with the physical aspects of quality of
life within the first week post partum. Patients who had a vaginal delivery were less
anaemic and had better actual physical function than the caesarean cohorts but the
185
difference in quality of life scores had resolved by 1 week post partum (Jansen, Duvekot
et al. 2007). This is typically when haemoglobin levels return to the non-pregnant range
(Milman 2006). In patients who remain anaemic, the anaemia is associated with higher
levels of fatigue until the anaemia resolves (Lee and Zaffke 1999).
4.1.2.1.3 Iron deficiency anaemia
In 'normal' otherwise healthy patients with iron deficiency anaemia in Japan it was
found that patients with iron deficiency anaemia had reduced quality of life compared to
the normal population especially in the physical domains of quality of life. Treating the
anaemia with iron supplementation restored the quality of life of these individuals to the
same or better than the normal population. This effect was most pronounced in women
of childbearing age with no co-morbidity, which would suggest that it was the anaemia
and the impaired physical performance which was most affecting quality of life.(Ando,
Morita et al. 2006). Generally, in populations of low co-morbidity, anaemia is associated
with decreased physical function and decreased quality of life. Resolution of the
anaemia is associated with improved quality of life.
4.1.2.2 Anaemia secondary to chronic conditions
4.1.2.2.1 Anaemia and renal disease
There has been a great deal of research into anaemia associated with renal failure. In
patients with chronic severe kidney disease but not requiring dialysis, health related
quality of life is impaired compared to the normal population, but is better than those
patients on dialysis. Anaemia was ubiquitous in the non-dialysis dependent patients and
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treatment of the anaemia improves quality of life especially in the physical function
domains (Alexander, Kewalramani et al. 2007). In patients on dialysis it was also found
that anaemia was associated with a poor quality of life and treatment of the anaemia
improved quality of life in multiple domains.
The treatment of anaemia in renal failure is a quality of care indicator and the Renal
Association consider treatment of anaemia to have a profound influence on morbidity
and mortality in chronic renal failure such that standards for treatment have been set for
haemoglobin levels to be more than 100 g/L. In the US similar guidelines recommend
levels more than 110 g/L. The anaemia of chronic kidney disease results in fatigue,
reduced exercise capacity, impaired cognition and reduced quality of life and
exacerbates existing co-morbidities and increases the risk of death and its treatment is
considered of paramount importance (Locatelli, Covic et al. 2009).
4.1.2.2.2 Anaemia and cancer
Anaemia is very common in cancer patients and is dependent upon the type and stage of
the tumour and of the associated treatments (e.g. chemotherapy) received. The clinical
effects of anaemia often overlap with tumour related symptoms but the overall symptom
burden has been shown to be related to haemoglobin level. Anaemia is associated with
impaired functional capacity and quality of life in cancer patients and treatment of the
anaemia improves quality of life and functional ability (Bokemeyer, Aapro et al. 2007;
Pelegri 2007). A meta-analysis of 5 randomised controlled clinic trials of darbepoietin
alfa in a variety of tumours (solid tumour, lung cancer, non-myeloid haematological
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malignancy and lymphoproliferative malignancy) showed that a response in
haemoglobin levels to darbepoietin alfa treatment was associated with a meaningful
clinical improvement in fatigue which in turn was associated with improved physical
function (Cella, Kallich et al. 2004).
4.1.2.2.3 Chronic Obstructive Pulmonary Disease
Anaemia is common in patients with COPD. Studies estimate a prevalence of significant
anaemia between 36% to 48 % (Stanbrook 2003). There was also a correlation between
the severity of anaemia and the severity ofCOPD (Park 2003). In patients with COPD,
anaemic patients have lower scores in the physical function domains of the SF-36 score
than the non-anaemic patients. It is also interesting to note that the control group without
COPD who were also anaemic also had a reduced physical component scores on
assessment. Further analysis of the cohort in the Park et al study showed that there was
an association between anaemia and the physical function components of quality of life.
Other studies suggest it may be that there was a greater degree of co-morbidity in
patients who were anaemic and had moderate to severe COPD and that it was the co¬
morbidities that were contributing to this observed reduction in quality of life (Krishnan,
Grant et al. 2006).
4.1.2.2.4 Anaemia in cardiac failure
At least 20% of patients with cardiac failure have anaemia and it is an independent
marker for increased mortality. Anaemia is also more prevalent in those patients with
advanced age and more severe limitations of functional capacity (Tang and Katz 2008).
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The study by Silverberg et al investigating the effects of erythropoietin in patients with
heart failure was one of the most important papers for bringing this problem of anaemia
to light. They found a prevalence of 55% for significant anaemia and treatment of this
anaemia reduced the severity grade of the heart failure (i.e. improved physical function)
and reduced hospitalizations (Silverberg, Wexler et al. 2000). Since then there have been
many studies investigating the effects of anaemia in heart failure which have
consistently shown an association between anaemia, poor functional status and higher
risk ofhospitalisation and death (Murphy and McMurray 2008; Tang and Katz 2008).
4.1.2.2.5 Anaemia and diseases associated with chronic inflammation
Patients with rheumatoid arthritis are commonly anaemic with a prevalence of 33-60%.
Resolution of anaemia improves symptoms and quality of life in these patients.
A third ofpatients with inflammatory bowel disease have recurrent anaemia and it is
associated with a chronic fatigue state which has significant impact upon physical
function and quality of life. The majority of patients with inflammatory bowel disease
are younger than most chronic illness groups and the expectations of health in this
patient group are higher. Again, treating anaemia has been shown to improve physical
function and quality of life (Gasche, Lomer et al. 2004; Wells, Lewis et al. 2006). In
patients with liver disease due to hepatitis C virus and receiving haemodialysis it has
been noted that HRQL was not associated with the severity of liver disease but was
associated with anaemia (Afsar, Ozdemir et al. 2009).
189
4.1.2.3 Anaemia in the elderly
Anaemia is common in the elderly (~10% of individuals rising to 20% in those over 85
years) and is linked to an increase in morbidity and mortality. It is an independent
variable associated with poor outcomes such as poor physical function and quality of life
(Gabrilove 2005). The prevalence ofmobility problems increases as haemoglobin levels
fall (Penninx, Guralnik et al. 2003) and may be due to the reduced muscle strength in
anaemic elderly patients (Penninx, Pahor et al. 2004); additionally, anaemia was
consistently associated with significant impairments of the activities of daily living. The
functional decline seen in anaemic elderly patients has been found to be associated with
significant impairments in multiple domains of quality of life measures, especially in the
physical domains (Thein, Ershler et al. 2009).
4.1.3 Rationale for the investigation of anaemia in critical illness
The consistent theme from studies of anaemia in other patient groups is that anaemia is
common, has profound effects on physical function, quality of life, morbidity and
mortality, and is potentially treatable with improvements in all of these domains. A
recent panel of experts produced a series of recommendations aimed at treating anaemia
with a view to restoring physical function and quality of life in chronic medical
conditions which highlights the importance of anaemia treatment (Cavill, Auerbach et al.
2006). There have been few studies into the effects of anaemia during rehabilitation
from critical illness and we therefore believed that the further analysis of the anaemic
patients in our cohort could provide useful information to guide the development of
further focused studies into anaemia and potential treatments in this group.
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4.2 Materials and Methods
This chapter focuses on a subgroup of the cohort described in Chapter 3 (Sections 3.3
and 3.4). For the purposes of the subgroup analysis the patients were divided into gender
specific anaemia groups (haemoglobin concentration less than gender specific reference
range) and also severe anaemia groups (haemoglobin concentration less than 100 g/L) as
detailed below and Figure 4.2. A further analysis of patients who had a complete data set
for the follow up period was also performed (The 'Finisher's Analysis'). For this
analysis the patients were divided into 2 groups depending upon whether their
haemoglobin concentration was below or within the gender specific reference range at
the 3 month follow up visit.
4.2.1 Anaemia groups
4.2.1.1 Gender and Severe Anaemia groups
The study cohort was divided into subgroups at each time point (0 months, 3 months and
6 months) depending upon haemoglobin concentration at this time. The first analysis
related to groups determined by whether the haemoglobin concentration of the patient
was less than gender specific reference range (120 g/L for females and 130 g/L for
males) at the particular time point - 'gender anaemia'. Further analysis was performed
for severe anaemia where the group was determined by whether the haemoglobin
concentration of a patient was more or less than 100 g/L - 'severe anaemia'.
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Figure 4.2 Flow diagram illustrating patient group selection and analyses
4.2.1.2 Finisher's Analysis
A further analysis ofpatients who remained anaemic (with haemoglobin below gender
specific range) at 3 months compared to those who did not was also performed
specifically for patients where the complete data set was available for the follow up
period. This would allow for changes with time for a given parameter to be analysed
within a specific population.
4.2.2 Analyses
4.2.2.1 Groups determined by gender anaemia or severe anaemia at
each time point
4.2.2.1.1 Demographics and Baseline Characteristics
The baseline characteristics (age, ICU length of stay, APACHE II score) of the anaemic
and non-anaemic groups were compared using Student's t test. The proportion of
patients with severe organ failure (SOFA >3) for each component of the SOFA score
was recorded for each group. The proportion of each of the anaemic and non-anaemic
subgroup with severe organ failure during ICU stay was then compared using Fisher's
Exact Test.
4.2.2.1.2 Anaemia and quality of life
The cohort was again considered in two sub-groups, gender anaemia and severe
anaemia, at each time point. The proportion of each cohort with SF-36 component scores
less than mean values for the UK normal population was then calculated and analysed
with Fisher's Exact Test. The physical and mental component summary scores for the
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cohort were also compared for statistical difference at each time point with Student's t-
test.
4.2.2.1.3 Anaemia and perceived physical function
The cohort was again considered in the two sub-groups. The FAI score for the groups
was compared at each time-point (3 and 6 months) using Student's t-test.
4.2.2.1.4 Anaemia and actual physical function
The results of the 6 minute walk test and hand grip strength measurement of the two
subgroups at 3 and 6 months was compared with Mann Whitney U-test and Student's t-
test accordingly.
4.2.2.1.5 Anaemia and nutrition as assessed by hand grip strength
The raw data from the hand grip dynamometer was converted in to a percentage of the
normal value for patient's gender and age. A value less than 85% of normal was
considered as evidence of protein malnutrition (Klidjian, Foster et al. 1980; Goode
1985). Hand grip strength is an unusual measure of nutritional status and it is possible
that other factors such as neuropathy and myopathy could contribute to the development
of reduced grip strength. However it has been shown to be a robust predictor of
nutritional status in several patient groups and a better marker than the classic laboratory
indices of nutritional state (Webb, Newman et al. 1989; Wang, Sea et al. 2005). This is
likely to be due to the fact that hand grip strength represents the common easily
measured endpoint of the multiple potential factors reflecting a patient's physiological
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state (i.e. is a measure of frailty) and that nutritional state is an important determinant in
many of these components ofphysiological state. The proportion of patients with
evidence ofmalnutrition in each group was also compared using Fisher's Exact Test.
4.2.2.1.6 Anaemia and organotopic measures
The organotopic measures (albumin, CRP, creatinine) were compared using Student's t-
test at 0, 3 and 6 months. The creatinine concentrations were converted to estimated
glomerular filtration rate (eGFR) for the comparison ofproportions to account for
differences in age and gender (Burden and Tomson 2005). The proportion of each
subgroup who had an abnormal result (either a CRP >10, reduced eGFR (<60ml/min), or
an albumin level less than 30g/L) was also recorded and the proportions compared with
Fisher's Exact Test.
4.2.2.1.7 Correlation between outcome measures and haemoglobin
concentration
The data for quality of life (SF-36 PCS and MCS score), perceived physical function
(FAI), actual physical function (hand grip strength) and organotopic measures (CRP,
creatinine, albumin) which were normally distributed, were analysed for correlation with
haemoglobin concentration with Pearson's Test. Non-Gaussian data (eGFR, distance
walked in 6MWT) were analysed with Spearman's Test.
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4.2.2.2 Analysis of data from patients based on subgroups defined
by the presence ofgender anaemia at 3 months and who completed follow
up - The 'Finisher's Analysis'
4.2.2.2.1 Demographics and baseline characteristics
The baseline characteristics (age, ICU length of stay, APACHE II score) of these
anaemic and non-anaemic groups, as determined by haemoglobin concentration at 3
months, were compared using Student's t test.
4.2.2.2.2 Organotopic measures
The organotopic measures of the groups were compared at each time point (0, 3 and 6
months for haemoglobin concentration, serum creatinine and albumin and 3 and 6
months for serum CRP concentrations) and the change in these results over time
analysed with 2 way ANOVA for creatinine and albumin concentrations comparing
anaemic and non-anaemic changes over time and Mann-Whitney U-test for CRP.
The proportion of patients with evidence of protein malnutrition (HGS < 85% of normal)
was also compared at 3 and 6 months using Student's t test.
4.2.2.2.3 Measures of quality of life and perceived physical function
Physical component summary scores and Frenchay Activities Index were analysed for
the 2 groups for pre-morbid, 3 and 6 months using 2 way ANOVA.
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4.2.2.2.4 Actual physical function
Results from the 6 minute walk test and hand grip strength were analysed with the Mann
Whitney U Test.
4.3 Results
4.3.1 Gender and severe anaemia groups at ICU discharge, 3 and 6 month
follow up visits
The proportion ofpatients anaemic for gender and severe sub-groups at each time point
are shown in Table 4.1.
4.3.1.1 Demographics and clinical characteristics
The demographic and ICU characteristics of each subgroup are shown in Tables 4.2a, b
and c.
4.3.1.1.1 ICU discharge - Table 4.2a
These results that show that severely anaemic patients at ICU discharge had a
significantly longer ICU stay compared to those who were not severely anaemic (14.1
days compared to 4.7 days, p=0.03). This suggests that whilst 'gender anaemia' is a
common complication of all ICU stays and not related to the characteristics of ICU stay,
'severe anaemia' at ICU discharge is associated with a longer ICU stay. It may therefore
be that it reflects either a greater exposure to the many potential sources of blood loss in
ICU or that the underlying illness process resulting in an inability to mount an
appropriate response to the anaemia of critical illness is persisting.
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Table 4.1 Proportion of patients anaemic at each time point in the study
Proportion and 95% confidence interval of the proportion for gender specific
anaemia and severe anaemia groups shown
Hb < Gender specific range Hb < 100 g/dL
Number Proportion 95% CI Number Proportion 95% CI
Discharge 65/6g 0 96 0.87- 5Q/68 0-74 0.62-
3 months
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4.3.1.1.2 3 months - Table 4.2b
These results show that patients with 'gender anaemia' at 3 months were older (66 years
compared to 56 years, p=0.001) and had a longer ICU stay (19.2 days compared to 9.8
days p=0.008) compared to those who were not anaemic at 3 months. The persistence of
severe anaemia was again associated with a longer ICU stay.
4.3.1.1.3 6 months - Table 4.2c
There were no differences in demographics and baseline characteristics for the gender
anaemia group at 6 months following ICU discharge. The severe anaemia group was not
analysed as only one patient had severe anaemia at this time.
4.3.1.1.4 Proportion of anaemia groups with severe organ failure in ICU
The proportion of patients in each group (gender and severe anaemia) with severe organ
failure during ICU stay was not different at ICU discharge, 3 or 6 month follow up. This
suggests that the degree of organ failure during ICU stay does not affect whether
patients will remain anaemic following ICU discharge.
4.3.1.2 Quality of life
Figure 4.3a and 4.3b shows the PCS and MCS scores for anaemic and non-anaemic
groups at 3 and 6 months with the results summarised in Table 4.3. There is a strong
trend at both 3 and 6 months for patients with persisting anaemia to have a significantly
reduced physical quality of life and this reached statistical significance at 6 months,
median PCS 27.8 compared with 35.6, p=0.032.
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Figure 4.3a Physical (PCS) and 4.3b Mental (MCS) component summary
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Actualnumberofpatientsshownw thercent geibrack t PF=physicalfunction,Rrolep icalBPbodilya nGHgenerhe lthVvitalit , SF=socialfunctioning,ERr leem tio alMHment lh alth
The proportion of each study cohort with PCS scores less than mean values for UK
population were calculated and analysed with Fisher's Exact Test. The results show that
the majority (95%; 64/67) of the study cohort had an impaired quality of life prior to
ICU admission. In comparing anaemia groups at 3 and 6 months >75% had impaired SF-
36 scores especially on the physical domains compared to the normal population. The
proportions ofpatients whose SF-36 parameter was less than the mean normal values
was not significantly different in the anaemic or non anaemic groups when compared
with Fisher's exact test in either summary scores or individual components. The
proportions are shown in Table 4.4
4.3.1.3 Perceived physical function
The FAI scores for gender specific anaemia and severe anaemia are shown in Figure 4.4
and Table 4.5. The FAI score was statistically less in the anaemic groups compared to
the non-anaemic groups (both gender and severe anaemia groups) at all time points.
Median FAI scores were 18 for the gender anaemia groups compared to 25 for the non-
anaemic group at 3 months, and 12 compared to 24 for gender anaemia group at 6
months. A change of 4 in FAI score is considered clinically significant (Harrington,
Taylor et al.).
4.3.1.4 Actual physical function
4.3.1.4.1 6 minute walk test
The distance walked for gender specific and severe anaemia groups are shown in Figure
4.5 and Table 4.6.
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Figure 4.4 FAI for gender and severe anaemia groups
I Anaemic
] Non-anaemic
* indicates significant result with p value shown
Table 4.5 FAI scores for gender and severe anaemia groups







Number 21 21 3 26
F Median 18.0 25.0 0.021 1.0 19.0 0.040
A IQrange 7.0-24.5 16.0-31.0 - 11.0-27.5
I Range 0.0-37.0 9.0-45.0 0.0-18.0 0.0-37.0







Number 8 20 - - -
F Median 12.0 24.0 0.034 - - -
A IQrange 6.0-25.0 16.5-33.0
I Range 3.0-30.0 4.0-39.0

























Figure 4.5 Distance walked in 6 minute walk test
• Anaemic
o Non-anaemic
* indicates significant difference with p value shown
Table 4.6 Distances walked during 6MWT for gender and severe anaemia
groups







Number 17 15 3 29
D Median 0 257 0.121 0 198 0.365
I IQ 0-359 120-391 - 0-390
S range 0-437 0-535 0-315 0-535
T Range







Number 8 15 - - -
D Median 0 375 0.0355 - - -
I IQ 0-189 0-547




















Data expressed as median, interquartile range and range, and analysed with
Mann-Whitney U test
For the cohort at 3 months there was no difference in the distance walked between
anaemic or non-anaemic patients. At 6 months non-anaemic patients walked
significantly further (median 375m compared with Om, p=0.035). This may reflect a
greater degree of co-morbidity in the anaemic group as there were more patients with a 0
distance walked. This may reflect inability to attempt the test rather than actual physical
function being reduced.
4.3.1.3.2 Hand grip strength
The results are shown in Figure 4.6 and Table 4.7. At 3 and 6 months the gender
anaemic patients had significantly reduced percentage of normal handgrip strength
compared to the non-anaemic patients. This was not present for the severe anaemia
group at 3 months.
4.3.1.5 Organotopic measures
4.3.1.5.1 Nutritional status by hand grip strength
Hand grip strength as a marker of nutritional state was assessed using Fisher's Exact test
for the proportion of each group with HGS less than 85% of normal (Table 4.8). The
proportion of patients with evidence of protein malnutrition was significantly greater in
the anaemic compared to the anaemic groups at 6 months only.
4.3.1.5.2 Albumin
Results are shown in Figure 4.7a, Figure 4.7b and Table 4.9. At ICU discharge only the
severe anaemia group had a significantly lower albumin concentration.
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Figure 4.6 Percentage of normal hand grip strength









* indicates significant difference with p value shown
Table 4.7 Percentage of normal hand grip strength for gender and severe
anaemia groups







Number 21 21 3 39
H Median 56 80 0.008 50 70 0.160
G IQrange 46-74 65-99 - 56-88
S Range 24-132 29-149 44-56 24-149







Number 9 19 - - -
H Median 73 92 0.027 - - -
G IQrange 52-80 76-105
S Range 45-85 32-145
Data expressed as median, interquartile range and range; analysed with
Student's t-test
Table 4.8 Proportion of patients with gender and severe anaemia and
evidence of protein malnutrition (<85% of normal)









19 13 0.067 3 28 0.554
>85%
normal








1 12 " -
Data analysed with Fisher's Exact Test

















Discharge 3 months 6 months

































































































Dataexpressedmedian,interquartiler nga c Significantresultshighlightedibold.
range;analysedwithStudent'st-t t
At 3 and 6 months albumin concentration was found to be significantly different
between the groups both for gender anaemia and severe anaemia groups. The proportion
ofpatients in each group with serum albumin concentration <30 g/L was different at all
time points (Table 4.10).
4.3.1.5.3 Creatinine and eGFR
Results are shown in Figure 4.8a, Figure 4.8b and Table 4.11. Serum creatinine
concentration was not different between the groups at any time point. The proportion of
patients with severe renal impairment (eGFR<60 or grade 3 renal failure) was not
different between the groups.
4.3.1.5.4 CRP
Results are shown in Figure 4.9 and Table 4.12. CRP concentrations were found not to
be different at 3 months but were significantly higher in the anaemic group at 6 months
suggesting that the persistence of inflammation is associated with the persistence of
anaemia. The proportion of patients with an elevated CRP in each group was
significantly higher in the severe anaemia group at 3 months and in the gender group at
6 months (Table 4.13).
4.3.1.6 Correlation ofparameters with haemoglobin concentration
Results are summarised in Table 4.14. Haemoglobin concentration did not correlate with
quality of life measures. Distance walked in 6 minutes correlated with haemoglobin at 3
months but not at 6 months.
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Table4.10Proportionfpatientsw hgend rds vereanaemiaithl wserumlbuminconcent tion (<30g/L) TimePointDischarge GroupGenderSevere AnaemicNon- anaemicp-valueAnaemicNon- anaemicp-value <305920.2848130.0118 >306125 TimePoint3months GroupGenderSevere AnaemicNon- anaemicp-valueAnaemicNon- anaemicp-value <303200.24220.0193 >30020138 TimePoint6months GroupGenderSevere AnaemicNon- anaemicp-valueAnaemicNon- anaemicp-value <30170.30100.037 >30019026 Dataanalysedwi hFisher'sEx ctTest.
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indicates significant difference with p values shown
Table 4.12 Serum CRP concentrations for anaemia groups







number 22 20 4 38
13.5 5.0 ns 50.5 5.0 0.006
5.0-26.5 5.0-20.0 25.0-182.0 5.0-21.0
5.0-290.0 5.0-178 23.0-290.0 5.0-191.0
Time Point 6 months
Group Gender Severe
number 9 17 - - -
29.0 5.0 0.016 - - -
6.5-90.5 5.0-10.0
5.0-232.0 5.0-51.0
Data expressed asmedian, interquartile range and range; analysed with Mann-Whitney.
Time Point 3 months
Group Gender Severe
Anaemic Non-anaem p-value Anaemic Non-anaem p-value
<10 9 13 0.136 0 22 0.043
>10 13 7 4 16
Time Point 6 months
Group Gender Severe
Anaemic Nonanaem p-value Anaemic Non-anaem p-value
<10 3 13 0.046 0 16 0.384
>10 6 4 1 9
Data analysed with Fisher's Exact Test.


































































































Hb=haemoglobinconcentratiotimep t,PCSphysicalmp nesummaryre,MCSe t lomponent summarycore,dist=istancw lkedin6MWTCRP-re ctivprot incon en ration,eGFResti ated glomerularfiltrationte,creat=serumr atini eonce tra ion,albserumalb inc ncentration,%HGS= percentagehandgripstre gth,3=mo thss ssm nt,6tass ent.
Haemoglobin concentration correlates with hand grip strength and albumin
concentration at 3 and 6 months and negatively correlates with CRP at 3 months. There
was no correlation with serum creatinine or eGFR.
The results from the correlation analysis showed significant p values but the test specific
values of significance, the Pearson R2 or Spearman R values were less than 0.5 for all
results suggesting a relatively weak association. The strength of the association was
strongest for CRP and serum albumin concentration which is supportive of the link
between anaemia and ongoing inflammation.
4.3.2 Results for 'Finisher's Analysis' cohort
4.3.2.1 Demographic and Baseline characteristics of cohort of
patients who completed the study with complete analysis parameters
Demographics and characteristics of ICU stay of the 'Finisher's' groups are shown in
Table 4.15. Age and ICU length of stay were greater in the anaemic compared to the
non-anaemic groups. The proportion of patients with severe organ failure was only
different for the SOFA cardiac element. There was a significantly greater proportion of
patients requiring inotropic support in the anaemic group p=0.033.
4.3.2.2 Haemoglobin concentration at ICU discharge and 6 months
The haemoglobin concentrations of the groups are shown in Figure 4.10 and Table 4.16.
The results show that the groups are not significantly different at ICU discharge but the
difference at 3 months persists to 6 months.
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Table 4.15 Demographics and baseline characteristics of 'Finishers' cohort
Parameter Anaemic Non-anaemic p-value
Number 14 13
(male/female) 8/6 2/11















SOFA max 10.5; 7.0-13.0, 4-
14
8.0; 4.0-12.5, 4-15 0.235




Hb at ICU 90.5; 82.0-99.0, 93.0; 84.0-108.0, 0.244
discharge 79.0-117.0 81.0-138
Data expressed as median, IQ range and range. Differences between groups
analysed with Student's t test. The proportions of each group with severe organ
failure (SOFA >3) and the data for the cardiac component were analysed with
Fisher's Exact Test.













Anaemic and non-anaemic groups defined by haemoglobin concentration at 3
months




Median 90.5 93.0 ns
IQ range 82.0-99.0 84.0-108.0
Range 79.0-117.0 81.0-138.0













Time Point 6 months
Anaemic Non-anaemic p-value











Pre-morbid, 3 month and 6 month values for 'Finisher' groups analysed with







Discharge 3 months 6 months
4.3.2.3 Quality of life
4.3.2.3.1 Physical component scores
The quality of life PCS scores are shown in Figure 4.11 and Table 4.17. 2 way ANOVA
of the cohort shows that the PCS score changes significantly from premorbid to 3 and 6
months but that there is no statistical difference between the patients who were anaemic
compared to those who were non-anaemic at 3 months. Post hoc analysis using
Student's t-test to verify this result confirms that the PCS scores are not significantly
different pre-morbidly or at 3 months between the anaemic and non-anaemic groups.
However at 6 months the scores were significantly reduced in the anaemic group
compared to the non-anaemic group.
4.3.2.3.2 Mental component scores
The mental component summary scores showed no difference either with time or in
relation to anaemia at any time point (Figure 4.12 and Table 4.18).
4.3.2.4 Perceived physical function
The FAI scores are shown in Figure 4.13 and Table 4.19. 2 way ANOVA of the data
shows that the FAI scores change significantly with time (p<0.001), but there was no
statistical difference found between the trajectories in the cohorts dichotomised by
anaemia at 3 months. Examining the data further the change in FAI score from pre¬
morbid to 3 months was analysed with a paired t-test and it was found that there was a
significant deterioration in FAI at 3 months (compared with pre-morbid levels; p=0.003)
for the anaemic group but not for the non-anaemic group, although the trend was the
same (p=0.077).
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Pre-morbid, 3 and 6 month values for 'Finishers' groups. Anaemic and non-
anaemic groups defined by haemoglobin concentration at 3 months. * indicates
significant change over time (p=0.017).




Median 42.5 41.1 ns
IQ range 27.1-56.5 25.9-52.3
Range 13.5-59.2 16.6-60.7
Time Point 3 months
Anaemic Non-anaemic p-value
number 14 13
Median 28.4 32.9 ns
IQ range 23.3-35.2 27.9-36.7
Range 19.9-55.3 23.7-41.0
Time Point
Anaemic Non-anaemic p-value anaemia
number 14 13 ANOVA t-test
Median 27.1 36.3 ns 0.029
IQ range 24.2-36.9 30.1-51.5
Range 20.1-32.3 29.1-56.5
Data expressed as median, interquartile range and range; analysed with 2 way
ANOVA and post hoc Student's t-test for premorbid, 3 months and 6 month
values.










Data expressed as median, interquartile range and range; analysed with 2 way
ANOVA and Student's t-test for pre-morbid, 3 months and 6 months values.




number 14 13 ANOVA/t test
Median 53.3 49.4 ns
IQ range 38.0-57.8 32.7-54.4
Range 28.3-61.3 18.4-58.7
Time Point 3 months
Anaemic Non-anaemic p-value
number 14 13
Median 42.2 41.4 ns





Median 45.3 40.6 ns
IQ range 36.9-55.8 32.9-59.9
Range 29.5-69.0 14.2-64.0
Data expressed as median, interquartile range and range; ana ysed with 2 way
ANOVA and Student's t-test for discharge, 3 months and 6 month values.

















Data expressed as median, interquartile range and range; analysed with 2 way
ANOVA and Student's t-test for pre-morbid, 3 months and 6 month values.
* indicates significant change with time, p<0.001. # indicates significant
difference with Student's t-test within group, p=0.003.
Table 4.19 Frenchay Activity Index scores for 'Finisher' groups
Time Point Discharge
Anaemic Non-anaemic p-value anaemia
number 14 13 ANOVA t-test
Median 29.5 27.0 ns ns
IQ range 20.5-34.5 21.0-31.0
Range 13.0-37.0 9.0-39.0
Time Point 3 months
Anaemic Non-anaemic p-value anaemia
number 14 13 ANOVA t-test
Median 13.0 22.0 ns ns
IQ range 4.5-24.0 16.0-29.0
Range 0.0-37.0 8.0-45.0
Time Point
Anaemic Non-anaemic p-value anaemia
number 14 13 ANOVA t-test
Median 18.0 22.0 ns ns
IQ range 6.0-28.5 16.0-30.0
Range 3.0-37.0 12.0-39.0
Data expressed as median, interquartile range and range; analysed with 2 way
ANOVA and Student's t-test at discharge, 3 months and 6 months.
4.3.2.5 Adual physical function
4.3.2.5.1 Six minute walk test
The results for 6 MWT are shown in Figure 4.14 and Table 4.20.There was no
difference between anaemic and non-anaemic groups in distance walked at either time-
point. The distance walked did not change between 3 and 6 months for the anaemic
group but for the non anaemic group it did increase significantly from 3 to 6 months
(p=0.003). This may suggest that the non-anaemic group are recovering their physical
function to a greater degree than the anaemic group.
4.3.2.5.2 Hand grip strength
The percentage of normal hand grip strength for each group is shown in Figure 4.15.
There was a significantly reduced percentage of nonnal hand grip strength in the
anaemic compared to the non-anaemic group at 3 and 6 months (p=0.020 and p=0.037
respectively) (Table 4.21). The HGS increased significantly from 3 to 6 months for the
anaemic groups but not the non-anaemic group.
4.3.2.6 Organotopic measures
4.3.2.6.1 Hand grip strength
Considering the proportions of each group with evidence of protein malnutrition through
measurement of HGS there was significantly greater prevalence of protein malnutrition
in the anaemic group at 3 months (p=0.033) which was no longer present at 6 months
(Table 4.22).
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* indicates significant change within the group between the two time-points
p=0.033
Table 4.20 Distance walked in 6 MWT for 'Finisher' groups
Time Point 3 months
Anaemic Non-anaemic p-value
number 13 13
Median 0 198 ns
IQ range 0-359 60-436
Range 0-359 0-535
Time Point 6 months
Anaemic Non-anaemic p-value
number 13 13
Median 0 420 ns
IQ range 0-434 179-565
Range 0-870 0-604
Data expressed as median, interquartile range and range; analysed with Mann-
Whitney test for 3 month and 6 month values.





















3 months 6 months
* indicates significant change within the group between the two time-points
p=0.033
Table 4.21 Hand Grip Strength for 'Finisher' groups


























Data expressed as median, interquartile range and range; analysed with
Student's t-test at 3 and 6 months.
Table 4.22 Proportion of patients in Finisher group with less than 85% of
normal hand grip strength suggesting protein malnutrition






<85 13 7 0.033 9 6 ns
>85 1 6 5 7
Data analysed with Fisher's Exact Test.


























There was no significant difference in albumin, creatinine or CRP between the groups at
any time point (Figure 4.16). The albumin concentration did increase significantly from
discharge to 3 months in both groups (p<0.001) but only increased significantly from 3
to 6 months in the anaemic group (p=0.03).
4.4 Discussion
In the Ps and Qs Study (Chapter 3) we aimed to investigate the relationship between
health related quality of life and physical function. In this subgroup analysis we aimed to
explore the potential relationship between anaemia and physical function and quality of
life. The 'gender / severe' anaemia analyses aimed to look at the differences between
anaemic and non-anaemic patients at each time-point following critical illness. The
'finisher's' analyses aimed to look at a specific cohort ofpatients who remained anaemic
at 3 months following ICU discharge and investigate which factors were associated with
and may have contributed to these patients remaining anaemic and how the presence of
anaemia affected the patient's actual and perceived physical function and quality of life.
We also investigated which factors may be associated with improvement of the anaemia
by 6 months.
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4.4.1 Study design and limitations
The relationship between anaemia, physical function and quality of life in patients
recovering from critical illness has never been investigated previously. We gathered
appropriate data in a complex cohort of paints with acceptable levels of recruitment and
loss to follow up during the study (discussed in Chapter 3). The major limitation of this
analysis was of relatively small patient numbers particularly at 6 months; this was
addressed in the 'gender / severe' analyses by looking at all available data at each time
point. However this had the potential to confound the results as the loss to follow up and
incomplete data available for all patients who were assessed could mean that the cohort
ofpatients at 3 months were distinct from those at 6 months. This potential bias also
existed in the 'finisher's' analysis which only included patients who had a complete
dataset for the whole study. In conjunction with the 'gender / anaemia' study it was
believed that this was a useful exploration of potential factors affecting recovery
following critical illness, though it was recognised that the statistical significance and
clinical significance of such an analysis should be interpreted with caution especially
because of the risk of type II error.
4.4.2 Gender and severe anaemia analysis
Anaemia was prevalent at ICU discharge: 97% of our entire cohort was 'gender'
anaemic and 73% had severe anaemia at ICU discharge. This anaemia persisted with
52% and 33% ofpatients remaining anaemic at 3 and 6 months respectively.
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4.4.2.1 Factors associated with the persistence of anaemia
The presence of severe anaemia during recovery from critical illness was associated with
a longer ICU stay, increased age but not with a greater illness severity or a greater
development of organ failure during ICU stay. This was different from other studies
within our population where renal failure and thrombocytopenia were associated with an
increased risk of being anaemic at ICU discharge(Walsh, Lee et al. 2006). By 6 months
the possible contribution of age and length of stay to the presence of anaemia has
diminished. Patients who were anaemic at 6 months had a reduced hand grip strength
and serum albumin concentration and elevated CRP suggesting that malnutrition and the
persistence of inflammation contribute to the persistence of anaemia. Renal function
does not appear to influence the development or persistence of anaemia during recovery,
though very few of the cohort had significant renal impairment during follow up.
4.4.2.2 The effects of anaemia on quality of life and physical function
4.4.2.2.1 Quality of life and anaemia
Anaemia at 6 months was associated with a reduced physical 'quality of life'. The
reduced quality of life prior to 6 months may therefore be due to other factors such as
pain and muscle weakness which have a greater direct impact upon physical function
compared to the less obvious effect of anaemia on patients who are likely to be
inherently less active (i.e. the type ofpetrol in a car does not affect the performance
when it has broken down!).
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4.4.2.2.2 Perceived physical function and anaemia
Anaemia was associated with a worse perceived physical function as measured by
Frenchay's Activity Index.
4.4.2.2.3 Actual physical function
Actual physical function as measured by the six minute walk test was impaired in the
gender anaemia group compared with the non-anaemic patients at 6 months, although
this effect was not present prior to this. Thus it is possible that ongoing physical
recovery of the anaemic group was being prevented by the persistence of anaemia,
although the possibility that anaemia was an epiphenomenon cannot be excluded.
Ongoing inflammation was prevalent in anaemic patients at 6 months which may
indicate that anaemia and poor physical function are linked indirectly through the
persisting inflammatory state rather than directly. The HGS was also impaired in the
anaemic groups, and this was evident as early as 3 months. The use of hand grip
dynamometry may therefore be a useful tool in assessing patients following critical
illness as it appeared to discriminate well between the anaemic and non anaemic groups
at all time points and for both subgroup analyses. It also reflected the differences and
changes in serum albumin concentrations reinforcing its use as a marker of nutritional
assessment. It was also much more readily accepted and understood by the patients as a




Again the results show that anaemia is common and persistent. 50% of the 'complete'
cohort who were anaemic at 3 months remained anaemic at 6 months. Interestingly, 2 of
the patients who were not anaemic at 3 months were subsequently anaemic at 6 months.
4.4.3.1 Factors associated with the persistence of anaemia
The patients who were anaemic at 3 months were older, had a greater ICU length of stay
and a greater requirement for inotropes / vasopressors during ICU stay compared to
those who were not. This could potentially reflect that these patients had a greater
inflammatory response during their ICU stay which persisted following recovery from
the initial illness or that they required greater optimisation of their haemodynamic
parameters and of oxygen delivery during ICU stay due to anaemia. Protein malnutrition
and inflammation were associated with anaemia. Malnutrition had resolved by 6 months.
4.4.3.2 The effects of anaemia on quality of life and physical function
4.4.3.2.1 Quality of life and perceived physical function
Anaemia did not appear to affect the quality of life or the perceived physical function
following of critical illness. This is not consistent with the findings for the gender /
severe anaemia analysis. This may be due to the 'Finisher's Analysis' representing a self
selecting cohort who by virtue of remaining in the study reflect a higher degree of
function than one which included all the patients at each time point. However the
analysis did show that quality of life and perceived physical function was significantly
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affected by the development of critical illness and that this impairment persists to 6
months following ICU discharge.
4.4.3.2.2 Actual physical function
Actual physical function as measured by the 6MWT was not influenced by the presence
of anaemia however the non-anaemic group did increase the distance walked
significantly between 3 and 6 months. This could reflect a hierarchy of factors which
contribute to impaired physical function following critical illness whereby the effects of
anaemia are masked by greater physical complaints. As symptomatology improves,
anaemia may then start to be a limiting factor in recovery. It may also reflect that
patients who develop critical illness may have significantly impaired actual physical
function prior to their critical illness affecting the usefulness of such a measure of
physical function during rehabilitation.
4.5 Conclusions
There are several important findings from this subgroup analysis, some of which are
contradictory depending upon which analysis is considered. The key finding of the
Gender / Severe subgroup analysis is that persistent anaemia following critical illness is
associated with impaired physical quality of life and impaired perceived AND actual
physical function. However this finding is not wholly supported by the data, since the
'finisher's analysis' did not demonstrate a similar effect of anaemia. The finisher's
cohort however, contains a smaller number of patients who are subject to self-selection
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bias, and as such, the results of this subgroup analysis should be interpreted with
caution.
The presence of anaemia during recovery in both analyses was also associated with
increased age and a longer ICU stay but not with illness severity during critical illness.
Furthermore, malnutrition and persistent inflammation were associated with ongoing
anaemia in both studies.
.Assessment of physical function following critical illness is complex and simple
measures ofphysical function such as hand grip strength rather than 'gold standard'
assessments such as walk tests may be more sensitive to detecting impairment due to the
heterogeneous patients group and the varied potential complications they develop.
Physical rehabilitation from critical illness is becoming a cornerstone of ICU follow up
care and may be a key determinant of a patients overall recovery from critical illness.
Since anaemia may limit this physical recovery, treatment of anaemia may be an adjunct
in rehabilitating patients. Further studies are now warranted to confirm the association of
anaemia with impaired physical recovery and, if confirmed, randomised controlled trials
of treatments for anaemia should be undertaken to translate these research findings into
clinical benefits for patients.
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Chapter 5
Conclusions and Future Directions
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5.1 The three 'Rs'
'... For the secret of the care of the patient is in caring for the patient'
Dr Francis Peabody.
The burden of critical illness begins with the acute physical and psychological distress
which develops when the patient's illness requires timely intervention to prevent death.
It is increasingly apparent that many patients and their families experience persisting
physical, psychological and cognitive dysfunction during recovery. Addressing these
long term problems is necessary to allow consideration of the 'real' cost of critical care
provision, both in human and financial terms. Although most patients do make a good
recovery from critical illness and are satisfied with their new state of (albeit reduced)
health, there are a significant number ofpatients who need recognition, resources and
research to improve their quality of life.
The components of long term outcome are multi-factorial and are dependent upon the
individuality of the patient's response to illness, the interaction between pre-morbid
disease and critical illness, and the heterogeneity of the population, ICU environments
and clinical practice. Determining which of the many factors throughout this extended
period is responsible for the outcome measure being studied is one of the most
challenging aspects of ICU research.
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The research presented in this thesis aimed to determine the prevalence,
pathophysiology and impact on quality of life of two common and potentially related
complications of critical illness in the longer term - anaemia and physical morbidity.
5.2 Research in the critically ill
5.2.1 Recruitment and retention
One of the greatest problems encountered during this research related to recruitment and
retention within the study. In TRAC, recruitment was much slower than anticipated. We
recruited ~75% of eligible patients resulting in 30 patients enrolled after 1 year. 6
patients died during follow up and 5 (17%) were Tost' to follow up. In the Ps and Qs
study we recruited 63% of eligible patients resulting in 68 patients enrolled after 1 year.
Only 35 patients remained in the study for the full 6 months, with 9 patients dying
during follow up and 24 being Tost'.
These figures are similar to other small ICU cohort studies but are less than the 70-80%
retention considered acceptable for social science research and the much higher retention
rates seen in the large multicentre ICU trials. This high attrition rate within our studies
has the potential to impair the internal and external validity, particularly with bias
introduced by 'differential dropout' between comparison groups. Differential dropout
describes the evolution of a different study cohort over time due to differences between
the patients who remained in the study compare to those who dropped out.
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5.2.2 Methods used to reduce patient dropout
2 review articles suggest several methods which are believed to improve patient
retention (Robinson, Dennison et al. 2007; Tansey, Matte et al. 2007). We utilised many
of these strategies: respect for patients, flexibility of researcher hours and patient
scheduling and good patient tracking systems. Despite this many patients 'disappeared'.
This was partially due to many of the patients admitted to the intensive unit having
'chaotic' lifestyles with alcohol and drug problems. Additionally, one major test, the six
minute walk test, had very poor patient acceptability and was potentially a cause for
subsequent dropout.
5.2.2.1 Unique methods to improve retention
We attempted to improve patient retention by flexible scheduling, supported transport
and visiting the patients in their own home, even offering to utilise a self powered
treadmill at home to assess physical function (although all patients refused this option!).
Despite this, retention remained difficult. Anecdotally, the burden of recovery with
significant ongoing symptomology and multiple clinic appointments seemed to
overwhelm many patients such that the perceived extra burden of ongoing participation
in research was too much.
5.2.2.2 The home visit and ICU follow up clinics
The visiting of patients in their own homes provided a unique insight into the problems
faced by the survivors of critical illness. Many of the patients simply wanted advice on
how to get modifications to their home, access to appropriate benefits, and have their
242
specific problems, mainly muscle weakness and pain, treated by physiotherapy and
medication. They also wanted reassurance and a 'medical MOT' by the doctors and
nurses who they perceived as having helped them through their illness, as well as
explanations for the multiple hospital appointments and investigations they felt they
were being subjected to as part of their routine clinical care. This was particularly true
for surgical patients who had developed medical complications of their admission.
These interventions seem ideally suited to being addressed in the outpatient clinic
environment. During the course ofmy research I have attended several ICU follow up
clinics. They have varied from clinics which appeared to be run as data collection
exercises (rather than for the benefit of the patient) to the other extreme of indulgence of
physician vanity. At their best there have been clinics which have focused on each
individual's and their families' specific needs, as well as addressing ICU related
complications. Clinics can help to co-ordinate medical follow up in a cohesive manner
when multiple specialities are involved in long term follow up. They can also provide
social support and benefits advice and perhaps most importantly act as patient advocates
in endeavouring to get the simple, but life changing, things done for the patient.
Although ICU follow up is well established in the UK, a recent review of current
research from ICU follow up clinics and the early findings from the PRACTICAL study
found that there was no evidence of benefit from attendance (Williams and Leslie 2008)
(Cuthbertson, Rattray et al. 2007; Cuthbertson, Rattray et al. 2009). This may be because
chronic symptomatology is not easily addressed by infrequent contact with healthcare
professionals and the emphasis may therefore need to be on intensive physical
rehabilitation rather than the holistic post ICU care.
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Cancellation and non-attendance rates were high for the clinics reinforcing the problems
found in retaining patients in research, as it was difficult to retain patients in follow up
focused ostensibly on benefiting the patient. The ICU clinic offers the opportunity to
address the'three Rs' and focused assessment of the potential benefits of such clinics
would be required to establish their role. In patients with chronic complex medical needs
such as long term ventilation, the medical aspects of the clinics are run in conjunction
with 'complex needs assessment' clinics with involvement of specialist nurses and social
work input. These types of clinic have been shown to be effective for the elderly
population in reducing hospital and nursing home admission (Beswick, Rees et al.
2008). As the elderly have many problems similar to the survivors of critical illness it
could be concluded that such a clinic could have a role post ICU.
5.2.3 Methodological conclusions
In summary, ICU research is complex and retaining patients in research studies is often
difficult to achieve. Novel methods such as visiting patients in their own homes does not
improve retentionper se but does provide valuable insight in to the lives of the survivors
of critical illness. In designing a battery of assessments, it is important that the tests
should be acceptable to the patient. In the Ps and Qs study, and potentially in other
studies post ICU, the 6 minute walk test was a poor assessment of physical function as
many of the patients were immobile through muscle weakness, pain or other co¬
morbidity. As there were many reasons why patients did not perform the test it does not
accurately reflect the physical function of the population. The 6MWT has been
established in specific populations (such as patients with ARDS) but not in the
244
heterogenous critical illness group. The hand grip dynamometry assessment appeared to
be a portable, safe and acceptable test, with good clinical relevance and may well have a
role in ascertaining physical function in ICU follow up.
Drop out rates could be expected to be high due to the often chaotic lifestyles ofmany of
the patients and the overwhelming burden of symptoms and other medical appointments
making further commitment unappealing to the patient. This makes ICU studies prone to
drop out bias as only motivated patients remain in studies. Therefore, it is acknowledged
that final data sets representing only those patients who completed the entire study may
not wholly reflect the original cohort and results should be interpreted with caution.
5.3 The TRAC study
The TRAC study showed that anaemia persists up to 6 months following discharge and
was associated with evidence of an ongoing inflammatory state and impairment of
erythropoiesis. Health related quality of life was also noted to be impaired raising the
possibility that anaemia may affect quality of life following critical illness
5.4 The Ps and Qs study
The Ps and Qs study showed that survivors of critical illness had a normal pre-morbid
perceived physical function but a reduced quality of life. Both were significantly
worsened by the critical illness and remained impaired up to 6 months. Actual physical
function in our heterogeneous population was reduced to levels associated with very
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severe chronic disease. There was evidence of a significant level ofpost traumatic stress
disorder, persisting anaemia and malnutrition but no other organ dysfunction during
recovery.
5.5 The Ps and Qs anaemia subgroup analysis
Further analysis of the Ps and Qs data was performed to investigate potential links
between anaemia, physical function and quality of life. The results showed that
persistent anaemia following critical illness was associated with impaired physical
quality of life and impaired perceived AND actual physical function in snapshot of all
available patients at a given time-point. However, when a cohort of patients who
completed follow up was used for analysis such that the change within a cohort could be
accurately reflected over time, a link between anaemia and physical function was not
established. This could be due to complete cohort being prone to selection bias or the
severity of physical impairment was such that the effect of anaemia was overwhelmed.
The presence of anaemia during recovery in both analyses was associated with increased
age and a longer ICU stay but not with illness severity during critical illness;




Anaemia is a common complication of critical illness which is not related to the severity
of illness on admission to, or degree of organ failure developed within, ICU. There are
obvious strategies for reducing iatrogenic blood loss such as paediatric tubes, return of
aspirates and appropriate (rather than regular) blood sampling; modification of these
factors could be evaluated to determine whether the prevalence of anaemia at ICU
discharge could be reduced.
Since anaemia may contribute to impaired quality of life and physical function,
strategies to treat it need to be evaluated. It was surprising how few of our patients
received transfusion following discharge to the wards. Consideration of all methods to
improve haemoglobin levels such as transfusion, recombinant erythropoietin and
modulation of the inflammatory response should be considered despite the attendant
risks. There is a suggestion from our research that the physical complications are
overwhelming early in the recovery period potentially masking the contribution of
anaemia to additional symptomology. As physical recovery improves, the impact of
concurrent anaemia becomes apparent and there is a window where effective treatment
of anaemia could be of great potential benefit.
Quality of life was dramatically impaired by critically illness, mainly in the physical
domains and remained impaired at 6 months. Surprisingly, patients' mental health
components of quality of life remained essentially nonnal. This is despite a significant
prevalence of PTSD, which is known to be associated with marked impairment of
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quality of life in other patient groups. It may be that "survival euphoria" overcomes any
concomitant mental health disturbance.
Actual physical function was severely impaired and showed little signs of improvement
by 6 months. However, our research suggests the 6MWT may be a poor assessment tool
in the post ICU population and therefore this finding must be interpreted with caution.
Perceived physical function although impaired showed signs of recovering with time,
perhaps reflecting the resolution of physical symptoms allowing small improvements in
what the patient feels they are able to achieve, despite significant persisting actual
physical disability. In the longer term, the perception of improvement may be translated
into actual physical recovery.
Importantly, our studies showed an association between anaemia and impairment of
quality of life and physical function, raising the possibility that treatment of anaemia
may be an important strategy in improving physical rehabilitation following critical
illness.
5.7 Future directions
In conclusion these studies show that physical function and health related quality of life
are dramatically affected by critical illness. Anaemia is highly prevalent in this
population and is associated with ongoing inflammation and impaired erythropoiesis.
Furthermore, anaemic patients potentially have a reduced quality of life and physical
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function as compared with non-anaemic survivors. Therefore, treatment of anaemia and
early physical rehabilitation may be the key to improving patients' longer term quality of
life and physical function especially later in the recover period when the initial
impairments preventing physical function are resolving. Physical rehabilitation from
critical illness is becoming a cornerstone of ICU follow up care (Tan, Brett et al. 2009)
and may be a key determinant of a patients overall recovery from critical illness. Since
anaemia may limit this physical recovery, treatment of anaemia may be an adjunct in
rehabilitating patients. Further studies are now warranted to confirm the association of
anaemia with impaired physical recovery and, if confirmed, randomised controlled trials
of treatments for anaemia should be undertaken to translate these research findings into
clinical benefits for patients.
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In the last 3 months how often have you undertaken:
1. Preparing main meals
2. Washing up after meals
0 = Never
1 = Less than once a
week
2 = 1-2 times per week






8 Walking outside for > 15
minutes
9. Actively pursing hobby
10. Driving car/going on bus
0 = Never
1 = 1-2 times in 3 months
2 = 3-12 times in 6
months
3 = At least weekly
In the last 6 months how often have you undertaken:
11. Travel outing/car ride 0 = Never
1 = 1-2 times in 6 months
2 = 3-12 times in 6
months






3 = Heavy/All necessary
14. Reading books 0 = None
1 = 1 in 6 months
2 = Less than 1 in 2
weeks
3 = More than 1 every 2
weeks
15. Gainful work 0 = None
1 = Up to 10 hours/week
2 = 10-30 hours/week
3 = Over 30 hours/week
TOTAL , Subscale 1 , Subscale 2 , Subscale 3
Revised guidelines for using the Frenchay Activities Index
The aim is to record activities which require some initiative from the patient. It is important to
concentrate upon the patient's actual frequency of activity over the recent past, not distant past
performance nor potential performance. One activity can only score on one item.
Specific item information:
1. Needs to play a substantial part in the organization, preparation and cooking of main
meal. Not just making snacks or reheating prepared food.
2. Must do all or share equally, e.g. washing or wiping and putting away. Not just rinsing an
occasional item.
3. Organization of washing and drying clothes, whether in washing machine, or by hand or
at laundromat. Sharing task equally, e.g. loading, unloading, hanging, folding.
4. Dusting, polishing, ironing, tidying small objects or bedclothes. Anything heavier is
included in item 5.
5. All heavier housework including changing beds, cleaning floors, fires and windows,
vacuuming, moving chairs, etc.
6. Playing a substantial role in organizing and buying groceries, whether small or large
amounts. Must go to the shop and not just push a cart. Can include collection of pension
or going to the Post Office.
7. Going out to clubs, church activities, cinema, theatre, drinking, to dinner with friends,
etc. May be transported there, provided patient takes an active part once arrived. Includes
social activities at home, initiated by the patient, e.g. visits from family or friends not
where main purpose is to provide care.
8. Sustained walking for at least 15 minutes (allowed short stops for breath). About one
mile. Can include walking to do shopping, provided walks far enough.
9. Must require some 'active' participation and thought, e.g. propagating or caring for
houseplants, knitting, painting, games, sports (not just watching sport on television). Can
be mental activities, e.g. reading specialist magazines, doing the stocks and shares or
window shopping for pleasure.
10. Must drive a car (not just be a passenger), or get to a bus/coach and travel on it
independently.
11. Coach or rail trips or car rides to some place for pleasure. Not for a routine 'social outing'
(i.e. shopping, going to local friends). Must involve some organization and decision¬
making by the patient. Excludes trips organized passively by institutions unless patient
exercises choice on whether to go. The common factor is travel for pleasure. Holidays
within the six months are divided into days per month e.g. a 7-day holiday equals 1 or 2
days per month.
12. Gardening outside:
a. Light = occasional weeding or sweeping paths
b. Moderate = regular weeding, raking, pruning, etc.
c. Heavy = all necessary work including heavy digging.
13. Household maintenance:
a. Light = repairing small items, replacing lamp lightbulb or plug
b. Moderate = spring cleaning, hanging a picture, routine car maintenance
c. Heavy = painting/decorating, most necessary household/car maintenance.
14. Must be full-length books, not periodicals, magazines or newspapers. Can be talking books.
15. Work for which the patient is paid, not voluntary work. The time worked should be averaged
out over six months. For example, one month working for 18 hours/week over the six-month





Not at all 0
once only 1
2-3 times scores 2
4-6 times 3
every day 4
Have you had painful images, memories or thoughts of the events relating to Intensive
Care?
Have you had distressing dreams of the event?
Have you felt as though the event was re-occurring?
Have you been upset by something which reminded you of the event?
Have you been avoiding any thoughts or feelings about the event?
Have you been avoiding doing things or going into situations which remind you of the
event?
Have you found yourself unable to recall important parts of the event?
Have you had difficulty enjoying things?
Have you felt distant or cut off from other people?
Have you been unable to have sad or loving feelings?
Have you found it hard to imagine having a long life span fulfilling your goals?
Have you had trouble falling asleep or staying asleep?
Have you been irritable or had outbursts of anger?
Have you had difficulty in concentrating?
Have you felt on edge, been easily distracted, or had to stay on guard?
Have you been jumpy or easily startled?
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Time course of anemia during six months follow up following
intensive care discharge and factors associated with impaired
recovery of erythropoiesis*
Anthony P. Bateman, FRCA; Fiona McArdle, MSc; Timothy S. Walsh, MD
Objectives: Anemia is a common complication of critical ill¬
ness, but its duration after intensive care discharge and possible
contributory factors have not been studied. Our aim was to follow
patients discharged anemic from the intensive care unit (ICU) for
up to 6 months and determine the duration of and possible
reasons for persisting anemia.
Design: Prospective observational cohort study of intensive
care (ICU) survivors with moderate-severe anemia at the time of
ICU discharge. Erythropoietic and inflammatory markers were
measured at regular intervals over six months to assess red cell
production and factors limiting recovery from anemia.
Setting: An 18-bed medico-surgical ICU in a Scottish university
teaching hospital.
Patients: Patients who required >24 hrs of ventilatory support
and were discharged from intensive care with hemoglobin < 100
g/L were studied prospectively over 6 months. 30 patients were
recruited; 19 completed 6 months follow-up, 6 died during the
study period, and 5 completed part of the follow up. Patients with
ongoing renal failure or chronic hematologic disorders were ex¬
cluded.
Measurements and Main Results: 47% (9 of 19) of patients
completing 6 months follow up recovered from their anemia. The
median time to recovery was 11 wks (1st, 3rd quartiles: 9,26 wks).
10 patients (53%) were still anemic 6 months after ICU discharge.
No patients developed iron, vitamin B12 or folate deficiency. An
inappropriately low erythropoietin response to anemia was ob¬
served in virtually all patients and did not distinguish nonrecov-
ering patients. Patients with delayed recovery or persisting
anemia during the 13 wks following ICU discharge had higher
levels of circulating inflammatory markers (IL-6 and C-reactive
protein) and did not exhibit reticulocytosis during the weeks
following discharge.
Conclusions: Anemia persists in many patients following crit¬
ical illness and is associated with ongoing inflammation, inap¬
propriate erythropoietin response and poor marrow red cell pro¬
duction. (Crit Care Med 2009; 37:1906-1912)
Key Words: anemia; critical illness; erythropoietin; erythropoiesis
Anemia is a common complica¬tion of critical illness (1, 2).Once present it frequently per¬sists until intensive are unit
(ICU) discharge unless modified by blood
transfusion or less well established prac¬
tices such as erythropoietin administration.
The Transfusion Requirements In Critical
Care (TRICC) study (3) has resulted in a
more consistent use of restrictive transfu¬
sion practice with typical median pretrans-
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fusion hemoglobin values between 78-85
g/L (2) When a restrictive transfusion pol¬
icy is used the prevalence of anemia at ICU
discharge is as high as 80% (4). Recent
studies show that anemia is frequently still
present at hospital discharge (5), and has
normochromic normocytic characteristics
similar to the anemia of chronic disease.
Other epidemiologic studies followed pa¬
tients for up to 28-30 days following ICU
admission, but did not report anemia out¬
comes specifically for the post ICU recovery
period (1, 6). It is not known how long
anemia persists among ICU survivors or
what factors influence the rate of recovery.
Many patients suffer reduced quality
of life after hospital discharge, often as¬
sociated with symptoms typical of anemia
such as fatigue and breathlessness (7, 8).
Many factors could contribute to these
symptoms, but in other settings such as
chronic renal failure (9), cancer (10) and
cardiovascular disease (11, 12) anemia is
associated with a poor quality of life and
treatment improves symptoms. These ob¬
servations are consistent with the hy¬
pothesis that anemia contributes to mor¬
bidity following critical illness.
The primary aim of this exploratory
study was to determine the time period
between ICU discharge and resolution of
anemia in a cohort of patients discharged
with significant anemia (hemoglobin <100
g/L). Our secondary aims were to study the
components of erythropoiesis during recov¬
ery from critical illness and explore factors
that might contribute to persistent anemia.
MATERIALS AND METHODS
Design and Setting
We performed a prospective cohort study
following patients over a 6 months period fol¬
lowing ICU discharge. The study received local
ethics committee approval; informed consent
was obtained from the patients. Patients were
recruited from the 18-bedded medico-surgical
ICU of the Royal Infirmary of Edinburgh, a
university hospital receiving acute admissions
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for all specialities except neurosurgery, colo¬
rectal surgery and urology.
Recruitment
We planned to recruit all eligible patients
over a 6 months period. We estimated a re¬
cruitment rate of 1-2 patients per week and a
total study cohort of 40 patients. All 412 pa¬
tients discharged alive from the ICU during an
11 month period were screened for inclusion
to the study. Inclusion criteria were: Patients
requiring more than 24 hrs advanced physio¬
logic support (invasive ventilation alone or
noninvasive ventilation plus support for an
additional organ failure); hemoglobin concen¬
tration <100 g/L at ICU discharge; age >16
yrs. Exclusion criteria were: preexisting hema¬
tologic disorder; treatment with immunosup¬
pressant or cytotoxic drugs; acute or chronic
renal failure requiring renal replacement ther¬
apy at time of discharge; patients residing out-
with reasonable geographical follow up; pa¬
tients discharged for palliative care or not
expected to survive to hospital discharge, and
patients unable to give informed consent.
Patient Characteristics
We recorded demographic data, clinical
diagnosis, Acute Physiology and Chronic
Health Evaluation II (APACHE II) score and
worst Sequential Organ Failure Assessment
(SOFA) score during ICU stay, hemoglobin
concentration on admission to ICU and ICU
length of stay. Although we excluded pa¬
tients who required renal replacement ther¬
apy at the time of ICU discharge, we calcu¬
lated the eGFR for all patients at study entry
using the Modification of Diet in Renal Dis¬
ease standard formula (13). At follow-up we
recorded whether patients had received
blood transfusions, iron, vitamin B12 or fo¬
late supplements during the study period.
Study Protocol
Patients were followed up at 1,3, 6, 9,13 and
26 wks post ICU discharge either in hospital or
their homes. We measured hemoglobin concen¬
tration (Hb), mean cell hemoglobin (MCH),
mean corpuscular hemoglobin concentration
(MCHC) and mean red cell volume (MCV) at all
visits. We used locally defined population refer¬
ence ranges for hemoglobin to define anemia
(male <130 g/L; female <115 g/L). We obtained
advice from an expert group before the study (see
acknowledgments) and established a range of mea¬
sures to assess erythropoiesis by group consensus.
We defined the following abnormalities a priori:
Absolute iron deficiency was defined as
plasma ferritin concentration of <12 p.g/L or
<100 pg/L in the presence of elevated inflam¬
matory markers. Patients with ferritin >100
pg/L were defined as having no evidence of
iron deficiency irrespective of inflammatory
markers (14).
Functional iron deficiency (impaired in¬
corporation of iron during erythropoiesis de¬
spite adequate body iron stores) was defined as
the presence of >5% hypochromic red cells
(%HYPO) and/or a concentration of hemoglo¬
bin in reticulocytes (CHR) of <28 pg/L (15).
Vitamin B12, plasma folate and red cell
folate deficiency were defined as values below
the laboratory reference ranges.
Inappropriate erythropoietin response to
anemia was defined as a circulating erythro¬
poietin concentration that was lower than
published values relating hemoglobin with
plasma erythropoietin concentration(16, 17).
Specifically we defined an abnormal erythro¬
poietin concentration as <40 mlU/mL and
<20 mlU/mL for hemoglobin concentrations
of <100 g/L and <120 g/L respectively.
Persistent inflammation was defined as de¬
tectable (>10 pg/mL) circulating interleu-
kin-6 (IL-6) and/or CRP >5 g/L (18).
Evidence ofnew erythropoiesis (a measure
of bone marrow responsiveness) was defined
as a reticulocyte count above the normal
range (>55 x 109) (19) and/or an increase in
soluble transferrin receptor (sTfR) concentra¬
tions above normal values using a locally de¬
termined control distribution.
Analyses of the standard hematologic pa¬
rameters were carried out in the hospital lab¬
oratory. %HYPO, CHR analyses were carried
out within 3 hrs of sampling. Samples for
serum assays were spun within 2 hrs and
stored at — 80°C. Serum erythropoietin con¬
centrations were measured by enzyme linked
immunosorbant assay (ELISA) at Simbec Re¬
search Ltd, Methry Tydfil, UK. Serum IL-6 and
sTfR were measured using ELISA kits (Quan-
tikine R&D Systems, Minneapolis, MN).
Analysis
We plotted hemoglobin values against time
and calculated the proportion of anemic patients
at each time point. For this analysis we used
lower limits for gender specific population ref¬
erence ranges as cut off values. To assess the rate
of recovery from anemia we calculated rates of
increase in hemoglobin between visits. An in¬
crease of 10 g/L per week is frequently quoted as
a healthy response to blood loss. We also in¬
cluded a lower cut off at 5 g/L.
We explored differences between patients
who recover more quickly from anemia after
ICU discharge ('responders') with those who re¬
mained anemic or recovered slowly ('nonre-
sponders') by comparing variables for the sub¬
groups whose hemoglobin was within the
reference range at 13 wks with those who re¬
mained anemic. We compared patient character¬
istics at baseline, including measures of illness
severity (APACHE II score and worst nonneuro-
logic SOFA score), and ICU length of stay. To
explore pathophysiological factors associated
with poor recovery we compared variables at the
3 wks visit using the Mann-Whitney test and
Fisher's exact test to compare proportions. Week
3 was chosen as it was expected that the greatest
divergence between the two groups would be
apparent early in those who would recover.
Microsoft Excel and GraphPad Prism (Ver¬
sion 4) were used for analyses.
Exploratory Assessment of
Impact on Health-Related
Quality of Life (HRQoL)
We measured HRQoL using the SF-36 self-
reporting questionnaire at 3 and 6 months. To
explore the possible associations between ane¬
mia at ICU discharge and subsequent HRQoL,
we compared our data with a previously pub¬
lished nonselected patient cohort of ICU pa¬
tients followed up in Scotland for HRQoL out¬




We recruited 30 patients (77% recruit¬
ment rate for eligible patients; Fig. 1). Six
patients died during the study follow up
(20% death rate) and 5 patients dropped
out or were lost to follow up (17% drop
out rate). Demographic and clinical char¬
acteristics for the study cohort and the
timing and causes of death during the
study are shown in Table 1.
Two of the female patients were pre¬
menopausal. One patient had normal men¬
ses and was no longer anemic by the third
week of follow up. The other patient did not
return to normal menses until 3 months
following ICU discharge; her hemoglobin
returned to normal range by 6 months. No
patients received blood transfusions during
the study follow up period and none were
prescribed iron, folate or vitamin B12 sup¬
plements. No patients had known malig¬
nancies. No patients received erythropoie¬
tin therapy during the study.
Time Course of Anemia after
ICU Discharge
Hemoglobin concentrations over the
study period and the proportions of pa¬
tients remaining anemic at each time
point are shown in Figure 2. Among the
patients remaining in the study 63% (12
of 19) were anemic at 13 wks and 53% (10
of 19) were anemic at 26 wks compared to
gender specific reference ranges. 32% (6
of 19) and 16% (3 of 19) of patients had a
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Figure 1. Flow chart of study recruitment. NIV, noninvasive ventilation; Hb, hemoglobin; Rx,
prescription; ICU, intensive care unit.
hemoglobin concentration <110 g/L at
13 and 26 wks respectively. Among the
patients whose anemia recovered during
the study period the median time to en¬
tering the gender specific reference range
was 11 wks (1st and 3rd quartiles 9 and
26; range 1 to 26 wks). Using rates of
increase in hemoglobin between visits,
from weeks 1 to 3 only 30% (n = 7)
patients demonstrated a hemoglobin in¬
crease of >10 g/L per week and 60% (n =
13) an increase s5 g/L per week. Among
those patients still anemic at 6 wks post-
ICU discharge, none demonstrated an in¬
crease ^5 g/L per week over the remain¬
der of the study period.
Etiology of Anemia
Baseline hemoglobin levels (median (1st,
3rd quartile)) for patients at recruitment
(week 0) were 88.5 g/L (84.0, 95.0). Subse¬
quent values and additional hematologic pa¬
rameters are summarized in table 2.
Absolute Iron Deficiency. Ferritin
concentrations were >12 p.g/L in all pa¬
tients throughout the study. Some ane¬
mic patients with detectable circulating
inflammatory markers had ferritin values
12-100 pig/L, particularly at later time
points, but this was unusual. The data
suggested that absolute iron deficiency
was rare, but may have been present in a
small number of patients during the later
stages of recovery.
Functional Iron Deficiency. The CHR
was >28 pg throughout the study in
virtually all cases. Some patients had
>5% hypochromic red cells early in the
study, but this was not seen later in the
study. Among patients with >5% hypo¬
chromic red cells the mean cell hemo¬
globin concentration (MCHC) was nor¬
mal. These data suggested that the
detection of functional iron deficiency was
test-specific. If present, based on percent
hypochromic red cells, it was only present
in the early post-ICU period.
Evidence of Vitamin B12 or Folate De¬
ficiency. Only one patient had a vitamin
Bj2 level marginally below the reference
range (value 165 ng/L) at week 26. One
patient had a folate level marginally be¬
low the reference range (value 1.8 jjeg/L)
at week 13, which recovered without
treatment by week 26. For all other cases
and time points there was no biochemical
evidence of vitamin BJ2 or folate defi¬
ciency. The data showed that vitamin B12
and folate deficiency rarely contribute to
anemia after intensive care.
Persistent Inflammation. IL-6 and
CRP were elevated in most patients at
ICU discharge and persisted in many
patients at the early evaluation time
points (Table 2). There was a highly
variable pattern during long-term fol¬
low up, but some patients continued to
have elevated circulating concentra¬
tions of inflammatory markers at 3 and
6 months after ICU discharge.
Inappropriate Erythropoietin Re¬
sponse. We found that inappropriately
low erythropoietin concentrations were
highly prevalent throughout the study,
and were present in all patients who re¬
mained anemic during the later stages
(Table 2). These data showed that the
healthy erythropoietin response to ane¬
mia was either blunted or absent.
Evidence ofNew Erythropoiesis. A mi¬
nority of patients (approximately 20%)
had elevated sTfR during the study pe¬
riod, but these levels were only mod¬
estly increased compared to controls
and did not appear to relate to the de¬
gree of anemia (Table 2). There was a
range in patterns of reticulocyte re¬
sponse. Patients who remained anemic
at later time points tended to demon¬
strate a lack of reticulocyte response to
anemia. Together, the data showed a
hypo-active bone marrow given the de¬
gree of anemia.
Comparison of Responders and
Nonresponders at Week 3 After
ICU Discharge
There were no major differences in
age, ICU length of stay, admission
APACHE II score, and worst nonneuro-
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Table 1. Demographics and characteristics of patients recruited to the study
Number. Median
Demographic (1st and 3rd Quartiles; Range)
Gender(6/9) 20/10
Age (yrs) 66.5 (55, 77; 35-83)
APACHE II at admission 21 (16, 24; 7-38)
Worst SOFA score during ICU stay 9.5 (7.2, 14.0; 5-18)
ICU length of stay (days) 12 (9,23; 2-46)
Hemoglobin at ICU admission (g/L) 96 (80,104; 65-164)
eGFR at study entry (mL/min/1.73 m2) 84.9 (53,102; 13-154)
Primary Diagnosis Number
Respiratory




Post cardiac arrest 1
GI
Perforated viscous 4




Ruptured abdominal aortic aneurysm 2
Unexpected complication of surgery
Excess bleeding (thyroidectomy) 1
Protracted surgery (elective abdominal 1
aortic aneurysm repair)





No organism identified 1
Deaths
Characteristics, Time in Study Cause of Death
Male 85 yrs, 1 wk Cardiac failure
Male 83 yrs, lwk Respiratory failure
Female 49 yrs, 3 wks Decompenesated liver failure
Male 81 yrs, 9 wks Respiratory failure
Female 62 yrs, 9 wks Infective exacerbation COPD
Female 79 yrs, 9 wks Pulmonary embolism
APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assess¬


















Figure 2. Distribution of hemoglobin concentrations for all patients (dark gray) and male and female
subset (mid and light gray, respectively). Box and whisker plots illustrating median, inter-quartile
range and range. The boxes including numbers at each time point represent the number of patients
remaining anemic (numerator) and the number of samples obtained at each point (denominator).
logic SOFA score between responders and
nonresponders at 3 months post-ICU dis¬
charge (Table 3). Nonresponders received
more red blood cell units in ICU. There
were no clinically or statistically impor¬
tant differences in measures of absolute
or relative iron deficiency, vitamin B,2
status, red cell folate, or serum folate
between responders and nonresponders
either at 3 wks after ICU discharge or at
any time point over the study period (Ta¬
ble 3). Patients whose anemia did not
recover by week 13 had significantly
higher CRP concentrations and a trend to
higher IL-6 concentrations at week 3 af¬
ter ICU discharge. These patients had
lower reticulocyte counts consistent with
persisting marrow hypo-responsiveness
in the post-ICU period. Ferritin concen¬
trations were significantly higher in the
nonresponder group. There was no differ¬
ence in circulating erythropoietin con¬
centrations between the groups; both
groups had inappropriately low erythro¬
poietin concentrations 3 wks after ICU
discharge. Examining trends over time,
the nonresponder group tended to have
higher CRP and lower reticulocyte counts




Quality of Life (HRQoL)
SF-36 questionnaire data are shown
for the patients in table 4. Data from a
nonselected cohort of ICU survivors from
a Scottish ICU with similar case-mix are
also included (20), together with age/
gender matched UK normal population
(21)data. Although numbers in the study
cohort were small, patients who were dis¬
charged anemic from ICU had a markedly
reduced mean SF-36 score at both 3 and
6 months compared to the normal popu¬
lation. Compared to the nonselected ICU
cohort data, mean scores were also re¬
duced across all domains, but particularly
in the physical function and role physical
categories. Formal statistical compari¬
sons were not made.
DISCUSSION
To our knowledge this is the first
study examining the time course and
pathophysiology of anemia during long
term follow up after intensive care. Ane¬
mia recovered at rates expected for
healthy individuals in only 30% of
cases. In the majority of patients recov-
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Table 2. All measured parameters during the study
Parameter/NR Week 1 Week 3 Week 6 Week 9 Week 13 Week 26
Hemoglobin (g/L) 92(87,100) 106(96,115) 109(101,122) 112(105,123) 119(107,132) 122(111,135)
Ferritin (jxg/L) (NR <12 or <100 367(146,769) — — — 130(44,386) 76(24,179)
if CRP >5)
CHR pg (NR 28-35) 32.1 (30.4, 33.9) 32.0 (30.5,33.5) — 30.8 (29.2, 32.6) 30.4 (28.9, 31.8) 31.9 (26.3, 32.9)
%HYPO(NR<5%) 4.05(2.05,6.95) 2.90(0.75,6.10) — 2.05(0.70,5.10) 1.40(0.70,3.20) 0.70(0.15,1.50)
STfR nmol/L (NR <51) 38.4(19.7,45.7) 30.3(22.8,50.9) 37.1 (24.0,47.8) 38.2(27.9,46.6) 36.5(22.3,48.5) 42.4(22.7,49.1)
EPO mlU/mL (NR >40 if Hb <100) 18.1(8.8,25.9) 14.0(9.7,21.6) — 17.9(11.4,23.7) 11.3(8.6,20.2) 12.8(9.9,21.9)
IL6 (pg/mL) (NR <10) 49.1(30.9,99.1) 29.3(12.7,58.8) 14.8(9.4,36.9) 18.2(8.9,39.5) 12.3(7.8,27.1) 10.9(8.6,17.5)
CRP (mg/dL) (NR <5) 51.0(21.0,108.0) 16.5(5.0,60.0) 10.0(5.0,23.5) 15.0(5.0,61.5) 9.0(5.0,21.0) 5.0(5.0,11.5)
Vit B12 (ng/L) (NR 170-730) 610(429,1279) — — — 353(296,494) 326(265,410)
Serum folate (pg/L) (NR 2.0-13.5) 5.70 (3.70,7.45) — — — 7.85 (3.70,8.85) 6.50 (3.80,9.80)
Red cell folate (pg/L) (NR 95-570) 254(198,391) — — — 283(147,322) 237(164,398)
Reticulocytes X10~9 (NR <55) 99.9(72.8,140.7) 72.6(54.9,91.0) — 63.4(45.8,91.3) 62.4(46.7,92.5) 67.0(51.9,96.9)
NR, normal range; CHR, concentration hemoglobin in reticulocytes; %HYPO, percentage hypochromic red cells; STfR, soluble transferrin receptor;
EPO, erythropoietin; IL-6, interleukin-6; CRP, C-reactive protein.
The values are given as median (first, third quartile).
Table 3. Week 3 parameters of inflammation, erythropoietin, and marrow response for "responder"
(anemia recovered by week 13) vs. "non-responder" (failure to recover by week 13) groups
Responder Group Nonresponder Group
Parameter (N = 7) (N = 12) p
Baseline characteristics
Age (yrs) 57.2 (54.0-63.0) 69.9 (64.5-75.5) 0.075
ICU stay (days) 11.0 (4.0-12.0) 14.5 (9.0-17.0) 0.150
APACHE II (admission) 23.0 (16.0-28.0) 20.5 (14.5-25.0) 0.554
SOFA max (not neuro) 8.0 (6.0-12.0) 10.5 (7.5-14.5) 0.472
ICU Transfusions (units) 2.0 (0.0-8.0) 7.0 (4.0-16.0) 0.188
Proportion of patients with abnormal 2/7 (28.5%) 5/12 (41.6%) 0.654
eGFR (<60 mL/min/1.73 m2)
Parameters
Hemoglobin (g/L) 115 (110.0-120.5) 105(100.5-115.0) 0.208
Erythropoietin concentration (mlU/mL) 14 (10.2-19.25) 13.2 (10.7-14.2) 0.690
Number (proportion) with inappropriately 5/7(71%) 8/11 (72%) 1.000
low erythropoietin levels
CRP (mg/dL) 5(5-11) 60 (27.8-124.5) 0.013"
Number (proportion) with elevated CRP 2/7 (28%) 8/8 (100%) 0.007"
IL-6 (pg/mL) 11.99 (8.01-14.44) 32.48 (18.03-49.62) 0.197
Number (proportion) with elevated IL-6 1/7 (14%) 6/9 (66%) 0.060
Reticulocytes (X109) 62.1 (53.2-98.0) 43.6 (33.8-54.8) 0.014"
Number (proportion) with reticulocytes 2/7 (29%) 9/11 (81%) 0.049"
<55 x 109
Ferritin 3 months (pg/L) 90.0 (15.0-130.0) 365.5 (45.5-512.5) 0.0312'
Vitamin B12 3 months (ng/L) 348 (297-541) 359 (285-589) 0.7577
Folate 3 months (pg/L) 9.4 (6.2-17.1) 5.8 (2.6-8.1) 0.0549
ICU, intensive care unit; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA,
Sequential Organ Failure Assessment; CRP, C-reactive protein; IL, interleukin.
"Significant p values. All values median (1st, 3rd quartile) unless stated.
ery was slow or absent such that 63 and
53% of all patients were still anemic at
3 and 6 months respectively, and 32 and
16% respectively had hemoglobin val¬
ues <110 g/L.
Strengths and Weaknesses. Our co¬
hort was an unselected mixed general
ICU population with a high illness sever¬
ity and varied case-mix. Patient numbers
were relatively small as the protocol re¬
quired frequent follow-up either in hos¬
pital or at the patients' home and multi¬
ple blood analyses. As a result there was a
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possibility of type II error, so we limited
analysis to descriptive methods, with the
exception of the exploratory comparison
of patients whose anemia recovered at 13
wks versus those with persisting anemia.
We achieved high rates of follow-up and
sampling, which decreased the chance of
bias. The investigations used to describe
the etiology of anemia and the definitions
of different contributory factors were pre¬
defined by an independent expert panel of
hematologists. Some important sub¬
groups were excluded, notably patients
with persisting acute renal failure or pre¬
existing chronic renal failure. These pa¬
tients have an independent reason for
erythropoietin deficiency and impaired
erythropoiesis, and also tend to have
greater ongoing blood loss from sampling
and dialysis circuits (22). Although treat¬
ment decisions were not dictated by the
study, no patients received any blood
transfusions, iron/folate, erythropoietin
or other treatments that might have con¬
founded our findings.
Meaning of Our Findings. Our data
strongly suggest that recovery was limited
primarily by a hypo-reactive bone marrow.
This may have been in part a result of
inappropriately low circulating erythropoi¬
etin levels, although this was a feature of
both responders and nonresponders early
in the study follow up. It is well docu¬
mented that circulating erythropoietin
concentrations are lower than expected in
anemic patients during ICU stay; our data
indicate that this persists into the recovery
period. The hypo-reactive bone marrow
that characterized the nonresponding pa¬
tients is typical of an anemia of chronic
inflammatory disease in which pro-inflam¬
matory mediators inhibit erythrogenesis
(23, 24). In the exploratory comparison be¬
tween patients whose anemia recovered by
3 months and those in whom it persisted
we found no obvious differences in the
characteristics of ICU stay, although these
analyses had a high risk of type II error.
Despite the small numbers of patients com¬
pared, circulating IL-6 and CRP concentra¬
tions were higher in the nonresponder
group during this early period of recovery,
which supports the conjecture that persis¬
tent anemia after critical illness is associ¬
ated with a chronic inflammatory state.
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Table 4. Individual SF-36 parameters for patients in the study group at 3 and 6 months post-ICU (N = 19 at both time points)
Physical Role Bodily General Social Role Mental
Function Physical Pain Health Vitality Function Emotion Health
UK Normal population 76.2 (22.3) 75.9 (37.5) 76.9 (24.0) 68.1 (21.9) 61.8 (21.2) 86.2 (22.7) 84.8 (30.6) 76.4 (18.4)
3 months post-ICU discharge
UK ICU nonselected cohort 59.4 (24.1) 47.4 (32.8) 63.4 (30.2) 58.0 (23.7) 48.4 (22.9) 63.7 (35.7) 79.3 (28.1) 75.5 (20.1)
Study group 40.2 (27.3) 11.9 (26.9) 49.3 (32.5) 47.8 (22.5) 38.1 (20.5) 54.2 (31.2) 50.8 (44.2) 67.2 (18.9)
6 months post-ICU discharge
UK ICU nonselected cohort 61.7(28.7) 53.1 (34.1) 66.0 (31.7) 58.7 (25.4) 51.9 (24.3) 69.2 (32.9) 81.3 (28.0) 76.8 (19.7)
Study group 44.6 (30.4) 17.6 (32.8) 60.6 (26.5) 43.3 (20.2) 42.6 (21.4) 56.6 (25.8) 49.0 (44.3) 62.8 (24.1)
ICU, intensive care unit.
For comparison, UK matched normal population values (21) and values from a nonselected Scottish ICU cohort (20) are included. All values mean
(standard deviation).
The nonresponder group also had signifi¬
cantly higher ferritin concentrations,
which is most likely an indication ofgreater
inflammation as ferritin is a positive acute
phase protein. During follow up, 65% and
60% of patients still had detectable circu¬
lating IL-6 at 3 and 6 months respectively
after ICU discharge, and 48% and 31% had
elevated CRP concentrations. This is a pos¬
sible explanation for the "inappropriate"
erythropoietin response and impaired
erythropoiesis. Inflammatory mediators are
known to inhibit erythropoietin production
and the marrow response to circulating
erythropoietin^, 26). Serum from ICU pa¬
tients, particularly those with sepsis, di¬
rectly inhibits erythroid precursors, and
can induce apoptosis of red cell precursors
(27, 28).
There was little evidence of iron, folate
or Bj2 deficiency at any point in the
study. In a small number of patients fer¬
ritin concentrations fell late in follow up
in patients whose anemia recovered, of¬
ten in association with normalization of
inflammatory markers. This could indi¬
cate either resolving inflammation or a
decrease in iron stores resulting from ac¬
tive erythrogenesis. None of these pa¬
tients developed evidence of absolute iron
deficiency during the study period using
our predefined criteria. The interpreta¬
tion of the indices of functional iron de¬
ficiency was difficult and contradictory
between methods of assessment. Overall
there was little evidence for significant
functional iron deficiency. The high per¬
cent hypochromic red cells observed in
some patients early after ICU discharge
was consistent with previously reported
findings during ICU stay (29-31). Al¬
though this could indicate impaired in¬
corporation of iron into red cells another
explanation could relate to red cell shape
changes that occur during sepsis and in¬
flammation (8, 32), which are not ac¬
counted for in the automated red cell
analysis. It is also possible that functional
iron deficiency only becomes apparent
when the marrow is stimulated with ex¬
ogenous erythropoietin.
The clinical importance of anemia
during recovery from critical illness is
unknown. It is well documented that pa¬
tients suffer fatigue and breathlessness
following critical illness even without de¬
monstrable lung pathology (8). It is pos¬
sible that anemia contributes to these
symptoms, but no studies have specifi¬
cally addressed this question. Our HRQoL
data, although exploratory, support the
hypothesis that the presence of anemia at
ICU discharge is associated with poorer
recovery at 3 and 6 months compared to
other ICU patients and is associated with
markedly reduced HRQoL compared to
the general population, especially in
physical function domains. Further ade¬
quately powered studies are needed to
explore whether the relationship between
anemia and HRQoL is causative or simply
an epiphenomenon. The relationship be¬
tween anemia and HRQoL reported in
other patient groups, such as those with
chronic kidney disease and cancer sug¬
gest this merits further study (9, 10).
CONCLUSIONS
We have shown that anemia persists
for at least 6 months following intensive
care discharge in many patients with no
history of preillness anemia. The erythro¬
poietin response to anemia is blunted
during this period and bone marrow is
hyporeactive in many patients, especially
those with persistent systemic inflamma¬
tion.
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